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Toxoplasma gondii is an obligate intracellular protozoan parasite with a haploid genome. 
Toxoplasma has the capacity to infect any warm-blooded animal and infects between 30-80% of 
humans and 47% of wildlife surveyed globally. Although this parasite possesses an exceedingly 
flexible replication strategy, with both a prevalent asexual replication cycle in any intermediate 
host, and a fecund sexual cycle capable of producing in excess of 100 million infectious oocysts 
exclusively in its definitive felid host; the extent to which each replication method is utilized to 
transmit this generalist parasite in nature has long been under debate. Sexual recombination in 
Toxoplasma is an advantageous trait that allows the parasite to admix population genetic 
diversity to generate new biological potential, such as the ability to invade new hosts, evade host 
immunity, or cause outbreaks. However, despite its fecund sexual cycle, Toxoplasma has a 
genetically limited population structure that is dominated by just a few clonal lines that circulate 
predominantly in North America and Europe. Two theories exist to explain this clonal population 
structure, the first suggests that the clonal lines are highly adapted for oral transmission among 
intermediate hosts and are expanding exclusively asexually within this population of hosts, the 
second states that the clonal lines are particularly fit clones that are being expanded in cats by 
uniparental self-mating due to Toxoplasma’s lack of mating types and its ability to undergo 
unisexual expansion via single clone infection in the definitive host. In support of the latter 
theory, fungal pathogens have been shown previously to cryptically expand certain clones when 
sexual recombination occurs between closely related strains. The recombinant progeny produced 
are typically indistinguishable from each other due to the use of limited, low-resolution markers 
that fail to capture the genetic differences between the two mating clones.  
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During the tenure of this thesis, studies have been published that chart Toxoplasma global 
population genetic diversity, but no study has examined intra-typic (i.e., within a clonal lineage) 
population genetics at whole genome resolution. Work shown here interrogates the most 
prevalent clonal lineage characterized worldwide, Type II, and the most prevalent clonal lineage 
in North America, Type X. Work here aims to determine at whole genome resolution the intra-
typic genetic relationship within two previously reported clonal lineages: Type II and Type X 
(also referred to as HG12), and whether strains within these two clonal groups isolated across 
different geographies and animal host species, are evolving via sexual recombination or genetic 
drift. Strains studied in this thesis were examined by limited sequencing at established 
Toxoplasma genotyping markers, as well as by whole genome sequencing, which has only 
recently come into use to interrogate genetic diversity and determine the extent to which 
recombination is occurring within the genome of this parasite. Type II strains were identified to 
have undergone limited mitotic drift within the lineage, and the polymorphism detected was 
generally correlated with the region of the strains’ geographic isolation. However, distinct 
haploblocks of Type II sequences bearing the hallmarks of different geographic regions were 
identified in a subset of Type II isolates, and these admixtures suggested that intra-typic 
recombination (unisexual mating) was occurring between Type II strains of distinct geographies. 
Proof of unisexual mating between two highly homologous, but independent clones, was 
identified phylogenetically by an incongruence between nuclear and maternally inherited 
organellar genomes among these Type II strains. Importantly, genotyping using just ten low 
resolution PCR-RFLP markers generally predicted that the strain belonged to the Type II lineage, 
because relatively few admixtures between Type II and other genetic backgrounds were 
identified after increasing the resolution to WGS. Although at first glance this appears to support 
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a model whereby Type II strains bypass their sexual cycle, and are expanding largely asexually, 
closer examination of the haploblocks of geographically shared polymorphism identified a 
number of Type II strains that possessed different admixtures of these Type II, geographically 
derived haploblocks. This observation was parsimonious with recombination among clade-
specific genotypes and supports expansion by unisexual mating.  
The other clonotype supported by low-resolution PCR-RFLP analyses, and interrogated 
here, Type X, is the most prevalent genotype infecting wildlife in North America. This thesis 
performed an unprecedented, longitudinal study of isolates collected over a 7-year period from a 
single host species, Southern sea otters, in a localized geographic region. In contrast to the Type 
II lineage, outcrossing was especially pronounced among the Type X strains examined. In fact, 
Type X was determined to be a clade of sexually-related progeny from at least one sexual cross 
between a Type II ancestral strain and a previously unknown strain of mosaic ancestry, referred 
to as g/d. When infected in mice, Type X strains displayed a range of virulence phenotypes from 
highly virulent to avirulent, like a Type II strain. Because these natural isolates resembled 
recombinant progeny, the Type X strains were utilized as if they were true F1 progeny from a 
sexual cross and a QTL was performed to identify genes conferring mouse virulence. The 
analysis identified a novel virulence gene, ROP33. Evidence from whole genome sequencing 
demonstrated that while Type X strains resembled closely related progeny, mitotic drift had 
occurred within these strains prior to their infection in sea otters. However, the observed mitotic 
drift, in combination with the clear and limited number of crossover break points in Type X, 
supports a model in which only a limited number of crosses between Type II and a strain of 
distinct ancestry occurred to generate the Type X strains, but that the Type II strain that crossed 
with the g/d parent was divergent. Two mouse virulent Type X strains were engineered to be 
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drug resistant and crossed with a cat-competent Type II ME49 strain to perform a forward 
genetic screen to identify the murine virulence loci. Rather than selecting progeny that were 
double-drug resistant, progeny from these crosses were individually isolated prior to drug 
selection and then tested to establish whether they were recombinant. Progeny isolated in this 
unbiased manner allowed for a more accurate determination of the degree to which clones 
derived from meiosis undergo outcrossing versus self-mating. In four independent genetic 
crosses, the relative recombination rate was low (approximately 1-3%), rather than the expected 
25% rate indicating that in all instances, self-mating was favored. Taken together, the evidence 
from the Type II and Type X population genetic analyses, as well as from several independent 
sexual crosses between these two clonal lineages, established that sexual outcrossing is more 
prevalent than previously envisaged, but that the majority of clones derived from sexual 
replication closely resemble a single parental type that was amplified by self-mating. And in 
geographies with predominantly clonal population genetic structures, it is clear that unisexual 
mating between closely-related strains will be underestimated and not considered as a major 
contributor to maintaining the clonal population genetic structure. As a consequence, whole 
genome typing is required to resolve differences between strains within a clonal group, which are 
preferentially admixing with each other. 
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Chapter 1 - Introduction 
 
General Overview 
An integral paradigm in the evolution of protozoan parasites is the role sexual replication 
plays in their expansion and adaptation to the environment. Until recently, the extent to which, or 
even the existence of a sexual cycle and whether genetic hybridization plays a significant role in 
the life cycle and transmission of protozoan parasites has been under debate (Tibayrenc and 
Ayala 2014, 2002; Ramirez and Llewellyn 2014) The population genetic structure of many 
protozoan parasites has been described as clonal, signifying that the limited number of genetic 
markers used to study their population genetics were in linkage disequilibrium. This assumed 
clonality has led to the assumption that in protozoa sexual recombination is either extremely rare 
or impossible, despite that fact that many genes known to facilitate sexual recombination are 
expressed in these parasites (Cornelissen and Overdulve 1985; Sibley 2009; Pfefferkorn 1981; 
Pfefferkorn, Pfefferkorn, and Colby 1977). One possible explanation proposed to reconcile 
protozoan sexual cycles with a clonal population structure, is that inbreeding between more 
closely related strains within the population has masked the extent to which genetic hybridization 
is occurring (Heitman 2010). Hence, sexual recombination is missed either because the 
characterizing genetic marker density is too low or because extensive inbreeding has purified the 
genomes of the admixture blocks derived from different ancestries. With the advent of whole 
genome sequencing, it is now clear that genetic hybridization among highly inbred lines can 
increase structural variation, in the form of chromosomal copy number somy, gene dosage, and 
localized CNV (copy number variation) above what would be predicted if the parasite line 
expanded solely asexually. These genetic admixture fingerprints can be used to identify the 
 2 
extent to which strains within a clonal population are propagated asexually or by sexual 
inbreeding. Mitotic drift occurring over time also allows previously designated clonal strains to 
be differentiated by genome sequencing based on low frequency polymorphisms that could be 
missed using only low-resolution markers. These mitotically derived single nucleotide 
polymorphisms (SNPs) can be utilized to classify genomic recombination within clades. 
Determining the contribution of asexual versus sexual propagation is important because sexual 
recombination of genomes allows parasites to adapt to ever-changing environments and to 
expand their host range. Although genetic hybridization is both costly to maintain as well as 
disadvantageous to well-adapted pairs of parasites and hosts, it is nevertheless an advantageous 
trait to populations, and is ubiquitous across many domains of life.  
While bacteria and viruses do not undergo explicit meiotic recombination within their 
genomes, reassortment of viral genomic segments or horizontal gene transfer within bacteria 
effectively shuffle the genomes to create new combinations of virulence and survival related 
genes, which serve a similar purpose to that of meiotic recombination seen among protozoan 
parasites (Schneider et al. 2011; Bellanger et al. 2014; Vijaykrishna et al. 2011). In fungi, sexual 
recombination between clones, even within uniparental mating, can recombine genomes, which 
can lead to antigenic variation as well as improved adaptation when fungi transition into the 
rapidly adaptable, but slow growing, diploid state from the faster growing haploid state (Heitman 
2010; Feretzaki and Heitman 2013). Although sexual cycles for many parasitic protozoa have 
only recently been discovered, and it is not clear how frequently protozoan sex is occurring in 
nature, the ability of recombination to impact both the fitness and biological potential of these 
parasites has been demonstrated. Genetic hybridization in both experimental crosses and natural 
isolates of Leishmania parasites has demonstrated the potential for genetic admixture to generate 
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progeny that acquire genetic traits from both parents (Rogers et al. 2014; Romano et al. 2014). 
Genetic shuffling of metabolic pathways has also allowed Plasmodium to overcome selection by 
drug-treatment regimens in endemic regions (Miotto et al. 2013; Claessens et al. 2014). 
Toxoplasma gondii is a highly prevalent and successful protozoan parasite that is considered a 
generalist pathogen due to its ability to infect, and be propagated by, all warm-blooded 
vertebrates on the planet. Part of its success is attributed to its capacity to expand either asexually 
among its intermediate hosts, or to utilize a highly fecund, sexual cycle in its definitive felid 
host. As such, it is an ideal model organism to investigate the contributing role which sexual 
recombination plays in the expansion and acquisition of biological traits that impact the fitness of 
this parasitic pathogen. 
Sexual recombination has previously been identified as an advantageous trait within 
Toxoplasma, allowing the parasite to produce progeny capable of escaping host immune defense 
mechanisms that both parents are unable to withstand. For this haploid parasite, the most 
parsimonious explanation is that the progeny derived from avirulent parents have recombined 
alleles from both parental genomes into novel combinations that facilitate resistance to host 
immunity, allowing certain progeny to exhibit gain of virulence, or biological fitness phenotypes 
(Grigg, Bonnefoy, et al. 2001). Indeed, subsequent forward genetic experiments mapped the 
principally responsible genes for this gain of virulence to particular allelic combinations of two 
parasite protein kinases referred to as ROP5 and ROP18 (Saeij et al. 2006; Taylor et al. 2006; 
Behnke et al. 2012). In these studies, from the analysis of marker typed genomes of recombinant 
progeny from sexual crosses between Type III and either a Type I or II strains, ROP5 and 
ROP18 were predicted to cause the differential virulence between the parental strains and when 
deleted from the virulent Type I parent abrogated virulence. Later studies found that this 
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virulence was dictated by the allelic combination of ROP5 and ROP18 inherent in the genome, 
as only the correct combination (found in Type I strains) allowed ROP5 and ROP18 to bind and 
phosphorylate host immune-related GTPases (IRGs) to hide the parasitophorous vacuole of 
Toxoplasma from host cellular immunity (Behnke et al. 2011; Fleckenstein et al. 2012).  
Furthermore, it has been theorized that the expansion and evolution of the mouse IRGs, one of 
the innate cellular immunity protein classes that defend against in vivo parasite growth, is 
directly correlated to the adaptation of Toxoplasma parasites to the murine host (Lilue et al. 
2013). Additionally, it has been hypothesized that the differential combinations of toll-like 
receptors 11/12 (TLR11/12), the primary innate receptors for murine detection of Toxoplasma, 
found across different host species are linked to the expansion of this parasite into new host 
ranges (Gazzinelli et al. 2014).  
However, despite the advantages of genetic recombination, and the existence of genetic 
mosaics within the Toxoplasma population genetic structure (Lorenzi et al. 2016), Toxoplasma is 
generally considered to possess a predominantly clonal population genetic structure (Khan, 
Dubey, et al. 2011; Howe and Sibley 1995). A limited number of apparently clonal strains 
dominate the population of Toxoplasma globally (Lorenzi et al. 2016; Shwab et al. 2014). This is 
especially true for the populations circulating in North America and Europe (Khan et al. 2006; 
Khan, Dubey, et al. 2011; Fux et al. 2007; Khan, Taylor, et al. 2009; Minot et al. 2012). It is 
highly unusual for a sexually active organism to display such limited genetic diversity of strains 
as sexual recombination should broadly increase the strain population diversity. One explanation 
for limited diversity is the retention of certain chromosomes among Toxoplasma clones that 
facilitate an increased ability to expand asexually via oral infection between susceptible 
intermediate hosts (Khan et al. 2006; Khan, Miller, et al. 2011). Alternatively, evidence from 
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waterborne outbreaks has established that uniparental mating occurs in nature (Wendte, Miller, 
Lambourn, et al. 2010), thus a particularly successful clone could have expanded sexually by 
self-mating and produced the current clonal population structure. Differentiating between these 
two scenarios is a primary objective of this thesis project. 
To explain the widespread abundance of identical genotypes within many species of 
parasitic protozoa, Tibayrenc and Ayala proposed the clonal theory to explain the simple 
population genetic structures identified for many protozoan parasites. Simply, the clonal theory 
argues that recombination within the parasitic protozoa is infrequent, and that the vast majority 
of isolates within a population are expanding asexually. The molecular determinants that are 
responsible for generating the clonal population are outside of the speculation of the clonal 
theory; rather it is an observed phenomenon of population propagation. Theories to explain the 
clonal theory include the use of too few, poorly resolved genetic markers to resolve closely 
related strains, drug selection sweeps, founder effect on the population due to a limited number 
of strains initially genetically founding a sampled area, the natural selection of parasites by 
susceptible versus resistant hosts, or environmental selection whereby oocyst viability within the 
environment determines the infection of parasites into new hosts. The clonal theory argues that 
population clonality is principally propagated by asexual replication and expansion within the 
population. It argues that sexual replication, if it exists, is not sufficient to break the preponderant 
clonality observed, and it fails to include uniparental mating as a possible mechanism to explain 
clonality among haploid parasites. The premise of the clonal theory applied to Toxoplasma 
isolates is that the population is expanding predominantly asexually despite the fact that 
Toxoplasma possesses a highly fecund sexual propagative ability.  
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The clonal population theory is well supported, especially in North America and Europe 
where most isolates from humans, livestock, and wild animals appear to be from only four clonal 
lineages, designated Type I, II, III and X (Khan, Dubey, et al. 2011; Shwab et al. 2014; Dubey et 
al. 2011). However, there are notable exceptions to the clonal theory. Differences between Type 
II strains collected from more distant locations, such as Australia and Israel, demonstrate that 
genetic differences can be resolved between strains within the Type II clonal lineage (Verma et 
al. 2015; Pan et al. 2012; Parameswaran et al. 2010). Whether this is consistent with the clonal 
theory cannot be readily determined with the currently available genetic markers and will thus 
require whole genome sequencing to resolve. Likewise, phenotypic differences between Type I 
strains have been observed across different laboratories and over time, indicating that the Type I 
lineage, as with Type II, is either not clonal or has acquired independent mutations from genetic 
drift during asexual replication, that are sufficient to yield distinct phenotypes (Khan, Behnke, et 
al. 2009). 
These apparent exceptions to the clonal theory necessitate a re-examination of the 
Toxoplasma intra-typic (or within lineage type) population genetic structure to ascertain whether 
genetic recombination has occurred. Because Toxoplasma contains a highly fecund sexual cycle 
but can also be maintained indefinitely among its intermediate hosts by asexual expansion, it is a 
choice model system to test the applicability of the clonal theory on protozoan pathogens, as well 
as to test the extent and contribution of sexual recombination to the population structure and 
dynamics of this globally-expanded eukaryotic parasite. It is the goal of this dissertation to apply 
whole genome sequencing and designer scripts to distinguish genetic recombination from genetic 
drift, and to determine the degree to which sexual recombination has impacted the dominant 
North American clonal lineages: Type II and Type X. While many studies have focused on the 
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diversity of this parasite worldwide, none have explored a single clonal lineage in any depth. 
Hence, the work herein will examine the sufficiency of the clonal theory in Toxoplasma and the 
extent to which sexual recombination is shaping the population genetic structure of this 
ubiquitous protozoan parasite.  
Toxoplasma Lifecycle  
Toxoplasma gondii is a eukaryotic unicellular parasitic protist within the phylum 
Apicomplexa, subclass Coccidian of which other known parasites include Plasmodium, 
responsible for malaria, and Cryptosporidium, a well-known livestock parasite. All parasites 
within the Apicomplexa phylum are defined by their apical complex, a cytoskeletal structure 
found at the anterior end of the parasite that is comprised of a microtubular network organized 
into apical rings that tether the inner membrane complex and a series of unique organelles. These 
organelles, known as rhoptries, dense granules, and micronemes, facilitate host cell penetration 
and the establishment of their intracellular host environment. Toxoplasma is an obligate 
intracellular parasite, capable of infecting any warm-blood animal, and is capable of establishing 
infection in any nucleated cell. As a generalist parasite, Toxoplasma has a number of unique 
mechanisms to invade the host cell and manipulate the intracellular conditions toward a 
favorable environment for the parasite.  
Most Toxoplasma infections come from ingestion of either tissue-encysted bradyzoites 
(the transmissible state of the asexual cycle) or environmentally stable oocysts (the 
transmissible state of the sexual cycle). Both infectious forms rapidly differentiate within the 
host small intestine into the disseminating stage, known as a tachyzoite, which spreads 









Toxoplasma is an obligate intracellular pathogen; thus, the parasite must invade a 
nucleated host cell in order to replicate. While Toxoplasma is capable of attaching to and 
invading any warm-blooded cell that it contacts, not all potential host cells are infected, even 
after Toxoplasma parasites have bound to their surface. “Kiss and spit” is the term coined by 
Boothroyd and Dubremetz to describe the interactions between the Toxoplasma apical complex 
organelles and a potential host cell prior to invasion (Boothroyd and Dubremetz 2008). During 
initial contact with the potential host cell, the apical complex secretes specialized protein 











(Carruthers and Sibley 1997). If invasion conditions are not determined satisfactory to the 
parasite, a process that is still undefined, invasion does not commence following the “kiss and 
spit” injection. These uninfected cells, can be identified via intracellular staining of several 
secreted Toxoplasma proteins. For example, early invasion proteins such as GRA15 are often 
identified in cells that parasites attach to, but do not enter. These unsuitable host cells are 
referred to as injected, but uninfected. However, if the Toxoplasma-secreted proteins prepare 
the host cell sufficiently, the parasite begins the host cellular invasion process. 
Once invasion of the host cell begins, the Toxoplasma parasite forms a tight junction 
with the host plasma membrane, a structure that has been dubbed the moving junction (Sharma 
and Chitnis 2013). It is at this point that the proteins from the rhoptry necks and micronemes 
are secreted, injecting the host with factors such as RON2 and AMA1, which form part of the 
moving junction that is critical for translocation of the parasite into the host cell (Tonkin et al. 
2011). Microneme release is closely followed by rhoptry release, which injects protein kinases 
(such as ROP5 and ROP18) into the cell. These rhoptry proteins are trafficked to a number of 
cellular locations and are generally associated with the formation and protection of the parasitic 
compartment Toxoplasma forms, called the parasitophorous vacuole (PV) (Carruthers and 
Sibley 1997; Sharma and Chitnis 2013). Some of these ROPs are known to attach to the 
cytoplasmic side of the parasitophorous vacuole membrane (PVM) as it is forming, but others, 
known as evacuoles, remain within their own smaller vacuoles in the host cytoplasm until later 
in parasite maturation (Hakansson, Charron, and Sibley 2001). Finally, the parasite secretes the 
dense granule organelles into the host. While not all of these proteins have a known function, 
the majority of those investigated facilitate parasite manipulation of the host cellular 
environment, such as GRA15 which is known to activate host NF-kB to allow a more 
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productive infection (Rosowski et al. 2011). Only once all three sets of secretory organelles 
have released their contents into host cells can a successful invasion event be realized, with 
Toxoplasma parasites contained within the PV.  
Once the cellular environment is prepared by the secreted proteins, Toxoplasma begins 
active invasion of the host cell. Parasites actively invade the host cell using acto-myosin motors 
within the Toxoplasma to pull the parasite’s moving junction and the connected host plasma 
membrane around the invaginating parasite in a process akin to forced endocytosis. During 
invasion, the parasite uses the moving junction to exclude host proteins from the stolen plasma 
membrane in order to ensure parasitic vacuole evasion from detection by innate intracellular 
host defenses (Mordue et al. 1999). 
Following successful invasion of host cells, Toxoplasma further modifies its host 
environment to fulfill its parasitic needs and to avoid host detection. In addition to the evasion 
of the host using host-self membrane to create the parasite specific vacuole, Toxoplasma 
additionally studs the PVM with its own defensive proteins released from the rhoptry and dense 
granule organelles during invasion to combat intracellular host defenses. These will be 
explored in depth later in this chapter. To satisfy its needs as a parasite, Toxoplasma recruits 
key host organelles into close proximity with the PVM in order to more efficiently scavenge 
host resources. Specifically, the host mitochondria and endoplasmic reticulum are recruited to 
the surface of the PVM despite Toxoplasma having functional copies of both organelles within 
its own cytosol (Boyle and Radke 2009; Seeber and Steinfelder 2016; Adomako-Ankomah, 
English, and Danielson 2016; Pernas et al. 2014; Sedwick 2014). Indeed, in vitro scavenging of 





Following the establishment of a stable infection in a permissive intermediate host cell, 
the parasite undergoes mitosis and divides asexually within the PV. During this phase of its life 
cycle, the Toxoplasma tachyzoite (named for its distinctive banana shape), replicates its 
organelles and begins to divide in a unique process called endodyogeny (Dubey and Frenkel 
1972). During endodyogeny, the tachyzoite allocates copies of its least complex organelles, 
such as the Golgi, to opposite sides of the mother cell. Within the multiple-membrane enclosed, 
complex organelles, such as the nucleus, apicoplast, and mitochondria, the genetic content is 
internally replicated; the organelle elongates, and then divides (Striepen et al. 2000; Matsuzaki 
et al. 2001; Vaishnava and Striepen 2006). These organelles then utilize the centrosomes of the 
dividing parasite to segregate evenly between the two sides of the mother cell. After the 
organelles have evenly partitioned, two identical daughter cells develop and eventually divide 
within the mother cell’s plasma membrane in a process that greatly resembles bacterial binary 
fission (Ferguson et al. 2005; Ferguson and Dubremetz 2014). As the process completes, the 
mother cell’s inner membrane complex dissolves and releases the two complete daughter cells 
into the PV. Although it unknown how the various tachyzoites within the PV coordinate this 
event, mitotic division within the PV is generally synchronized such that all daughter cells are 
released at approximately the same time. This mitotic synchronization is often utilized by 
researchers to determine how many mitotic events have occurred since the host cell was 
invaded (Ferguson and Dubremetz 2014).   
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Figure 1-2: Toxoplasma lifecycle and replication among hosts 
Toxoplasma can infect and replicate in any warm-blooded animal across the globe. It has two major replicative 
cycles, the sexual cycle which can only occur in the definitive feline host and the asexual cycle which occurs in all 
hosts infected with this generalist parasite. When a feline ingests an infected intermediate host, bradyzoites from the 
intermediate host traffic through the cat’s digestive tract until they reach the intestine. In the intestine, these 
bradyzoites invade epithelial cells and differentiate into tachyzoites which spread through the cat. Some of these 
tachyzoites traffic to the gut enterocytes where they differentiate into merozoites which then undergo gametogenesis 
to produce male and female gametes. These gametes fuse to produce the immature, unsporulated oocyst which is 
then excreted in the feces of the feline. In the environment, these immature oocysts sporulate and mature into the 
highly infectious oocyst. Ingestion of the oocyst by any intermediate host (here a mouse), either via contaminated 
water or meat, causes these oocysts to excyst their sporozoite progeny in the host digestive tract. These sporozoites 
then differentiate into tachyzoites in the intermediate host. Carnivory and congenital transmission between 
intermediate hosts allows Toxoplasma to propagate asexually between hosts. Immune resistance within the host 
causes tachyzoites to differentiate into slow-growing bradyzoites which establish a chronic Toxoplasma infection of 
the host which may be passed to other hosts via carnivory of the primarily infected host. Infection of a pregnant host 
can lead to parasite-asexual host-congenital transmission. A loss of immune control can allow recrudescence of 
chronic infections where bradyzoite cysts differentiate into tachyzoites which can cause symptoms of toxoplasmosis 



























Eventually, tachyzoite replication causes the PV to become completely filled with 
mature tachyzoites. The filled PV takes up most of the available space inside of the host cell 
and pushes all of the host organelles against the host plasma membrane. At this point, the 
parasite receives an unknown signal and initiates egress from the host cell via host cell lysis, 
allowing the nascent daughter parasites to invade new cells and expand the host infection. In 
response to a yet undetermined egress signal, tachyzoites release a protein known as TgPLP1 to 
create a series of pores in both the PVM and the host membrane to allow the release of 
tachyzoites from their initial host cell (Eidell, Burke, and Gubbels 2010; Roiko, Svezhova, and 
Carruthers 2014). Cell death resulting from host cell rupture is the cause of most clinical 
manifestations of toxoplasmosis (Dubey and Jones 2008). Released tachyzoites then invade 
resident cells in proximity to the initially infected cell. This expansion technique makes use of 
Toxoplasma’s ubiquitous invasion mechanisms to allow the parasite to spread both locally (via 
invading intestinal cells in close proximity to the initial infection site) or to disseminate 
throughout the host by invading immune cells, such as macrophages, that are summoned via the 
innate and effector arms of the immune system to control Toxoplasma infection. This process 
facilitates dissemination of the Toxoplasma infection to more distant parts of the infected host, 





To survive and establish long-term, chronic infections within a host, the tachyzoite can 
undergo a developmental switch from its fast growing, actively replicating form, to the slow 
growing bradyzoite form, which has the capacity to encyst inside a host cell. Proliferating 
tachyzoites in an immune-competent host are eventually detected by the innate and effector 
arms of the immune system. Innate immune cells activated by IFN-g generate an immune 
response against tachyzoites that can kill off most of the parasites circulating during acute 
infection (Suzuki et al. 1988). In certain cell types, such as striated muscle and the central 
nervous system, Toxoplasma escapes this immune activation by differentiating into its 
chronically infectious bradyzoite form, which derives its name from the Greek word “brady” 
that means slow. The exact trigger for differentiation is unknown, although it is likely a 
combination of host immune stress in response to tachyzoite growth and intracellular signaling 
within the PV (Skariah, McIntyre, and Mordue 2010; Soete et al. 1993; Bohne, Heesemann, 
and Gross 1994). Once differentiated, bradyzoites replicate within the PV at a much lower rate 
than their tachyzoite predecessors in order to remain largely undetected by the host immune 
system (Watts et al. 2015). In the majority of infected hosts, Toxoplasma persists because the 
immune response induced by tachyzoites, which successfully limits tachyzoite proliferation, is 
unable to clear bradyzoite tissue cysts. However, these bradyzoite cysts require a steady state of 
host immune control to remain quiescent. Latency of the infectious bradyzoite cysts not only 
allows Toxoplasma to be transmitted to any carnivorous intermediate host to complete its 
asexual cycle, it also complicates the survival of chronically infected hosts, since any 
perturbation that causes immune suppression can lead to recrudescence of Toxoplasma 
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infection, as is seen in pregnant women, organ transplant, and AIDS patients (Brabin 1985; Ayi 
et al. 2016; Derouin, Pelloux, and Parasitology 2008; Dubey and Jones 2008; Gross et al. 
1997).  
 
Parasite Sexual Cycle 
 
When an intermediate host with bradyzoite tissue cysts is consumed by the definitive 
feline host, Toxoplasma will enter its sexual cycle. Bradyzoite cysts, which are resistant to 
stomach acid, pass through the feline stomach and traffic to the small intestine where they 
infect the feline intestinal epithelium. Although asexual replication within the guts of a variety 
of intermediate hosts is well characterized, the developmental switch that commits the parasite 
to differentiate into a merozoite, instead of a tachyzoite, and enter its sexual cycle within the 
feline lumen is poorly characterized, beyond a basic ultrastructural description (Ferguson, 
Hutchison, and Siim 1975). As such, characterization of the distinct life cycle signals and 
stages present in the sexual cycle is largely a black box in the Toxoplasma field. Within cat 
epithelial enterocytes, the vast majority of bradyzoites differentiate into merozoites rather than 
the default tachyzoite produced in all intermediate hosts (Hehl et al. 2015). Merozoites then 
undergo asexual expansion, much like their tachyzoite counterparts, for a non-specific number 
of mitotic replications. At some point, typically 3-5 days post infection, merozoites 
differentiate into the sexual stages of Toxoplasma. Each haploid merozoite differentiates into 
either haploid microgametes (male gametes) or a single haploid macrogamete (female gamete) 
within its host cell (Ferguson 2002). The microgametes resemble eukaryotic spermatozoa but 
are bi-flagellated, whereas macrogametes closely resemble eukaryotic oocytes and similarly 
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bear maternally inherited organelles within them, such as the mitochondria and the apicoplast 
organelle that is present in a majority of Apicomplexan parasites (Ferguson 2002). 
Macrogametes are also known to produce a thick outer wall that later becomes the oocyst outer 
wall and which makes microscopic interrogation of the sexual stages particularly difficult 
(Ferguson and Dubremetz 2014). 
It has been determined empirically that gametes are produced in a roughly one to one 
ratio, but there is no current evidence about gamete sexual determination, gamete attraction to 
one another, where fertilization occurs, or why the sex ratio differs drastically from that of 
other apicomplexan parasites. It has been suggested previously that the ratio of micro-to-
macrogametes produced would support a model whereby Toxoplasma sexual recombination is 
biased toward self-mating (Ferguson, Hutchison, and Siim 1975; Ferguson et al. 1974; Read et 
al. 1995). Whether fertilization occurs intracellularly, or extracellularly is a matter of debate. 
Regardless, gametes are found within the lumen of the feline gut where it is postulated that 
microgametes receive a chemical signal to locate the unfertilized macrogamete. The gametes 
then fuse to create the diploid oocyst that can be formed from gametes from a single strain 
infection to create a clonal oocyst, or if multiple strains of Toxoplasma have infected the feline, 
then mixed-strain recombinant oocysts may be formed. While there is some evidence that not 
all strains of Toxoplasma can self-mate during sexual expansion, there are not enough sexual 
crosses to definitively pin-point the cause of this (Fux et al. 2007). The oocysts are then 
excreted from the cat in its feces (Ferguson 2002).  
Once excreted into the environment, sporulation of the oocyst occurs. The diploid 
oocyst (2N) undergoes mitosis twice without fission to produce a single zygote with four 
identical 2N genomes (8N total). This DNA replication is followed by meiosis I where sexual 
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recombination of the genomes occurs to produce two separate sporocysts, each with two 2N 
recombined genomes (4N total per sporocyst), encapsulated inside of the oocyst outer wall. The 
8N oocyst containing two 4N sporocysts then undergoes division in meiosis II to create four 
independent 1N sporozoites inside of each sporocyst, to create a total of eight 1N sporozoites 
inside two sporocysts inside of the single oocyst. In total, eight haploid sporozoites, all 
independently recombined and assorted from one another, are sporulated and matured inside a 
single oocyst after excretion from the definitive feline host. Once the oocysts are sporulated 
they are capable of infecting any warm-blooded vertebrate. Oocysts are incredibly 
environmentally stable to both physical and chemical assault and have been shown to be viable 
in various conditions for years without losing infectivity (Yan et al. 2016; Lindsay and Dubey 
2009; Jones and Dubey 2010; Lindsay, Blagburn, and Dubey 2002; Dubey 1998). The oocysts 
are transmitted either through contaminated water or food and pass through the host gut until 
stomach acid and lowered carbon dioxide levels begin the process of excystation and the 
sporozoites are released into the host small intestine (Freyre and Falcon 2004; Tilley et al. 
1997). At this point, sporozoites rapidly differentiate into tachyzoites and begin the asexual 














Figure 1-3: Oocyst sporulation after environmental excretion 
Oocyst zygotes are formed by micro and macrogamete fusion in the feline definitive host. These immature oocysts 
are then excreted into the environment where they sporulate. The diploid oocyst (2N) undergoes mitosis twice 
without fission to produce a single zygote with four identical 2N genomes. These four 2N genomes undergo meiosis 
I to form two sporocysts, each with two 2N recombined genomes. Each of these sporocysts genomes undergoes 
meiosis II to form four independent 1N sporozoites inside of each sporocyst inside of the oocyst. In total, eight 
independently recombined and assorted, haploid sporozoites are contained in a single oocyst after excretion from the 

























Parasite Life Cycle Transmission 
 
Toxoplasma can be transmitted to a new host via its asexual life cycle when tachyzoites 
are passed vertically to a developing fetus following infection of a non-immune pregnant 
female, or from immune females that fail to maintain sufficient immunity to control the 
recrudescence of latent bradyzoite cysts. The process of vertical transmission (via congenital 
infection) is one way in which a single clone can be expanded asexually to maintain the 
parasite life cycle in the absence of the definitive felid host (Hide 2016). Alternatively, because 
bradyzoite cysts are orally infectious, it is also possible to horizontally expand a single strain 
asexually across a broad intermediate host range via carnivory and scavenging (Fux et al. 
2007).  
Parasite sexual transmission occurs when tissues harboring bradyzoite cysts from 
infected intermediate hosts are consumed by the definitive felid host. The fecundity of the 
sexual cycle is profound. A single feline is capable of expanding the parasite 107-fold once 
infected. Oocysts defecated from the definitive felid host are highly infectious. If a cat is 
infected by a single Toxoplasma genotype, the parasite can undergo its full sexual cycle by self-
mating, as a single strain is capable of producing both micro and macrogametocytes and no 
obvious mating-type locus is present in the Toxoplasma genome. This form of sexual 
transmission is very difficult to distinguish from parasites that are expanding asexually, as all 
progeny from the sexual cycle of a feline infected with a single strain of Toxoplasma are 
virtually identical to the parental strain. However, if two or more genetically distinct strains 
infect a single feline, the same exponential biological expansion occurs, but now many of the 
progeny from this outcross are recombinant genetic admixtures between the two parental 
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genomes. Outcrossing has been shown previously to greatly impact the biological potential of 
the parasite because it brings alleles from both parental strains into new combinations that 
impact virulence or the capacity to inactivate host immune signaling networks, as has been 
described previously (Grigg, Bonnefoy, et al. 2001; Saeij et al. 2006; Taylor et al. 2006). 
Furthermore, because oocysts are generally highly infectious and are readily dispersed (in 
water supplies, for example), they have a greater potential to infect a wider range of hosts 
(including herbivores and carnivores) than the 1:1 asexual transmission rate from carnivorous 
consumption of bradyzoite infected prey (Dubey 2001).  
Due to its capacity to utilize both its sexual and asexual cycles, Toxoplasma has a vast 
array of replication techniques that help this parasite dominate as one of the most prevalent 
parasites in both humans and animals on the planet. Sexual self-mating has been previously 
observed for other parasitic pathogens, including fungi and kinetoplastids (Heitman 2010; Sun 
et al. 2014; Iantorno et al. 2017). Unlike other heteroxenous coccidians, Toxoplasma is distinct 
among the apicomplexan parasites in having the replicative flexibility to sexually recombine 
without the necessity to do so to propagate. Furthermore, Toxoplasma is not limited to either 
outcrossing or self-mating when it sexually recombines, which could lead to the 
underestimation of the occurrence of sexual replication within the Toxoplasma population 
structure because it is very difficult to differentiate transmission of clones from the asexual 
cycle (bradyzoite cysts) from that of oocysts derived from sexual self-mating. To understand 
which of these two cycles is responsible for the widespread dissemination of parasite clones, it 
will be necessary to develop tools that can distinguish the extent to which infection by 
bradyzoites or sporozoites occurs in nature, or to determine whether sexual self-mating 
generates sufficient structural variation -in the form of copy number variation (CNV), 
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alterations in ploidy, or other hallmarks of meiosis- that can be used to distinguish between 
these two mechanisms of transmission.  
 
Prevalence of Toxoplasma in Humans 
 
 Humans are the most widely surveyed of all intermediate hosts of Toxoplasma. 
Prevalence rates vary across different geographies, and infected people are found on every 
continent on the planet, including Antarctica (Dubey 2010). While human infection represents 
the majority of infection information obtained for a single host, especially across both 
geographical and longitudinal studies, humans are ultimately an unproductive host for 
Toxoplasma. Humans are neither generally prey for large felids, which would facilitate 
propagation of parasite clones via the sexual cycle, nor are they considered prey for other 
carnivores and scavengers to facilitate asexual transmission. Furthermore, humans do not 
readily transmit Toxoplasma vertically via congenital infections (as discussed later). This 
evidence suggests that humans are a dead-end host for parasite transmission (Li et al. 2014). 
Infection rates by Toxoplasma vary widely across the parasite’s range based on geographic and 
environmental compatibility to oocyst infection (for example, frozen climates are less likely to 
have oocyst-initiated infections), cultural proclivities that can increase contaminated food 
transmission (such as the consummation of raw meat or unsterilized water), and human 
immune susceptibilities.  
Across the human population, Toxoplasma endemic infection rates vary widely from 
4% in Korea to 92% in the Amazon regions of Brazil (Ryu et al. 1996; Figueiró-Filho et al. 
2005). These infections can stem from a variety of sources, including meat containing 
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bradyzoite cysts and unwashed vegetables contaminated with soil oocysts (Tenter, Heckeroth, 
and Weiss 2000; Boyer et al. 2011; Mead et al. 1999). However, perhaps the most prevalent 
and least recognized source of human Toxoplasma infections comes from the contamination of 
water sources with cat-derived oocysts (Boyer et al. 2011; Demar et al. 2007; Jones and Dubey 
2010; Torrey and Yolken 2013; Vaudaux et al. 2010). This contamination is greatly facilitated 
by the high environmental stability of oocysts. Oocysts have been found to be environmentally 
stable across a wide range of environmental conditions, however transmission to human hosts 
is much higher under certain conditions (Dubey 1998). In a large-scale analysis of human 
clinical data, the McLeod group determined that the infection of humans by Toxoplasma was 
significantly increased in warm, damp areas over that of drier mountainous areas (Lykins et al. 
2016). This transmission variation may partially explain why endemic Toxoplasma infections 
are much higher in warm, humid areas such as the North American south and the Amazon 
regions of Brazil over that of cooler and drier northern North America and Europe where 
conditions are less favorable to oocyst environmental stability. However, this report also points 
out that seroprevalence of Toxoplasma may be underestimated due to a combination of 
asymptomatic infections and under/miss-diagnosis of Toxoplasma infections as other common 
diseases. These problems are especially prevalent in uninsured human populations, which are 
both more likely to live and work in endemic regions, which increases exposure to the parasite, 
and who are less likely to seek treatment unless symptoms become severe (Yan et al. 2016).  
Humans may in fact be more resistant hosts to Toxoplasma than other intermediate 
hosts since they rarely succumb to the parasite without extant immune suppression. Most 
infections in humans are asymptomatic and thus go unreported and untreated. Indeed, the 
detection of Toxoplasma in immune suppressed communities is invariably higher than it is in 
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the general population, and quite possibly represents the true prevalence of Toxoplasma 
infection in humans (Ayi et al. 2016; Herrmann et al. 2014; Lykins et al. 2016). Moreover, 
even symptomatic infections can go unrecognized as the symptoms of Toxoplasma resemble 
those of more common diseases such as the common cold and influenza (Lykins et al. 2016). 
Strain differences in Toxoplasma account for some of the diversity seen in human 
parasitic infections (Rico-Torres, Vargas-Villavicencio, and Correa 2016; Xiao and Yolken 
2015). However, the differences between strain infections are difficult to parse because most 
human infection data is systematically limited by a lack of human host genetic characterization 
and diversity, and the limited ability to adequately sample in vivo parasites to characterize 
genetics. Much of our knowledge of human infections comes from one of three limited subsets: 
symptomatic immune-competent patients, symptomatic immune-compromised patients (such as 
those with AIDS or organ transplants), and pregnant women (usually asymptomatic) surveyed 
prenatally as a state-required, transmission preventative measure. Not only do these survey 
methods miss most asymptomatic infections, but most offer only rudimentary characterization 
of the strain the patients are infected with. The majority of infections in humans are 
characterized by either serological reactivity or via PCR amplification of parasite DNA from 
the host blood (Zhang et al. 2016; Wyrosdick and Schaefer 2015). Both methods come with 
severe limitations beyond the limited sample of humans surveyed. For serological testing, 
Toxoplasma parasites are strain typed based on the reactivity of antibodies in the serum to 
peptides designed to segregate only the three most common clonal types of Toxoplasma 
(Vaudaux et al. 2010; Shobab et al. 2013; Kong et al. 2003; McLeod et al. 2012). While this 
reactivity is seen in both acute and chronic infections it can be lacking in immune compromised 
infections due to immune inability to produce a response to the parasite peptides 
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(Schoondermarkvandeven et al. 1993). PCR amplification of the parasite DNA from the blood 
of human infections is problematic as this detection requires free parasites in the blood stream.  
As most Toxoplasma parasites are tissue resident rather than blood-born, these free parasites 
are often in limited supply, and only multi-copy genes can be amplified, which are genetically 
less informative than the strain specific diagnosis that is only possible using highly 
polymorphic single-copy genes (Piergili Fioretti 2004).  
It has been shown that human infections in areas of endemic Type II Toxoplasma 
regions trend mainly toward asymptomatic infections, which are mainly detected during the 
mandatory prenatal screenings of pregnant women as well as from recrudescence of 
Toxoplasma in immune compromised humans (Ayi et al. 2016; Herrmann et al. 2014). In 
comparison, human infections in areas such as Brazil, that possess a more diverse population 
genetic structure of strains, tend to display more severe symptomatic infections that range from 
protozoan encephalitis to ocular toxoplasmosis (Demar et al. 2007; Ferreira et al. 2008; Grigg, 
Ganatra, et al. 2001; Jones and Dubey 2010). Indeed, ocular Toxoplasma infection has been 
closely associated with more diverse strains which are less well-controlled by the human 
immune system and are more capable of breaching the blood-brain barrier (Fekkar et al. 2011; 
Grigg, Ganatra, et al. 2001; Shobab et al. 2013; Grigg, Dubey, and Nussenblatt 2015). 
Information on the origin of the parasite infection (as opposed to parasite collection) as well as 
human genetics, are often not documented, making information derived from human infections 
tenuously characterized at best. These limitations create difficulties in separating the strain 
polymorphism differences linked to human disease from the differences in human immune 
system susceptibility that these strains encounter. However, this interaction between 
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Toxoplasma parasite strains and the host immune system is more well-understood in other, 
better studied intermediate hosts (i.e., rodents) of Toxoplasma, discussed later in this chapter.  
Toxoplasma infection is mainly problematic when it is not tightly controlled by the 
host’s immune system, such as is the case in the immune compromised. During organ 
transplantation, it is now common to treat seronegative recipients prophylactically to limit a 
potential infection from a seropositive donor (especially if donor testing was not done) (Paya et 
al. 2012; Derouin, Pelloux, and Parasitology 2008). Toxoplasma is also an immense problem in 
HIV endemic regions not only due to problems associated with primary infection in immune-
compromised hosts, but also for those Toxoplasma-exposed HIV infected individuals who 
develop AIDS. This patient group is particularly susceptible to a recrudescent infection, in 
which the latent bradyzoite stage reactivates to produce an acute symptomatic infection in the 
absence of protective immunity (Gross et al. 1997). Recrudescence is especially challenging in 
areas with high levels of immune-compromised humans as there is no intervention that yields a 
sterile cure of the Toxoplasma infection. While acute infections can be treated, the bradyzoite 
state is refractory to all known drug combinations and requires an intact immune system to 
control its ability to recrudesce and cause toxoplasmosis.  
Immune-competent seronegative pregnant women are at high risk of transmitting 
Toxoplasma to their developing fetus. Congenital transmission of an acute infection may occur 
without the mother displaying characteristic symptomology (Kim 2006). Congenital 
transmission is more frequent in areas with low endemic levels of Toxoplasma, because there 
are more at-risk seronegative women. In these areas treatment focuses on detecting and treating 
primary infections in women (Rico-Torres, Vargas-Villavicencio, and Correa 2016). In highly 
endemic areas, where a significant proportion of women of child-bearing age have been 
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previously exposed to the parasite, the risk of congenital transmission is lower due to existing 
maternal immunity. However, in regions where Toxoplasma genetic diversity is high, there is a 
risk of a seropositive mother contracting a secondary infection that breaks primary immunity 
and allows congenital transmission of the secondary, genetically different Toxoplasma strain to 
the fetus (Elbez-Rubinstein et al. 2009). Surprisingly, while adult human symptoms correlate to 
the infecting strain’s genetics, fetal disease severity is correlated primarily with the trimester of 
infection, with an inverse correlation between the likelihood of infection and the potential 
hazard to the fetus (late-term infections being correlated with less symptomatic congenital 
toxoplasmosis and earlier infections correlating more frequently with fetal abortion) (Boyer et 
al. 2011; Rico-Torres, Vargas-Villavicencio, and Correa 2016).  
Congenital Toxoplasma infection is often undiagnosed due to the lack of maternally 
inherited or fetus-produced antibodies against Toxoplasma for those fetuses infected later in the 
third trimester. Many congenitally infected infants only display symptoms later in life, often 
around puberty, with ocular toxoplasmosis as the most common presentation (Rico-Torres, 
Vargas-Villavicencio, and Correa 2016). However, ocular toxoplasmosis is not solely derived 
from congenital infections, and can occur during, or shortly after, acute disease. Generally, 
ocular toxoplasmosis is self-limiting and most cases are not treated unless the resultant lesions 
begin to cause progressive blindness (Harrell and Carvounis 2014). Unfortunately, treatment 
options are limited and often require direct ocular delivery of chemo-prophylactic agents to 
limit parasite growth. Even with treatment, ocular lesions remain, and clinical trials have not 
shown a strong correlation between treatment and prevention of vision loss, although treatment 
may limit future recrudescence that can trigger additional ocular scarring.  
 29 
Prophylaxis is more effective in preventing transmission of Toxoplasma into 
seronegative or immune-compromised humans, but treatment can only suppress acute 
infections and does nothing to clear chronic infections or tissue cysts. Furthermore, the 
pyrimethamine and sulfonamide drug combinations available to treat Toxoplasma infection 
have a number of undesirable side effects, in addition to not providing a sterile cure for the 
infection (Soheilian et al. 2005). Ideally, all possible at-risk humans would be vaccinated 
against Toxoplasma infection, but there are currently no human-approved Toxoplasma vaccines 
(Liu, Singla, and Zhou 2012). Instead, Toxoplasma-endemic regions focus on prevention of 
primary infections. This effort has included the addition of mandatory prenatal screening in 
areas such as France, Germany, and Brazil (Kim 2006). These efforts appear to have reduced 
the transmission of parasite congenital infections (Avelino et al. 2014).  
However, the majority of Toxoplasma infections found in humans have zoonotic origins 
(Schluter et al. 2014). While efforts can be made to keep food safe (via safe handling practices 
of meats and vegetables) and water may be stringently filtered to exclude oocysts, the zoonotic 
transmission of Toxoplasma to humans is unlikely to be contained any time soon. Due to the 
inherent lack of information from human hosts who are often asymptomatic, and are 
infrequently tissue sampled, perhaps the best way to appreciate the impact of Toxoplasma on 
the human population is through the study of the intermediate and definitive hosts that serve as 
zoonotic reservoirs for humans. This is especially true of oocyst-derived infections where 
sexual replication in the feline host allows for the genetic admixture and expansion of parasite 
clones that may have distinct biological potentials, including a greater capacity to infect and 
cause disease in humans.  
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Zoonotic Potential of a Generalist Parasite 
 
 Toxoplasma is considered a generalist parasite which possesses a heteroxenous lifecycle 
and is capable of infecting any species of warm-blooded animal on the planet, whereas other 
apicomplexan parasites are generally more host restricted. For example, although the genus 
Sarcocystis has a broad intermediate host-range, the majority of Sarcocystis species are 
specialized, each possessing a definitive host and a restricted (to one or a few) intermediate 
host species (Tenter 1995). Plasmodium also displays a limited host range. In general, a single 
Plasmodium species can only infect a small subset of mosquito species and an equally small 
number of intermediate host species (Molina-Cruz and Barillas-Mury 2014). Unlike these other 
apicomplexan parasites, the single species of Toxoplasma can utilize any warm-blooded animal 
as its intermediate host, and any felid as its definitive host. In addition, Toxoplasma has a 
remarkably flexible transmission cycle wherein it can undergo or bypass its sexual cycle 
because bradyzoites are orally infectious and are not terminally differentiated or committed to 
the sexual cycle. This allows Toxoplasma to maintain a high infection prevalence in its globally 
wide host range, where it infects animals across every continent and in every ocean on the 
planet.  
 The progression of toxoplasmosis in animal hosts mirrors that seen in humans. More 
strains have been isolated from animals due to the ease of animal tissue sampling for strain 
isolation. While the ability to isolate strains is higher in animals, most information from 
animals comes from post-mortem analysis of predominantly symptomatic infections. 
Additionally, domestic animals are more closely sampled, especially with regard to 
longitudinal and known-age of host studies than are wild animals. Wild animals tend to be 
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sampled opportunistically, for example when caught during hunting, or when they are 
inherently symptomatic. This biased sampling lead to the hypothesis in the field that wild 
strains of Toxoplasma are more likely to cause disease. However, a large portion of the “wild” 
animals diagnosed with clinical disease are from captive animals in domestic locations, such as 
zoos, and there is an increasing body of evidence that wild strains of Toxoplasma are just as 
likely as domestic strains to be avirulent in their respective hosts (Thompson 2013; Thompson, 
Lymbery, and Smith 2010).  
Perhaps the most significant host for Toxoplasma transmission is the cat. Every felid 
species is considered a definitive host and is capable of supporting the full sexual life cycle, 
including the ability to produce highly stable oocysts by outcrossing or same strain self-mating. 
This transmissible stage can infect any warm-blooded domestic or sylvatic animal that ingests 
it. The global Toxoplasma seroprevalence in domestic cats is estimated to be between 30-40%, 
however, as with humans, seroprevalence may underestimate the actual infection rate due to the 
low-level infection detection limit, especially using older tests (Schluter et al. 2014; Lopes et 
al. 2014). Furthermore, some labs have hypothesized that seroprevalence in wild cats is closer 
to 100% by adulthood, reaching these numbers as the animals aged (Lopes et al. 2014). Indeed, 
transmission rates in some intermediate hosts, such as the Southern sea otter, may be better 
correlated to wild felid populations rather than the domestic felids closely associated with 
humans (VanWormer et al. 2016). 
 Livestock are also an especially prominent, well monitored zoonotic source for human 
infections. Not all domestic livestock exhibit the same rates of seroprevalence, consistent with 
differential exposure and infectivity rates across meat animals, as well as different 
immunological defenses between animals against this generalist parasite. A meta-analysis of 
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food animals in the United States found the following seroprevalence rates in non-confinement 
pigs (31.0%), goats (30.7%), non-confinement chickens (24.1%), sheep (22.0%), confinement 
breeding pigs (16.7%), and confinement market pigs (5.6%) across the United States. The 
analysis also surveyed both cattle and confined chickens but found that both possess low 
seropositive rates (Guo et al. 2016). Several common factors influence infection rates of these 
species, including exposure to the environment and age of the animal surveyed. In all species of 
livestock assessed, seroprevalence rates increase linearly with animal age at time of survey 
(although breeders generally have higher seropositive rates than market stock), displaying a 
time-dependent correlation between exposure to potentially oocyst-contaminated water and 
feed, and seropositivity rates of all livestock species (Guo et al. 2015).  
The introduction of more stringent farming and fattening practices (reducing exposure 
to infected feed and environments) has significantly reduced the seroprevalence rates in swine 
(Tenter, Heckeroth, and Weiss 2000). As shown above, wild swine have the highest 
seroprevalence for Toxoplasma followed closely by organic, free-range farmed swine who have 
access to outdoor ranges. The lowest seroprevalence in swine has been observed in indoor-
raised and fattened swine that were taken to market at six months of age, although it is 
noteworthy that animals, like humans, have an increased likelihood of infection with 
Toxoplasma as they age. This becomes especially apparent when comparing samples from 
livestock and wild (or sylvatic) animals. While most domestic animals are surveyed 
systematically either at a set life stage or after culling for food production, most wildlife are 
surveyed from dead specimens either from hunting catch sampling or necropsy of animals 
found dead, which may not represent the most-healthy animals. Thus, while domestic animals 
are surveyed in a manner biased towards finding early or congenital infections, wild animals 
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are generally biased toward only the most symptomatic infections, which have resulted in the 
death of the animals.   
Despite the wide variety of intermediate hosts that Toxoplasma infects, certain hosts 
appear to be more susceptible to specific infectious stages (i.e., bradyzoite versus sporozoite). 
For instance, felines require a much lower dose of bradyzoites to create a productive infection 
than mice. Inversely, mice require significantly fewer sporulated oocysts to produce infection 
than the definitive felid host (Dubey 2001). Likewise, strain type susceptibility is another 
variable that affects host range. For example, birds are more likely to harbor Type I strains than 
rodents, whereas livestock are more likely to be infected with Type II or III strains than 
symptomatic wildlife, while wild animals in North America are most likely to be infected with 
Type X (Wendte, Gibson, and Grigg 2011). Host selection based on genotype is not uncommon 
among the Apicomplexa. As discussed previously, different species of Plasmodium and 
Sarcocystis are restricted to specific host species to complete their life cycles, and different 
species of Eimeria are known to partition in situ to different regions of the gastrointestinal tract 
within the same intermediate host (Mackinnon and Read 2004; Tenter 1995; Walker et al. 
2013). 
Previous work has suggested that two distinct pools of Toxoplasma-infected hosts exist 
that comprise distinct domestic and sylvatic transmission cycles with each host pool infected 
with largely non-overlapping Toxoplasma genotypes (Wendte, Gibson, and Grigg 2011). 
However, when host overlap occurs between the two transmission cycles, strains usually 
restricted to one host pool have been known to cause outbreaks, such as Type II strains in 
marsupials and sea otters (Conrad et al. 2005; Parameswaran et al. 2010). It is thought that 
these cross-cycle infection strains are more symptomatic due to a lack of adaptation between 
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the host immune system and the infecting Toxoplasma genotypes (Wendte, Gibson, and Grigg 
2011). In Brazil, where both domestic and sylvatic cycles have been more thoroughly surveyed, 
sylvatic cycle parasites are typically more genetically diverse than those found infecting 
domestic livestock. However, based on isolated parasites, the amount of cross-cycle 
transmission varies by location and hosts surveyed (Dubey et al. 2006; Silva et al. 2014; 
Vitaliano et al. 2014). Overall, it remains unclear how much host and parasite mixing 
definitively occurs between the domestic and sylvatic cycles as urban and rural hosts are rarely 
surveyed in overlapping geographical regions. Nowhere is the potential for outbreaks from 
novel genotypes more apparent than in “adapter” species of wildlife (e.g. raccoons and foxes) 
that have adapted to live in human environments that encroach upon wild environments, and 
which seem to can carry infections from diverse strains of Toxoplasma found infecting sylvatic 
animals into human contact (Thompson 2013).  
 
Population Genetics Indicate Toxoplasma is a Single Species with Multiple 
Diverse Clades Worldwide 
 
 Initial studies classified Toxoplasma as a single species that is dominated by three 
clonal lineages (referred to as Types I, II, and III). This work was based on the application of a 
limited set of PCR-RFLP markers, isoenzyme analyses, and parasite murine virulence (Darde, 
Bouteille, and Pestre-Alexandre 1992; Sibley and Boothroyd 1992). Although their genomes 
differ by less than 2% between clonal strains, each clonotype can be differentiated by 
specifically designed RFLP markers that target known polymorphisms between the clonal 
lineages. Additionally, each clonotype exhibits a largely unique and distinct virulence 
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phenotype in mice by which they were initially classified, which correlates well with genomic 
interrogations. Type I strains cause lethal infection in all laboratory mice, even at low 
inoculums, often killing with a single tachyzoite. Type II and III strains are much less virulent 
and require a dose of 2000 or >105 tachyzoites respectively to cause lethal infection in half of 
the mice infected (Sibley et al. 1992; Pfefferkorn and Pfefferkorn 1979). While all clonotypes 
can infect any warm-blooded vertebrate, they partition differentially among susceptible 
intermediate host populations in nature. Specifically, in humans the majority of infections are 
from Type II strains that cause chronic, asymptomatic infections, whereas Type I infections are 
rare but are associated with more severe eye disease (Boothroyd and Grigg 2002; Grigg, 
Ganatra, et al. 2001). Birds in contrast, are most commonly infected by Type I strains found as 
asymptomatic infections (Miller and Grigg, unpublished). Type III infections are highly 
prevalent in domestic animals and wildlife but are not typically found in human infections 
(Grigg and Sundar 2009).  
 Following the initial studies that defined the three archetypal lineages of Toxoplasma, a 
suite of 11 PCR-RFLP markers were developed and applied to determine the true extent of 
Toxoplasma global genetic diversity (Su, Zhang, and Dubey 2006). Further studies have applied 
microarray, microsatellite sequencing, EST sequencing, and finally whole genome sequencing of 
62 globally distributed Toxoplasma isolates to further refine the molecular characterization of the 
parasite’s population genetic structure (Ajzenberg et al. 2010; Blackston et al. 2001; Khan et al. 
2005; Su, Zhang, and Dubey 2006; Boyle et al. 2006; Lorenzi et al. 2016; Minot et al. 2012).  
Despite Toxoplasma’s highly fecund sexual cycle and its ability to recombine within any 
feline host, it has a surprisingly clonal-dominated population structure across many parts of the 
globe. In both North America and Europe, the population structure is dominated by the Type II 
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lineage (Shwab et al. 2014; Su et al. 2012; Wendte, Miller, Lambourn, et al. 2010; Howe and 
Sibley 1995; McLeod et al. 2012). Australia too exhibits a population that resembles a drifted 
version of the North American and European population structure (Parameswaran et al. 2010; 
Pan et al. 2012). Additionally, although limited data has been collected from the regions, 
Toxoplasma collected in China and East Asia also indicates the presence of a clonal population 
structure, albeit one comprised of lineages considered atypical in both North America and 
Europe (Dubey, Zhu, et al. 2007; Dubey, Huong, et al. 2007; Zhou et al. 2009). In fact, the only 
geographic region where the population structure of Toxoplasma is as expected for a parasite 
capable of sexual recombination is South America. In South America, the Toxoplasma 
population displays high genetic diversity and strain admixture, with no one genotype 
dominating. This panmictic population genetic structure exhibits a heterogeneous array of 
genetically inter-related strains that would be expected from continuous interbreeding between 
closely-related but genetically distinct lineages of Toxoplasma (Rajendran, Su, and Dubey 2012; 
Shwab et al. 2014). 
Explaining the origin and transmission dynamics for the panmictic population structure 
in South America compared to the clonal population structure in North America and Europe 
has been a matter of debate and has generated many opposing theories to explain how two 
apparently opposite population genetic structures co-exist in nature. While other parasites have 
shown evidence of clonal lineage sweeps, this is usually due to a selective advantage such as 
drug selection across the region surveyed, as with chloroquine selective sweeps and artemisin-
resistance in Plasmodium (Ariey et al. 2014; Miotto et al. 2013; Wootton et al. 2002). 
However, no drug sweep could explain the clonal dominance of just a few strains in North 
America and Europe as anti-parasitic drugs for Toxoplasma do not provide a sterile cure of the 
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parasite and thus would not allow an efficient genetic sweep. Nevertheless, biased sampling 
may have skewed the sampled population genetic diversity toward clonality, as most samples 
collected in Europe and North America are derived from a limited host subset of domestic 
animals and symptomatic humans (Wendte, Gibson, and Grigg 2011). One hypothesis to 
explain the clonal populations in North America and Europe is that the three archetypal 
lineages contain linked genes that make these parasites adept at oral transmission and take 
advantage of the parasite’s intermediate host life cycle to expand exclusively asexually (Su et 
al. 2003). This model is supported by evidence that suggests strains from the three archetypal 
lineages are relatively poor at outcrossing, tend to favor sexual self-mating in cats, and that a 
mating type locus may exist on Chromosome Ia (Khan et al. 2006; Fux et al. 2007; Khan, 
Taylor, et al. 2009). Once a clonal population structure exists, it would limit the opportunities 
for mixed strain super-infections due to cross-protective immunity, especially between closely 
related strains (Waldeland and Frenkel 1983; Jensen et al. 2015). Because sexual recombination 
in the definitive host relies on the ingestion of co-infected intermediate hosts, sexual 
outcrossing and diversification would be limited by the relative absence of co-infected 
intermediate hosts in clonally limited populations. However, recent data indicates that mixed 
genotype co-infections occur with high frequency, at least among wildlife in North America 
(Gibson et al. 2011). Additionally, systematic sampling of wildlife displayed greater diversity 
of Toxoplasma strains in sea otters off the coast of North America, in marsupials in Australia, 
and in zoonotic human outbreaks in Africa, Suriname, and Brazil than the previously expected 
clonality (Yera et al. 2014; Demar et al. 2007; Rajendran, Su, and Dubey 2012; Vaudaux et al. 
2010; Parameswaran et al. 2010; Sundar et al. 2008). Furthermore, it is difficult to discern if 
apparent clonality results from sexual self-mating, unisexual crossing between two genetically 
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similar strains, or from asexual expansion using only the relatively few markers that have been 
applied toward genotyping the current population.  
An alternative hypothesis recently put forward to explain the clonal structure in North 
America is that sexual expansion of a limited number of highly fit clones has resulted in the 
clonal population structure, rather than asexual clonal expansion (Wendte, Gibson, and Grigg 
2011; Wendte, Miller, Lambourn, et al. 2010). Support for this model comes from evidence 
that the three clonal archetypes in North America are in fact highly fit progeny from a recent 
genetic cross between two discrete ancestral lineages (Grigg, Bonnefoy, et al. 2001).  
Expansion of this work by Boyle, using EST and genomic sequence data established that the 
clonal Type I lineage was the product of a cross between a Type II parental strain and an 
unknown “α” lineage, whereas Type III was a cross between a Type II parent and an unknown 
“β” lineage (Boyle et al. 2006). The clonal lineages have previously been shown proficient at 
sexual self-mating. During the sexual cycle, a single cat can produce over 100 million highly 
infectious oocysts, thus, definitive host infection can massively expand the infection base of a 
single isolate as has been seen in natural outbreaks whereby large numbers of intermediate 
hosts are infected by ingesting oocyst contaminated water (Wendte, Miller, Lambourn, et al. 
2010).  
 Sexual recombination between closely related strains, as within clonal lineages, 
necessitates using whole genome sequencing to resolve whether an isolate is an admixture, or is 
in whole genome linkage disequilibrium and has expanded asexually as a clone. It has been 
previously shown that a lack of resolution used to characterize isolates of Toxoplasma may lead 
to the mis-grouping of these isolates with other similar, but not identical, genotypes. An 
example of biased genomic characterization was found in the strain P89. P89 was originally 
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categorized as a I/III cross by a select few markers (Sibley et al. 1992); later, after the ancestral 
lineages of Types I and III were identified as the a and b lineages, P89 was labeled as the 
ancestral α strain (Boyle et al. 2006). However, when its whole genome was sequenced, P89 
was discovered to be a genomic admixture of strains bearing alleles from both the Type I and 
III lineages, whose genome had undergone significant genetic drift relative to both I and III 
(Sibley et al. 1992; Minot et al. 2012). Similarly, many of the atypical strains from South 
America were initially mis-categorized as clonal Type I strains due to the limitations of the 
genotyping PCR-RFLP markers used to classify them (Ferreira Ade et al. 2004). In North 
America, Type X isolates were originally classified as Type II strains until polymorphism in a 
single marker (GRA6) suggested these strains were in fact divergent from the canonical Type II 
clade (Conrad et al. 2005; Miller et al. 2004). Since, Type X was characterized as the fourth 
clonal lineage of North America after more genotyping markers were applied (Khan, Taylor, et 
al. 2009). 
Although Type X has been described as the fourth clonal lineage of North America by 
Khan et al, 2011, work by Sundar suggested that Type X may rather exist as at least 2 
recombinant strains based on a single unique PCR-RFLP marker that differentiates two alleles, 
referred to as A and X, from Type II (Sundar et al. 2008). More recently, two Type X strains 
(ARI, RAY) were whole genome sequenced, and determined to be genetic recombinants between 
a Type II line and another lineage, referred to as “g”, different from a and b (Lorenzi et al. 
2016). The previous characterization of Type X as the fourth clonal lineage in North America 
appears to have suffered from a lack of adequate markers to capture the true diversity of Type X 
genomes. This dissertation has amassed a set of Type X strains to determine whether this clade 
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exists as a clonal lineage, or a recombinant clade, in addition to determining its exact genetic 
ancestry. 
It is now evident that the limited number of PCR-RFLP markers discussed above fail to 
capture the true genetic diversity within the Toxoplasma population genetic structure (Shwab et 
al. 2014). With the accessibility of whole genome sequencing it is apparent that the population 
genetic structure of Toxoplasma needed to be re-visited at whole genome sequence resolution. 
The White Paper, which sequenced 62 Toxoplasma genomes to characterize the extent of total 
genetic diversity was completed during the time of this thesis, established that the majority of 
Toxoplasma strains are recombinants, and parsed the population into six recombinant clades 
(Lorenzi et al. 2016). Previously, only the three major clonal lineages were available for 
sequence analysis. Not only did the White paper increase the number of sequenced Toxoplasma 
genomes, but because the strains were selected based on divergence from the known genotypes 
(established using the standard set of Su markers), this allowed the community to better 
characterize the number of genetic ancestries within the population, and how they are 
distributed across the diverse strains sampled. The comparative analysis of the 62 genomes also 
showed evidence of strong geographic segregation between groups within the population, 
which supported previous work done using the existing, but limited markers (Minot et al. 2012; 
Shwab et al. 2014).  
Following the increase in whole genome sequencing quantity that the White paper 
brought to the Toxoplasma field, it was necessary to reassess at the genome level the admixture 
inherent within the population. To determine and visualize the number of genetic ancestries for 
any given population of Toxoplasma strains, the new genomes from the White paper as well as 
a few newly sequenced genomes from the Grigg lab were utilized in a collaboration between 
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the Grigg lab and the Parkinson group of computational biologists at the University of Toronto 
to develop a new agnostic clustering program termed PopNet. This program was created in 
conjunction with the work done in this thesis and while it is used to analyze the clonal lineages 
examined here, PopNet was initially created to analyze diverse populations to allow for a more 
detailed analysis of genetic admixture within the population structure of Toxoplasma. PopNet 
determines the number of genetic ancestries within a sliding window of discrete genomic 
blocks (i.e., 1kb, 10kb, or 100kb) and then computes how specific blocks of different ancestry 
are inherited across chromosomes within the population (Zhang et al. 2017). PopNet then 
paints each block based on which of the identified ancestries it shares the most common SNPs 
with, which allows for a highly resolved visualization of recombination blocks along each 
chromosome for each strain within any given analyzed population. PopNet identifies only 
common SNPs shared between strains and for the 62 sequenced genomes, it identified 14 
distinct ancestries, significantly more than the 6 clades previously identified for the same 
population by the White paper (Lorenzi et al. 2016). Additionally, PopNet allowed the 
resolution and painting of blocks of common inheritance across the genomes of these strains 
that has previously only been displayed as an average across the whole genome rather than 
painting for each chromosome. The analysis identified highly mosaic genomes among the 
diverse array of strains thus far sampled and showed that recombination has occurred more 
frequently than has been previously envisaged. The diversity inherent across the population 
suggested that admixture diversity may also be inherent within subsets of the Toxoplasma 
population as well as across the population.  
In nature, uniparental mating is common, such as in fungi, where it generates clonal 
genetic population structures, and significant structural variation. This structural variation is 
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readily distinguished from asexual expansion, which results in the step-wise accumulation of 
SNP mutations that are unique to a specific strain (Heitman 2010; Roach and Heitman 2014; 
Sun et al. 2014).  A major focus of this thesis has been to look within each of two clonal 
lineages at whole genome resolution to determine whether these strains are in genome-wide 
linkage disequilibrium and are being expanded exclusively asexually, as has been proposed 
previously, or by unisexual or self-mating in the definitive felid host. To assess this, whole 
genome sequencing was performed to calculate total allelic diversity, differences in somy, 
CNV, gene dosage, sequence haploblock recombination, and other hallmarks of genome 
evolution that would occur during uniparental mating.   
 
Minimum Ancestry Estimates and Timelines in the Establishment of the 
Clonal Lineages 
 
 Due to the flexibility of the Toxoplasma heteroxenous lifecycle and the fact that the 
parasite can lay dormant and in geographical isolation within an intermediate host for the life of 
that host, molecular clock estimates for the origin of certain clones within the population 
genetic structure are widely varied and depend heavily upon the assumptions used to model its 
phylogenetic diversity. While it is generally accepted that a bottleneck occurred in the 
evolution of the current dominant clones that comprise Toxoplasma’s population in North 
America and Europe, the causative factors for it are widely debated. Initial work assumed that 
sexual recombination was rare across T. gondii isolates and examined genomic regions under 
neutral mutation pressures, such as within introns of housekeeping genes. These neutral regions 
were utilized to determine the extent of genetic drift among strains within a clonal lineage. 
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Using these parameters, the Sibley and Ajioka groups estimated that Toxoplasma’s clonal 
lineages were derived from a single genetic cross approximately 10,000 years ago (Su et al. 
2003). The same group suggested that the more divergent strains found in South America were 
derived from similarly infrequent crosses and had undergone independent genetic drift for 
approximately one million years. They postulated that the recent expansion of the clonal 
lineages in North America and Europe was due to the ability of these clones to expand 
exclusively asexually via carnivory among intermediate hosts (Khan et al. 2006; Fux et al. 
2007; Su et al. 2003). A more recent study examined 13 global populations totaling 168 strains 
and suggested that Toxoplasma differentiated from its most recent common ancestor (H. 
hammondia) 11 million years ago and then underwent a global population sweep between 
150,000-1.5 million years ago. These authors attribute this global sweep to the domestication of 
felines across the developing agricultural world (Bertranpetit et al. 2016).  
All of these studies share a number of key assumption flaws that do not allow for an 
accurate determination of the molecular clock or time to minimum ancestry. Each study has 
utilized the mutation rate that was previously calculated for Plasmodium falciparum because no 
mutation rate calculation has been performed for Toxoplasma.  However, unlike Toxoplasma, 
Plasmodium is an obligate heteroxenous organism which must undergo sexual replication as a 
mandatory part of every successful transmission, and it lacks the ability to expand asexually 
between intermediate hosts (Meissner et al. 2007). Hence, its mutational clock is likely quite 
different from Toxoplasma’s. Furthermore, Toxoplasma has the ability to undergo sexual 
recombination uniparentally and unisexually to produce clones that are nearly identical to the 
parents. Thus, it is difficult to distinguish asexual expansion from that of sexual self-mating, 
especially within highly clonal populations where most strains are highly similar to one another 
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(Cornelissen and Overdulve 1985). With the discovery of ancient Toxoplasma DNA intermixed 
with ancient human DNA in mummies from Egypt, it may be possible to better elucidate the 
ancestral lineage of this generalist parasite, however this strategy remains to be tested (Khairat 
et al. 2013).  
 
Identification of Virulence Determinants for Toxoplasma 
 
Multiple factors contribute to the severity of disease attributed to a particular strain of 
Toxoplasma including parasite developmental stage, host immunity, polyparasitism, and 
especially parasite genotype (Wendte, Gibson, and Grigg 2011). Virulence is one of the most 
easily assayable phenotypes for parasite fitness within its host. In virulence, host death 
correlates with maladjustment of the parasite to the host. Toxoplasma is best adapted to its host 
when it can produce a chronic infection without morbidity or mortality that would inhibit host 
survival and thus parasite spread. Virulence varies depending on the host infected. Most of the 
work to determine virulence genes in Toxoplasma has focused on murine virulence between the 
clonal populations due to the mouse’s usefulness as both a model organism and a definitive part 
of the Toxoplasma lifecycle in nature as well as the lab.  
The increase in sequencing of known genomes of Toxoplasma has allowed for a more 
definitive comparison of the Toxoplasma genomes to those of related parasites such as 
Plasmodium, Neospora, and Sarcocystis. Through this work, it was determined that while the 
genomes of Toxoplasma, Neospora, and Hammondia were highly syntenic, Toxoplasma 
contained a set of gene families that were extensively expanded within the species, especially 
in comparison to these other parasites. These gene families were collectively referred to as 
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secretory pathogenesis determinants, or SPDs, and occurred as discrete haploblocks of gene 
arrays that were comprised mainly of the secreted ROP and GRA proteins, and SRS surface 
proteins thought to be important in parasite entry and modulation of host immunity. Proposed 
roles for the SRS genes include providing adhesion properties to facilitate attachment and entry 
into the diverse array of host cells this generalist parasite infects. ROP kinases, and GRA 
proteins have been identified as highly polymorphic effector proteins that hijack immune 
signaling pathways and function as virulence factors that enhance Toxoplasma pathogenesis in 
animal infections (Hakimi, Olias, and Sibley 2017). The combination of SPDs inherited is 




Table 1-1: Virulence determinant genes in Toxoplasma 
Known virulence determinant genes discussed below are summarized here with red indicating that the strain Type labeled has the capacity listed in the function 
row. Respective discovery publications as well as key publications that elucidated the function of these genes are listed. Predicted interacting partners are listed 
as derived from these papers.  
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Previously, an experimental cross between two mouse avirulent strains (II crossed with 
III) showed that virulence and infectivity in mice is a multigenic trait and that virulence alleles 
can be epistatic depending on the parasite genetic background. This epistasis can be removed 
by genetic recombination leading to hybridization between these haploid organisms (Grigg, 
Bonnefoy, et al. 2001). Work by the Boothroyd and Sibley groups later determined the gene 
products responsible for the acute virulence phenotype by using a forward genetic approach. 
Several of the 39 progeny from the II by III cross of two avirulent parental strains possessed 
different levels of murine virulence. This range of progeny virulence was utilized in a 
Qualitative Trait Loci (QTL) mapping of the cross using 250 unique genetic markers 
distributed across the 14 chromosomes of Toxoplasma, where five genomic regions were 
identified that contained candidate virulence genes (Khan et al. 2005). These regions were 
narrowed based on expression differences corresponding to the polymorphisms in a singular 
gene, ROP18 (Saeij et al. 2006; Taylor et al. 2006). Similarly, in a cross between Type I and III 
parents, 34 progeny were genotyped at 175 QTL markers to map genes contributing to murine 
virulence differences (Taylor et al. 2006). This secondary cross yielded the same ROP18 gene 
as the dominant genetic marker of acute murine virulence, but it was likewise encumbered by 
the same limitations of using only the limited set of genome markers available. Due to the lack 
of genetic markers, combined with a small number of progeny and subsequently limited genetic 
crossover events, the genomic regions containing the virulence enhancing genes were quite 
large. Indeed, a lack of well characterized sexual crosses between Toxoplasma types, as well as 
Toxoplasma’s extreme linkage disequilibrium among clonal archetypal lineages has extremely 
limited the use of genome wide association studies (GWAS) and population-based studies to 
determine virulence genes among strains (Taylor et al. 2006).  
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In addition to their individual activity as virulence genes, known combinations of 
virulence enhancing genes have been described, such as ROP5 and ROP18 (see below) that act 
cooperatively to overcome host immunological resistance and produce a virulent infection 
when in the correct allelic combination within the infecting parasite (Behnke et al. 2015; 
Shwab et al. 2016). It was this combination of a Type III ROP5 allele and a Type I ROP18 
allele that resulted in the virulent S23 clone derived from avirulent parents that was originally 
described by Grigg et al. 2001. However, it is clear that ROP5/ROP18 is not sufficient to fully 
account for mouse virulence, as there are several highly virulent strains that possess avirulent 
allelic combinations of ROP5/ROP18, such as BOF and CASTELLS (Khan, Taylor, et al. 
2009). These incongruous strains must therefore encode unknown virulence factors or 
combinations that have the potential for increased transmission, altered host potential, or are 
necessary for Toxoplasma to combat non-murine host defenses. Hence, as part of this thesis, 
the number of Toxoplasma crosses was expanded, and crosses between the more divergent 
lineages of Toxoplasma were specifically targeted, and genetically interrogated with whole 
genome sequencing, in order to increase marker density and reduce the size of the genomic 
regions that associate with the mouse virulence phenotype used to identify novel virulence 
factors.  
 
Toxoplasma Specific Pathogenesis Determinants that Manipulate the Host 
Environment 
 
Work within the last decade has mapped the factors encoded by Toxoplasma that trigger 
host immunity to regulate parasite proliferation. Specifically, parasitic pathogenic proteins 
 49 
(such as profilin) trigger the host innate immune response via TLR 11/12 (Gazzinelli et al. 
2014; Yarovinsky et al. 2005) or the inflammasome (Gorfu et al. 2014). Detection of the 
parasite causes a signaling cascade within infected cells, which leads to the production of IL-12 
and IL-18, which stimulate the production of IFN-g in natural killer and T cells, as well as 
TNF-a from monocytes. These innate factors cause activated host cells to upregulate innate 
recognition factors such as immunity-related GTPases (IRGs) and Guanylate-binding proteins 
(GBPs) that activate inflammatory transcriptional factors to protect against acute Toxoplasma 
infections (Hunter and Sibley 2012). Importantly, certain strains of Toxoplasma are known to 
actively manipulate the host cellular environment in a strain-dependent manner to facilitate 
productive infection. The level of activation of the innate immune system has been shown to be 
manipulated by the Toxoplasma parasite, in a manner that varies between strains (Hakimi, 
Olias, and Sibley 2017).  
Toxoplasma must carefully control its own proliferation and subsequent cellular lysis in 
order to ensure host survival. Thus, the parasite has developed mechanisms to carefully 
regulate the immune system of the host in order to produce a productive chronic infection with 
transmissible cysts that can perpetuate the Toxoplasma life cycle. To allow its success in nature 
and ability to infect such a broad host range, Toxoplasma has evolved numerous strategies to 
antagonize the wide-variety of immune systems across its host range. Consequently, it has 
evolved numerous species-specific virulence factors to facilitate the immune control that 
ultimately determines its host range. Although virulence is a highly complex, multi-genic trait 
that depends on multiple interactions between the host and the parasite, so far, only a handful of 
well-characterized parasite-protein virulence genes have been identified using crosses 
performed between the most common clonal lineages: ROP5, ROP16, ROP18, ROP38, 
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GRA15, GRA24, and SRS29c (Saeij et al. 2006; Taylor et al. 2006; Saeij et al. 2007; 
Fleckenstein et al. 2012; Wasmuth et al. 2012; Braun et al. 2013; Melo et al. 2013).  
The majority of these virulence gene candidates were found via QTL analysis as 
discussed above. The gene candidates were narrowed based on differences between the clonal 
lineages that could impact parasite virulence. Primarily, these have been polymorphisms in the 
genes, gene expression differences between the strains involved, and secretion potential based 
on protein predictions of the gene candidates. These genes have then traditionally been 
confirmed via single gene deletions to verify gene activity, and in some cases, mechanism of 
action.  
All previously known virulence factors have an influence on host immunity to 
Toxoplasma, whether by biasing the host toward a productive immune response, driving host 
immunity away from parasite niche detection within the host cells, or modulating 
Toxoplasma’s growth by upregulating the host immune system (Saeij et al. 2006; Taylor et al. 
2006; Saeij et al. 2007; Fleckenstein et al. 2012; Hakimi, Olias, and Sibley 2017). Moreover, 
the majority of these known Toxoplasma virulence factors seem to function in combination 
with another partner protein (often a pseudokinase and kinase working in parallel to produce 
optimal activity for their strain-specific activity) (Behnke et al. 2012; Fleckenstein et al. 2012; 
Jensen et al. 2013). The virulence of a strain of Toxoplasma relies on both the allele of the gene 
in question as well as the background genetics for the other interacting virulence factors that 
are present in the same genome.  
In the murine host, Toxoplasma utilizes a set of secreted proteins to defend against host 
intracellular immune proteins in order to protect itself from detection and destruction by the 
host innate immune response. For example, ROP18 has been shown to protect the 
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parasitophorous vacuole by phosphorylating host Immunity Related GTPases (or IRGs; 
especially Irga6) that come into cytosolic contact with the PVM (Hermanns et al. 2015; 
Steinfeldt et al. 2010). Phosphorylation by ROP18 promotes the release of IRGs from the 
PVM. This prevents the IRGs from accumulating on the PVM and marking it for lysosomal 
destruction (Saeij et al. 2006). Further examination determined that only certain alleles of 
ROP18, specifically the Type I and II strain alleles, are capable of driving this IRG release 
which promotes virulence in infected mice, but only in certain mouse strains (Behnke et al. 
2015; Hermanns et al. 2015; Shwab et al. 2016; Khan, Taylor, et al. 2009). A more recent 
characterization that investigated parasite protein-protein interactions indicated that ROP18 
also complexes with a number of other virulence proteins in a strain-specific manner to alter 
Toxoplasma murine virulence. Both Type I and II strains are known to express virulent alleles 
of ROP18, but the original QTL that indicated ROP18 as a major virulence factor also 
contained several other peaks, which were readily identified using a secondary QTL analysis, 
done by holding ROP18 constant to look for secondary interacting proteins (Saeij et al. 2006). 
This secondary analysis identified an interaction with the pseudokinase ROP5, as was further 
verified by investigating knock-outs of either ROP18, ROP5, or both proteins in combination 
(Niedelman et al. 2012; Etheridge et al. 2014; Behnke et al. 2015; Shwab et al. 2016). ROP5 
functions to scaffold IRGs and ROP18 and enhance the kinase activity of ROP18 to inactivate 
its target host IRGs. In fact, it has been hypothesized that the allele of ROP5 is critical for this 
interaction, which explains why Type II strains (which have a different suite of the tandemly 
arrayed ROP5 genes) are avirulent (Behnke et al. 2012; Niedelman et al. 2012). While both 
Type I and II strains contain the ROP18 virulent allele, only Type I and III ROP5 alleles are 
capable of coordinating a virulence-enhancing effect for ROP18 in mice. Thus, because only 
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Type I strains have virulent alleles at both ROP5 and ROP18, Type I strains kill mice at much 
lower doses than either Type II or III strains (Behnke et al. 2015; Hermanns et al. 2015; 
Niedelman et al. 2012; Shwab et al. 2016).  
The working model is that ROP5 contacts host IRGs that bind to the PVM and prevents 
their oligomerization prior to interaction with the ROP18 kinase (Fleckenstein et al. 2012). 
Once the IRG is associated with ROP18, the IRG complex gets phosphorylated and a key 
effector/detection arm of the innate cellular immune response is inactivated. While it has been 
established that only a certain combination of ROP5-ROP18 alleles is sufficient for virulence, 
no further papers have been able to resolve the molecular details of exactly how ROP5 
promotes ROP18 phosphorylation to inactivate host IRGs or why the correct combination of 
these proteins increases strain virulence (Adomako-Ankomah et al. 2014; Behnke et al. 2015; 
Behnke et al. 2011; Niedelman et al. 2012; Shwab et al. 2016; Steinfeldt et al. 2010; Behnke et 
al. 2012). Protein-protein interaction studies have suggested that ROP17 also interacts with the 
ROP5-ROP18 virulence-complex. It has been postulated that ROP17 may interact with host 
Guanylate Binding Proteins (GBPs) (Etheridge et al. 2014). Indeed, deletion of the Type I 
allele of ROP17 does further reduce the virulence of the attenuated ROP18 knock-out. 
Additional work has shown that ROP17 may be more involved with cyst burden in chronic 
infections rather than acute virulence, but this mechanism of action is unclear (Fox et al. 2016; 
Zhang et al. 2014; Zhao and Yap 2014). In addition, it has been established by co-purification 
studies that GRA7, although it does not bind directly to ROP18, facilitates the assembly of the 
ROP5-ROP18 virulence-complex by interacting with the ancillary ROP5 protein (Hermanns et 
al. 2015). Further, GRA7 is known to cause ROS activation and NF-kB signaling by binding to 
IRAK4 and TRAF6, two innate immune factor proteins located in the cytosol of the host cell 
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that promote NF-kB translocation to the nucleus. Further, deletion of both GRA7 and ROP18 
leaves Toxoplasma completely avirulent, but how this interaction augments the action of the 
ROP5-ROP18 virulence-complex is currently not understood (Yang et al. 2015; Alaganan et al. 
2014). GRA7 is also known complex with ROP2 and ROP4, so it is conceivable that the ROP5-
ROP18 virulence-complex is larger than currently characterized and may be expanded by 
additional strain-specific knockouts (Dunn et al. 2008).  
Humans lack most of the IRGs described in rodents, so it is unclear whether the IRG-
interacting ROP5-ROP18 mouse virulence complex is relevant during human infections. 
However, the ROP18 kinase has been shown to phosphorylate other host protein targets, 
including the transcription factor ATF6b. In human cells, ATF6b degradation is thought to 
prevent the presentation of antigens from Toxoplasma on host cell surfaces, affecting CD8 T 
cell recognition of infected cells, which could potentially impact parasite virulence during 
human infection (Yamamoto et al. 2011). Other virulence factors that have been described 
include the dense granule protein TgIST, which inhibits STAT1. TgIST traffics from the PVM 
to the host cell nucleus where it binds to both STAT1 and chromatin-remodeling proteins (Gay 
et al. 2016). Based on available mRNA data, this protein inhibits STAT1 induction of the IFN-g 
response early during host infection and promotes parasite infection competency (Hakimi, 
Olias, and Sibley 2017; Olias et al. 2016).  
The above virulence factors inactivate effector arms of host immunity, but Toxoplasma 
also secretes proteins that activate host immunity. These factors are thought to impact parasite 
pathogenesis and regulate parasite proliferation to promote a chronic, transmissible infection 
that facilitates the parasite’s propagation to new hosts. ROP16 was the first virulence factor 
discovered that promotes parasite transmissibility. ROP16 is secreted into the host cytoplasm 
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during invasion and traffics to the host nucleus where it creates a prolonged activation of 
STAT3/6 (except in the avirulent Type II strain, where a single point mutation blocks this 
effect) and consequently alters early IL-12 production kinetics, which in turns regulates active 
parasite proliferation (Saeij et al. 2007). Additionally, it has been shown that ROP16 activation 
increases the susceptibility of host macrophages (the preferred cellular host of Toxoplasma) to 
Toxoplasma, without activating macrophage pro-inflammatory pathways, which allows 
increased dissemination of the parasite within the host (Butcher et al. 2011; Yamamoto et al. 
2011; Hunter and Sibley 2012; Jensen et al. 2011; Melo et al. 2013). Co-deletion studies have 
shown that Type II ROP16 functions in concert with Type I GRA15 to stimulate host immunity 
and increase oral infectivity and cyst burden in mice (Jensen et al. 2013). GRA15 is similarly 
secreted into the host cytoplasm during infection and traffics to the host nucleus. Once in the 
host nucleus, certain alleles of GRA15 are known to induce the transcription of the NF-kB 
pathway (Rosowski et al. 2011). This activation has been previously shown to activate IL-12 
which is the main pro-inflammatory response that host cells use to activate early effector 
immunity against Toxoplasma (Yang et al. 2013). In co-immunoprecipitation studies of cell 
lysates, GRA15 has been shown to interact with GRA24, although the nature of their 
interactions has yet to be determined (Braun et al. 2013). Like ROP18, GRA15 is hypothesized 
to function as a scaffolding protein, in complex with GRA24 (Braun et al. 2013). Like GRA15, 
GRA24 traffics from the host cytosol into the host nucleus where it activates the transcription 
of a number of MAPK genes that ultimately leads to the upregulation of IL-12, as seen 
previously with GRA15 (Pellegrini et al. 2017). Unlike GRA15, GRA24 directly interacts with 
histone-modifying enzymes that manipulate the host chromatin to facilitate pro-inflammatory 
cytokine transcription (Braun et al. 2013). GRA24 has also been shown to affect the levels of 
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Cxcl1 and Ccl2 in host cells (Shastri et al. 2014). Similarly, GRA6 is another parasite 
polymorphic effector protein that traffics to the nucleus and activates NFAT4 in an allele-
specific manner. Like GRA24, Type I and III strain alleles of GRA6 upregulate the expression 
of Cxcl2 and Ccl2 which recruit immune cells to sites of active infection. The activation of 
NFAT4 has been suggested to modulate both the growth of the parasite within host cells (by 
activating innate immune cells to limit their replication) and also to broadly disseminate 
Toxoplasma in highly mobile, infected immune cells (Ma et al. 2014). Further evidence for this 
GRA6 immune regulation has been found in exotic strains where complementation of deletions 
in GRA6 can restore virulence (Fazaeli et al. 2000). In contrast, ROP38 is a rhoptry protein that 
downregulates the expression of MAPK pathway genes (Peixoto et al. 2010). In those strains 
that highly express ROP38, NF-kB activation is lowered and results in lower levels of anti-
parasitic IL-12 (Melo et al. 2013; Fritz et al. 2012). A small number of virulence factors are 
now being discovered that regulate the immune response to Toxoplasma without being secreted 
into the host cell. One of these is the surface expressed antigen SRS29C (also annotated as 
SRS2) that is a negative regulator of virulence controlled solely by strain-specific expression 
levels, rather than allelic type (Wasmuth et al. 2012). When alleles of Type I SRS29C were 
upregulated to Type II protein expression levels, parasites displayed both delayed 
dissemination as well as decreased virulence, indicating that even surface proteins may play a 
role in the manipulation of acute disease within infected hosts.  
As different strains of Toxoplasma evolve to subvert host immunity across the parasite’s 
broad host range, a parallel adaptation within the host immune system is occurring to detect and 
defend against Toxoplasma. This co-evolutionary arms race is potentially driving the evolution 
of Toxoplasma genetic diversity and its ability to extend its host range (Gazzinelli et al. 2014; 
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Hunter and Sibley 2012). While it is largely thought that Toxoplasma is capable of producing 
chronic infections in all animal hosts, the mechanism of action to produce these chronic 
infections likely varies with the infected host species. Studies in rats have identified a single rat 
gene, the inflammasome sensor Nlrp1b, that confers sterile immunity and complete resistance 
to all tested strains of Toxoplasma (Cavailles et al. 2006; Cirelli et al. 2014; Cavailles et al. 
2014). Additionally, recent work in human cell lines suggests that humans combat Toxoplasma 
infection differently than rodents. The differences between these host immune systems is such 
that studies performed in mice may not necessarily predict the outcome of human infection. 
This is largely because mice rely on their diverse range of IRGs and GBPs to intracellularly 
detect and control acute Toxoplasma infection and dissemination. Humans entirely lack 
functional IRGs, and GBPs in human hosts do not appear to confer protection in a similar way 
that mouse GBPs control parasite infection (Dupont and Hunter 2012; Gazzinelli et al. 2014; 
Hunn et al. 2011; Hunter and Sibley 2012; Selleck et al. 2013; Steinfeldt et al. 2010). This 
suggests that within the suites of polymorphic effector proteins that Toxoplasma encodes, a 
subset of these effector proteins may confer protection from host immunity in, for example 
rodents, whereas a different subset is required for successful infection in other intermediate 
host taxa, such as humans.  
Evolutionary selection can function at the parasite lifecycle stage as well as on the 
strain. Two sexual stage-specific Toxoplasma genes, AAH1 and AAH2 encode for aromatic 
amino acid hydroxylases that are required for successful completion of the parasites’ sexual 
cycle in the definitive feline host. Without these genes, feline infections yield substantially 
reduced numbers of oocysts, however these genes do not appear to have a dramatic effect on 
murine cyst burden (Wang, Verma, et al. 2017). This interplay of diversity between the parasite 
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and its host is likely a major driving factor in the evolution of Toxoplasma’s diverse population 
genetic structure. In fact, differences in the activation of host immunity across the parasite’s 
broad intermediate host range may ultimately determine which parasite strains expand across, 
or are the best fit for, any given animal species to produce a transmissible infection. This co-
evolution of Toxoplasma and its hosts makes sense for a highly successful generalist parasite as 
host selection determines which strains are expanded as transmissible infections across 
Toxoplasma’s diverse genetic population structure.  
 
The Role of Sexual Recombination in the Population Dynamics of Toxoplasma 
Evolution 
 
Toxoplasma is a highly successful parasite with the ability to infect any warm-blooded 
animal on the planet as well as an incredibly robust sexual cycle with the ability to both expand 
the current population by uniparental replication and diversity by mixed strain co-infection. 
Recombination between even avirulent strains of Toxoplasma has previously been shown to alter 
this parasite’s biological potential by bringing alleles from different genetic backgrounds into 
varying combinations within the same genomes (Grigg, Bonnefoy, et al. 2001). Indeed, diverse 
host selection of the admixture progeny that result from sexual recombination may be the key 
evolutionary driving factor underlying Toxoplasma evolution and host adaptation as intermediate 
hosts select for parasites that cause chronic avirulent infections (Agrawal 2006). Despite its 
fecund sexual cycle and due mainly to its supposedly clonal population structure, propagation of 
Toxoplasma has been postulated to occur mainly via asexual replication, while genetic 
recombination via meiotic sexual replication is thought to be infrequent due to a lack of 
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admixture observed in the population as a whole (Wendte, Miller, Lambourn, et al. 2010; Sibley 
and Ajioka 2008; Grigg and Sundar 2009; Boothroyd 2009; Minot et al. 2012).  
However, the studies that hypothesized that Toxoplasma sexual recombination is rare 
were hampered by a number of crucial limitations. One limitation to these conclusions is that 
most population studies have utilized relatively limited numbers and resolutions of genetic 
markers which were designed to differentiate only the largest divergences in these parasites’ 
genomes (Minot et al. 2012; Su et al. 2012). For instance, low marker resolution initially caused 
Type X strains to be classified as Type II strains despite their genomic diversity at several key 
markers (Dubey et al. 2011; Khan, Dubey, et al. 2011; Sundar et al. 2008). Additionally, most 
studies have focused on the diversity across the entire population and ignored any variation that 
has occurred within the clonal lineages, even when phenotypic differences were observed 
(Parameswaran et al. 2010; Khan, Behnke, et al. 2009; Yang et al. 2013; Verma et al. 2015). Due 
to this bias toward most dissimilar strain interrogations, lower diversity levels, such as those that 
derive over shorter time scales, have not been interrogated within the Toxoplasma population. 
Because of the limited diversity within the parasite population, it is possible that sexual 
recombination can be masked when strains of similar ancestries recombine, as can happen when 
the definitive host is infected by ingesting an intermediate host that carries a co-infection of 
genetically similar strains. Cryptic uniparental and unisexual meiotic recombination likely masks 
the extent to which sexual recombination is occurring within the population.  
However, with the advent and increased utilization of whole genome sequencing in the 
Toxoplasma field, an increased appreciation of diversity within the genetic population structure 
is becoming apparent. It was a major goal of this thesis to interrogate two common, clonal clades 
of strains within Toxoplasma population genetics to determine the extent to which these strains 
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are in linkage disequilibrium and are expanding asexually versus undergoing sexual 
recombination. Additionally, the new availability of the maternally inherited apicoplast genome 
can be utilized to compare the nuclear genome to maternally inherited genomes which do not 
undergo meiotic recombination. Incongruence between the inheritance of nuclear versus 
organellar genomes within a parasite is a hallmark of sexual replication for the parasite. This 
thesis aims to test the sufficiency of the clonal theory of expansion for describing the population 
structure of Toxoplasma. To assess this, whole genome sequencing was performed to calculate 
total allelic diversity, differences in somy, CNV, gene dosage, sequence haploblock 
recombination, and other hallmarks of genome evolution that would occur by uniparental mating. 
While whole genome sequencing is useful for determining broad recombination patterns within a 
sexual clade, genomes must be interrogated in sequence haploblocks in order to determine 
whether diversity stems from genetic drift, which is derived from mitotic replication errors and 
will be evenly distributed across the genome, or from sexual recombination, which distributes 
genetic diversity in haploblocks across the genomes, which can be clearly delineated by 
recombination crossovers.  
A collection of strains belonging to two clonal lineages, Type II and Type X, were 
sequenced at whole genome resolution to infer whether they replicate in nature predominantly 
asexually, or sexually by uniparental mating (which is virtually indistinguishable from asexual 
recombination by low-resolution marker typing), to identify the most likely route of transmission 
for these highly successful clades. SNP diversity was quantified in sliding windows, typically in 
1-10kb sequence blocks, and haplotypes were established. This analysis established that 
recombination was occurring at high frequency within these clades of supposedly clonal strains. 
While the Type II strains were closely related to one another, SNP diversity within this clade was 
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geographically clustered and was sufficient to readily detect sequence haploblocks of varied 
ancestry between these strains. Several of the North American Type II isolates were in fact 
mosaic clones containing haploblocks of Type II sequence that were indigenous to either Europe 
or North America. Hence, Type II exists as a clade of highly similar strains that preferentially 
recombine unisexually but which appear to be expanding asexually when only a few low-
resolution markers are used. Whereas for Type X, increased marker density and WGS analysis 
established that this clonal lineage was not clonal, but rather resolved as a sexual clade of 
recombinant strains comprised of at least three distinct ancestries (Type II, g, and d) that had 
recombined across the genomes of the strains within Type X. Both intra and extra clade sexual 
recombination was not only occurring more frequently than had been previously postulated 
across the Toxoplasma population, but unisexual crossing was likely contributing to the 
successful expansion of the Type II lineage in nature.  
During the course of this work, the Type X lineage was resolved into 12 distinct 
haplotypes that appeared to exist as a sexual clade of natural recombinants resembling F1 
progeny from a genetic admixture between a Type II strain and a novel genotype, g/d. 
Interestingly, the haplotype that expanded to cause the majority of avirulent infections in sea 
otters was highly virulent to mice. Our data supported a virulence shift model whereby generalist 
pathogens like Toxoplasma utilize their sexual cycles to produce virulent strains that can be 
maintained cryptically in nature according to their differential capacity to cause disease across 
the pathogen’s broad intermediate host range. This type of “zoonotic selection” has important 
public health implications. Strains capable of causing fatal infections can persist in nature by 
circulating as chronic infections in tolerant intermediate host species that act as reservoirs for 
potential epidemic disease. Because all Type X strains possessed avirulent combinations of 
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ROP5 and ROP18 alleles, the opportunity to identify new murine virulence alleles was realized. 
A forward genetic approach was pursued to separately cross two virulent Type X clones with the 
avirulent Type II parent to identify novel virulence alleles, as well as to increase the number of 
recombinant progeny available to the field for other quantitative trait studies. Furthermore, this 
work aimed to deduce the amount of genomic recombination crossovers that occurs within a 
sexual cross by whole genome sequencing individually isolated sexual progeny in a novel 
manner eliminating the bias that was inherent in previous isolation methods. This work was also 
done to more accurately enumerate the extent to which outcrossing versus self-mating occurs 
during sexual replication. In fact, work shown here determined that sexual recombination is 
occurring in a more biased manner within the definitive host than was previously envisaged and 
established that sex was biased toward similar strain mating, which may explain clonal 
population structures for pathogens, such as Toxoplasma, that possess highly fecund sexual 
cycles.   
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While it is well known that sexual replication can recombine the genomes of the 
generalist parasite Toxoplasma, how this diversity is potentiated across Toxoplasma’s wide host 
range and to what extent meiotic recombination shapes the population structure of this haploid 
protozoan parasite remains unclear. Sexual recombination increases the biological and genetic 
population diversity of eukaryotes by bringing alleles into novel combinations in their 
recombined genomes (Boyle et al. 2006; Grigg, Bonnefoy, et al. 2001). Many eukaryotes utilize 
genetic hybridization to increase their biological diversity: S. cerevisiae utilize sex to create 
beneficial aneuploidy (Selmecki et al. 2015), Leishmania sexually expand to increase copy 
number variation and polyploidy across the genome (Romano et al. 2014), Cryptococcus 
neoformans recombine chromosomal-encoded pathogenicity islands through sex (Sun et al. 
2014), and Plasmodium recombines VAR genes to alter antigenic presentation (Claessens et al. 
2014). Sexual recombination is known to increase the potential for adaptation to the parasites’ 
host environment. What is less clear, is how important sexual recombination is in shaping the 
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Toxoplasma population structure as a whole, as the species is thought to maintain large 
populations of clonal types by exclusive asexual expansion (Su et al. 2012).  
Toxoplasma can orally infect any warm-blooded animal giving it a flexible transmission 
cycle across a vast infectious host range.  The ability of this parasite to expand asexually by 
carnivory across its intermediate host range is thought to explain its clonal population structure 
in North America and Europe. However, Toxoplasma possesses a highly fecund sexual cycle 
when it infects its definitive feline hosts, with yields often in excess of 100 million highly 
infectious and environmentally stable oocysts per feline (Dubey and Frenkel 1976). During 
feline infection, parasites either outcross or self-mate. Genetic hybridization between two strains 
is known to occur readily when a cat is co-infected with multiple strains simultaneously, but in 
the absence of a mixed strain co-infection, single strains of Toxoplasma are known to self-mate 
as both micro and macro-gametocytes can be produced by a single clone and fertilize each other 
to produce viable oocysts (Cornelissen and Overdulve 1985; Pfefferkorn, Pfefferkorn, and Colby 
1977). Due to its haploid nature, progeny from self-mating are virtually indistinguishable from 
strains that have been expanded asexually when analyzed using low-resolution PCR-RFLP. 
Hence, self-mating is thought to sexually expand successful clones, while the degree to which 
this mechanism affects Toxoplasma’s clonal population structure remains enigmatic. 
When two Toxoplasma strains simultaneously infect a feline, genetic hybridization can 
occur between the strains to create progeny with diversified biological potential from those of the 
two parental strains (Grigg, Bonnefoy, et al. 2001). Indeed, genetic hybridization between two 
mouse avirulent clones previously yielded progeny that were dramatically more virulent than 
either of the two haploid parents (Grigg, Bonnefoy, et al. 2001; Sibley and Ajioka 2008). What is 
less clear is the extent to which successful strains are being expanded in nature. One model 
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suggests that these clones are being maintained exclusively asexually and have expanded 
because they possess increased oral infectivity (Su et al. 2003). Alternatively, sexual self-mating 
expansion of a single clone has been proposed to explain the parasite’s clonal population 
structure in some geographic niches (Wendte, Miller, Lambourn, et al. 2010). The ability of 
Toxoplasma to expand both asexually or through sexual recombination, makes Toxoplasma an 
ideal species to study how the interplay of sexual and asexual replication shape a eukaryotic 
pathogen’s population structure.  
Despite the prevalence of sexual recombination among eukaryotic parasites, clonal 
populations are abundant. Clonal populations are common for eukaryotic pathogens, but the 
mechanisms by which they are generated and maintained vary widely. Plasmodium clonal 
populations generally result from drug resistant sweeps (Miotto et al. 2013), Cryptosporidium 
remains clonal due to a strict host adaptation which prevents cross-strain interactions (Awad-El-
Kariem 1999), and Cryptococcus remain clonal due to a lack of mating type complementation 
(Billmyre et al. 2014). However, none of these adaptations are likely to explain clonality in 
Toxoplasma. Toxoplasma drug treatments do not select for the drug resistance sweeps evidenced 
in Plasmodium as available drugs have not been systematically applied, nor do they provide a 
sterile cure following treatment. Additionally, all tested Toxoplasma strains are capable of feline 
infection thus, a lack of interaction in the definitive host is unlikely to inhibit sexual 
recombination. One theory postulates that a shared inheritance of common Type II haploblocks 
allowed for oral transmission (and asexual expansion) of the clonal strains, but this adaptation 
does not restrict sexual replication of these strains (Su et al. 2003; Khan et al. 2006).  
Furthermore, Toxoplasma lacks mating type loci which would influence mate selection, and the 
majority of sexual crossing experiments reported to date have yielded recombinant progeny. The 
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lack of impediments to sexual outcrossing in Toxoplasma brings into question how often sexual 
recombination occurs and how it affects the population structure.  
 South American Toxoplasma strains have a population structure expected from a parasite 
with a definitive sexual cycle, possessing highly polymorphic genetic diversity, extensive 
recombination of this genetic diversity across genomes, and a wide range of virulence 
phenotypes in a variety of infected hosts. In contrast, despite a fecund sexual cycle, Toxoplasma 
has a uniquely clonal population structure in both North America and Europe, where the 
population is dominated by only four clonal lineages: I, II, III, and X (or HG12) (Lorenzi et al. 
2016; Zhang et al. 2017; Khan, Dubey, et al. 2011). The predominance of clonal lineages in both 
North America and Europe, has led to the clonal theory of parasite expansion, which posits that 
the Type I, II, III, and X clonal lineages are expanding exclusively by asexual replication (Sibley 
and Ajioka 2008; Tibayrenc and Ayala 1991, 2014). However, the clonal theory of expansion 
does not consider how this clonality is generated and as asexual replication is indistinguishable 
from uniparental self-mating, both may contribute to the clonal theory of expansion (Wendte, 
Miller, Lambourn, et al. 2010).  
 No study to date has systematically examined the contribution of the sexual cycle in the 
maintenance of Toxoplasma’s clonal population structure, as the majority of studies have 
focused on charting genetic diversity worldwide and did not examine the diversity that exists 
within a clonal lineage at whole genome resolution (Lorenzi et al. 2016; Sibley et al. 2009; Su et 
al. 2012). Additionally, a significant portion of the genomes in three of the clonal lineages was 
inherited by genetic hybridization with the Type II lineage, making the Type II genomic 
contribution to the population structure more prominent than other lineages (Boyle et al. 2006). 
Further this shared inheritance within the clonal lineages suggests that Type II genomic 
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inheritance is beneficial for clonal expansion (Khan et al. 2006). Because of the increased 
density of genotyping markers, especially microsatellite markers, it is evident that genetic 
diversity does exist within the clonal lineages, especially the widely prevalent Type II clade.  
Microsatellites differences, the result of polymerase error during mitotic DNA replication, can be 
used to differentiate closely-related strains, such as those from recent outbreaks, to determine 
strain diversity on a limited scale (Demar et al. 2007; Wendte, Miller, Lambourn, et al. 2010; 
Grigg and Sundar 2009; Vaudaux et al. 2010; VanWormer et al. 2014). Microsatellite typing 
analyses have demonstrated limited genetic diversity within Type II strains isolated from 
chickens in Israel and Australia, as well as in Type II-like strains derived from Australian 
wildlife infections (Verma et al. 2015; Parameswaran et al. 2010; Silva et al. 2017). Further, 
French patients seropositive for Type II infections displayed a range of disease presentations 
(Ajzenberg et al. 2009). This genetic and phenotypic diversity observed within a single 
worldwide clonal lineage makes Type II an excellent clade for the interrogation of the 
sufficiency of the clonal asexual expansion model to explain the Toxoplasma population 
structure.  
The nature of microsatellites, which allows their use for closely-related differentiation of 
strains, makes them less useful for the interrogation of more geographically diverse strains.  
However, with the availability of whole genome sequencing, these Type II genomes were 
interrogated in greater depth to elucidate the diversity between Type II strains identified by the 
Su marker PCR-RFLP analysis. Work done here with a globally-derived subset of Type II strains 
has allowed for the novel interrogation of the diversity within a clonal lineage and the clonal 
theory of expansion by whole genome sequencing. Seventeen Type II strains from across the 
globe were sequenced using a wide selection of linked and unlinked markers across the nuclear 
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and organellar genomes of these isolates. Each of these strains were also whole genome 
sequenced and reference mapped to both the nuclear genome and the maternally inherited 
organellar apicoplast genome to interrogate genomic evolution and test the sufficiency of the 
PCR-RFLP analysis to accurately predict the Type II designation. The appreciation of the 
polymorphisms across sequence typing markers, combined with characterization of unique 
genomic haploblocks of Type II sequence diversity via SNP density and whole genome 
interrelationship studies, such as NeighborNet and PopNet, established that strains belonging to 
the Type II clade display more genetic diversity than was previously envisaged. Importantly, this 
diversity was not evenly distributed across each Type II genome but was rather localized into 
distinct haploblocks that were inherited independently across the Type II strains, suggesting they 
were derived by intra-clade genetic hybridization. From these analyses, both sexual 
recombination and mitotically acquired genetic drift were observed in these genetic mosaics 
within the Type II lineage. While low-resolution PCR-RFLP analyses indicated that all strains 
belonged to the clonal Type II clade, sequencing of the PCR markers and whole genome 
sequencing of each strain established that sexual recombination between closely-related Type II 
strains is occurring and that sexual expansion by uniparental mating better explains how 




Type II Strains Comprise a Single Clade of Strains by Low-Resolution Typing 
 
 Previous interrogations of Type II strains identified genetic diversity within the clonal 
lineage by microsatellite typing (Silva et al. 2017; Verma et al. 2015; Parameswaran et al. 2010). 
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However, this diversity has never been investigated using single-copy polymorphic genes, let 
alone at the whole genome level, which captures genetic evolution over larger time scales. To 
examine the genetic diversity inherent within the Type II clonal lineage, 17 previously genotyped 
Type II strains from across the globe were selected as representatives of the Type II lineage. 
These strains were selected from 10 locations across 6 continents to encompass worldwide 
diversity within this clonal lineage (Supplemental Figure 1). To make relative genetic diversity 
comparisons, 3 Type I, 2 Type III, and 5 Type X strains, all of which have previously 
introgressed with the Type II lineage, were included in the genome-wide SNP diversity plots 
(Boyle et al. 2006; Lorenzi et al. 2016). Eight outgroup strains were also included to examine 
total genetic diversity across the entire Toxoplasma population. 
Traditionally, ten PCR-RFLP markers have been used to characterize newly isolated 
strains (Shwab et al. 2014). All of the Type II strains selected for this study were categorized by 
PCR-RFLP as Type II clonal strains (Figure 1A). These Type II strains, that were colored 
according to their geographic origin of isolation, resided on a single, well supported branch with 
no observable diversity within the concatenated-marker maximum likelihood phylogenetic tree 
(Figure 1B). Similarly, the Type I, III, and X clonal lineages grouped with their respective clonal 
clades. The grouping of these strains by PCR-RFLP supports their characterization as clonal 
lineages, however, it is known that the APICO marker breaks the Type II lineage into two 
separate genotypes (ToxoDB #1 and #3) but, these two genotypes are commonly referred to as 
the Type II lineage, as all nuclear-encoded markers are in linkage disequilibrium. Included in this 
analysis were, 4 Type II strains with the ToxoDB genotype #1 designation and 11 Type II strains 
with the ToxoDB genotype #3 designation.  
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Greater Marker Resolution Differentiates Type II Strains 
 
A lack of genomic resolution has previously been the culprit of incorrect strain 
classification, for example when the Type X strains were classified as part of the Type II lineage 
(Khan, Dubey, et al. 2011; Verma et al. 2015; Silva et al. 2017). To better resolve the Type II 
clade, the PCR-RFLP markers were sequenced and additional linked and unlinked sequenced 
markers were added across the genome. The full complement of markers included 10 markers 
defined by Su et al. (Shwab et al. 2014; Su, Zhang, and Dubey 2006) as well as 4 markers 
previously described by Grigg et al. (Wendte, Miller, Lambourn, et al. 2010; Grigg and Sundar 
2009; Parameswaran et al. 2010), increasing the sequence used for analysis by 120% 
(Supplemental Table 1). The ToxoDB PCR-RFLP markers covered 7135 bp of genomic 
sequence, but only accounted for 18 SNPs across the loci interrogated via RFLP digestion, 
whereas the sequenced markers covered 15782 bp of sequence and increased the number of SNP 
positions to 413. Microsatellite markers were excluded from our analyses because they diverge at 
a much faster rate than traditional typing markers and have the potential to back mutate, so they 
are less informative for determining ancestry. Microsatellites are more appropriate to interrogate 
strain differences at a single location or during an outbreak situation, whereas this study aims to 
determine genomic diversity over longer time scales within a clonal lineage.   
To establish the haplotypes for each of the Type II strains, all 14 pan-genomic markers 
were analyzed using 1000 bootstrap supported maximum likelihood trees for each marker 
separately and for all markers in a concatenated sequence (Figure 1C). Phylogenetic divisions of 
60% or greater bootstrap between tree branches identified unique alleles of independent ancestry. 
This threshold was chosen because it differentiates the Type II and closely related X strain 
phylogenies and is thus suitable to differentiate mitotic drift from unique genetic diversity 
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between clades. Analysis of the concatenated tree demonstrated that while Type II remained 
closely grouped, Type II strains divided into five sub-groups with >60% bootstrap support within 
the clade (Figure 1C). Of the 17 Type II strains analyzed, only ME49 remained in the original 
group. While minor mitotic drift is expected within closely-related clades of strains, the number 
of groups obtained from these sequenced markers was unexpected (Khan, Behnke, et al. 2009; 
Verma et al. 2015). Because the sequencing performed was limited, accounting for 0.02% of the 
genomes, these results suggested that whole genome sequencing was necessary in order to fully 
















Figure 2-1: Genotyping analyses identify genetic diversity within the Toxoplasma Type II clonal lineage 
A) Characterization of 10 standard Toxoplasma PCR-RFLP markers by restriction digest across 17 strains of Type 
II, 3 Type I, 2 Type III, 5 Type X, and 8 outgroup strains. Markers are shown with their chromosomal location, 
length of sequence, and RFLP digestion enzyme used. Strains are grouped by PCR-RFLP designation and their 
ToxoDB genotype is shown. Identity of the markers across these strains is listed based on observed digestion 
compared to known digestion patterns. B) Simulated maximum likelihood tree based on allele present using the 10 
PCR-RFLP markers. Allele identity from digests were concatenated and used to simulate a maximum likelihood tree 
with 1000 bootstrap support. All Type II isolates were color-coded based on the geographic location of the isolate. 
(North America, South America, Eurasia, Africa, Australia). This color scheme is used throughout the figures. C) 
Four additional markers were added to the ten original markers above (markers listed in Supplemental Table 1). All 
14 markers were DNA sequenced and concatenated to produce a maximum likelihood tree with 1000 bootstrap 
support. The tree was based on 15782 bp of sequence across the genomes of these strains. Strains were colored as in 






Whole Genome Sequencing Reveals the Nuclear-Organellar Incongruence and Reticulation 
Inherent in the Type II Lineage 
 
To better resolve the true diversity and genetic history within Type II, whole genome 
sequencing was performed for each isolate and reference mapped to the canonical Type II, ME49 
genome (ToxoDB Version 8.2) and apicoplast organellar genome (GenBank KE138841). As the 
apicoplast does not undergo meiotic recombination and is maternally inherited, it is ideal for 
characterizing incongruence between the nuclear versus apicoplast tree topologies that occurs 
when meiotic recombination shuffles the alleles of nuclear-encoded genes into novel 
combinations (Ferguson et al. 2005). The 35 kbp apicoplast of each strain was analyzed by a 
maximum likelihood tree to compare against the nuclear genome (Figure 2B). Mitotic drift 
within the apicoplast genome was expected due to the age of the Type II lineage (Boyle et al. 
2006). Assuming strains are expanding largely asexually, then the accumulation of SNPs during 
asexual replication should produce trees that are congruent between nuclear-encoded genes and 
those of the apicoplast. Additionally, strains from the same geographic isolation location would 
share the majority of the polymorphisms across the genome and should group closely (Silva et al. 
2017). While a significant portion of the Type II strains do geographically group, nuclear-
organellar incongruence was observed in multiple Type II strains. The Australian GoatTAS and 
South American TgNgBr1 strains grouped with the North American strains in NA 2 and 4 
respectively despite their distant geographical isolation. Additionally, the African Toxoplasma 
strain, TgCatEg45 grouped with the Eurasian strains rather than with the other two African 
derived strains (TgDogEg11 and TgCatEg51). Ten apicoplast-based groups of strains were 
identified from this sequencing. Importantly, the ten apicoplast groups displayed a marked 
incongruence from the ten nuclear inheritance groups based on the extended pan-genomic 
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marker sequences (Figure 2B and Figure 1C respectively). The incongruence between the 
nuclear and organellar genomes indicated that sexual recombination is occurring within the Type 
II clade.   
The incongruence observed between the maternally inherited genome and nuclear 
markers indicated that WGS is required to infer an accurate genetic history model and to 
interrogate the clonal theory of expansion in the closely-related Type II strains.  17 Type II, 3 
Type I, 2 Type III, 5 Type X, and 8 outgroup strains were sequenced and mapped against the 
canonical ME49 Type II strain to analyze intra-clade diversity. Over 973,800 SNP positions 
were identified across the genomes and used to assemble a NeighborNet tree based on the 
divergence between strains (Figure 2A). Indels were excluded due to their poor integration with 
phylogenetic analysis software. As expected, the Type I and III clonal lineages shared edge 
blocks of reticulation due to their common ancestry with the Type II lineage, but otherwise 
grouped as single branches (Boyle et al. 2006). Type X strains grouped onto a number of 
branches, providing the first evidence that Type X is not a clonal lineage (see Chapter 3) but 
rather recombinant progeny from at least one sexual cross with Type II (Khan, Dubey, et al. 
2011; Sundar et al. 2008). All Type II strains grouped together on a single reticulated branch, as 
expected for a closely-related clade of strains, whose branch length is consistent with Type II 
ancestral divergence from the other clonal lineages (Khan, Dubey, et al. 2011; Lorenzi et al. 
2016; Shwab et al. 2014; Sibley and Ajioka 2008; Zhang et al. 2017). Close inspection of the 
Type II branch (Figure 2C), however, showed evidence of both minor mitotic drift within the 
Type II strains, evidenced by the short branch lengths between strains, as well as reticulation 
between the strains, such as that found between TgNgBr1 and ME49, indicative of sexual 
recombination between the strains. As with the apicoplasts (Figure 2B) the nuclear genomes of 
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the Type II strains generally grouped based on geographic isolation (Figure 2C), with a few 
notable exceptions such as GoatTAS, a strain isolated in Australia that grouped with the African 
strains. The strain reticulation combined with the incongruence between the nuclear and 
organellar genomes tree topologies suggest that Type II strains are recombining their genomes 
within this closely-related clade. As NeighborNet trees examine the polymorphic differences 
between strains but ignore the position of these polymorphisms, it is necessary to examine the 
position of these SNPs across the genomes to determine the evolutionary inheritance of these 
strains. Positional analysis via SNP density plots is necessary to assess whether these SNPs are 
inherited in recombination blocks (referred to as haploblocks) indicative of sexual recombination 
or at random across the genome, as would occur in asexually expanding strains that accumulate 







Figure 2-2: Incongruence between Type II nuclear and organellar genomes identifies sexual recombination 
within the Type II lineage 
A) All strains were whole genome sequenced and reference mapped to ME49. Over 973,800 SNP variant positions 
were called and used to construct a NeighborNet tree based on nuclear genomic sequencing. Strains were colored 
based on geographic isolation (North America, South America, Eurasia, Africa, Australia). B) WGS of strains were 
reference mapped to the 35 kbp ME49 apicoplast sequence (GenBank KE138841). 232 SNP positions were 
identified and a fasta file of the entire apicoplast sequence was constructed for each isolate. Apicoplast genomes 
were aligned to produce a maximum likelihood tree in the MEGA program with 1000 bootstrap support. 
Incongruence between the organellar and nuclear genomes grouped via the NeighborNet analysis support a model 
whereby recombination has occurred among the Type II isolates examined. C) Inset of NeighborNet tree in A 
focusing only on the Type II strains. Type II strains are significantly different from the other clades of strains in this 
analysis. Mitotic drift is apparent in the independent branching patterns of the Type II isolates. Meiotic 






Marker Recombination is Indicative of Meiotic Recombination Across Type II Strains 
 
To investigate whether the genetic relationship between Type II strains is supported by a 
model of clonal expansion, sexual recombination, or some combination of both, individual 
maximum likelihood trees were created for each of the nuclear encoded single gene copy typing 
markers (Supplemental Table 1). To differentiate minor mitotic drift from independent evolution 
of a divergent allele, a bootstrap of 60% or greater was used to support a new allele designation. 
For each tree, all Type II strains were colored green while the I, III, and X lineages were colored 
red, blue, and purple respectively (Figure 3). Each locus bears a novel allele that has not been 
described in any of the canonical clonal strains or any of the 8 outgroup strains selected to assess 
genetic diversity within the species. Not only is this novel allele observed to possess greater than 
60% bootstrap support and is divergent from the canonical Type II allele, but multiple strains 
bear the same allele at most loci. Importantly, no minor mutational drift was reported for each of 
the alleles resolved indicating a recent genetic origin. This data is parsimonious with sexual 
replication reshuffling a limited set of alleles within the Type II clade, presumably by unisexual 
mating. In total, 11 haplotypes were resolved across the 14 markers used to describe the 17 Type 
II strains (Supplemental Table 1A). Evidence for recombination is apparent at the majority of 
loci. For example, two alleles are resolved among Type II strains at both BAG1, a marker on 
chromosome VIIb, and SAG3, a marker on chromosome XII. The tree topology is congruent for 
11 out of 17 strains, with ten versus one sharing either a canonical or novel Type II allele 
between the two markers, respectively. For the remaining 6 strains, crossing of the blue and 
orange lines depicts incongruence in the tree topologies and supports genetic hybridization as the 
most likely explanation (Figure 3A) for these two unlinked markers. Again, for two other 
unlinked markers versus L358, on chromosome V, and PK1, on chromosome VI, two alleles are 
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resolved, and two strains 3675 and 3131 are incongruent, visualized by the crossing of the 
orange and blue lines (Figure 3B). The crossing of the blue, orange, and green lines highlight the 
lack of congruence between the two sets of marker loci. Such incongruence across the Type II 
genomes can only be obtained via sexual recombination within the Type II clade of strains, 
arguing against the clonal theory of expansion for the Type II lineage. These recombination 
patterns were unexpected for a clonal lineage thought to be asexually expanding through the host 
population. To determine the extent to which recombination is shaping the genetic relationship 


















Figure 2-3: Segregation of unlinked and recombination among linked markers identified genetic 
hybridization within Type II strains 
Comparison of sequence typing markers shown via maximum likelihood trees with 1000 bootstrap support at each 
marker. Strain identity here is characterized by the PCR-RFLP designation in Figure 1A. ME49 classifies the 
canonical Type II allele and WTD1 classifies the Type X allele. New alleles at each marker are differentiated based 
on 60% or greater bootstrap support. A) Comparison of unlinked markers: BAG1 on chromosome VIIb and SAG3 
on chromosome XII. Green highlights strains that have Type II alleles at both loci. Purple highlights strains that 
differentiate Type X strains at BAG1. Pink highlights strains that contain a unique allele at both loci. The crossing of 
orange and blue highlight sexual recombination between the Type II strains as the alleles highlighted bear a unique 
allele at one locus and a canonical Type II allele at the other locus. B) Unlinked markers: L358 (chromosome V) 
compared to PK1 (chromosome VI). As above, green highlights strains that have Type II alleles at both loci. Orange 
and blue highlight strains that have undergone sexual recombination and possess a novel allele at one locus but a 






The Type II Population Clades into Several Distinct Sub-groups by Genomic Inheritance 
 
In order to interrogate the distribution of polymorphism and whether the novel alleles 
identified in the phylogenetic trees (that have genetic ancestry closest to Type II) exist in discrete 
haploblocks, or are randomly distributed across the genome, pairwise SNP diversity plots were 
generated for all Type II isolates, as well as reference Type I and III strains that are known to 
have previously recombined with Type II (Boyle et al. 2006). Although SNP diversity 
fingerprinting does not report the SNP identity, density patterns display strain differences across 
the genome as a whole, allowing visualization of a fingerprint of the diversity encoded within the 
genome all at once. Strains were reference mapped to ME49 and differences were shown as a 
quantification of diversity in 100 kbp windows across the genomes. The Type I RH reference 
strain possessed a Type II chromosome Ia and IV, and a Type II admixture block at the left side 
of chromosome VIIa, and right end of chromosome XI. The Type III VEG strain displayed a 
similar admixture with Type II sequence across roughly 40% of is genome, as expected based on 
previous admixture characterizations (Figure 4A). A select number of Type II strains showed 
similar admixture diversity as Type I and III, although the SNP density was approximately one 
log lower (3-5 SNPs per 10 kb block) in the regions that were different from ME49 reference, 
consistent with the diversity observed at the individual marker loci that were Sanger sequenced. 
To determine whether this diversity was in large haploblocks synonymous with recombination, 
and whether this was a common finding across the entire Type II clade, SNP density fingerprints 
were created for all Type II strains. The plots were grouped by geographic isolation (Figure 4B). 
Strong correlations between geographic isolation and genomic diversity were apparent indicating 
that Type II strains from different geographic locations can be differentiated from each other by 
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the accumulation of shared SNPs that are geographically restricted. Importantly, all of the North 
American isolates appear to be genome-wide admixtures that share distinct portions of their 
genomes with ME49, and other regions that share closest ancestry with Eurasian, African and 
Australian isolates. The picture that emerges is that the majority of Type II strains are distinct 
genetic admixtures of the SNP diversity present within the Type II clade. This is also captured by 
the inheritance of the apicoplast genome. For example, the Australian strain GoatTAS is distinct 
genome-wide, except for a large haploblock of sequence in the first third of chromosome VI 
which shares ancestry with North American strains. Not surprisingly, the Goat TAS apicoplast 
genome clades with the North America 2 apicoplast, indicating that this line has crossed with a 
Type II strain from North America (Figure 2B). Conversely, while Eurasian isolates CZ1 and 
PRU group closely by apicoplast phylogeny, their SNP densities are distinct and CZ1 
chromosome V shares ancestry with North American strains. SNP density fingerprints within the 
North American strains correlated well with the diversity seen in the apicoplast tree but showed 
more SNP diversity haploblocks than any other geographical sub-group, indicating that multiple 
sub-groups exist within this group of geographically-related Type II strains. Importantly, the 
SNP diversity among the North American Type II strains was inherited in discrete haploblocks 
rather than being randomly distributed across the genome, which strongly supported an 
admixture model for expansion of the Type II lineage by unisexual mating.     
While the pairwise SNP diversity plots can identify haploblocks that are different from 
reference, these SNP plots do not identify the ancestry of non-reference haploblocks. We next 
utilized PopNet to identify the number of discrete ancestries comprised within the Type II clade, 
and to map these ancestries across each genome to identify strains that are most similar to each 
other (Figure 4C). PopNet identifies chromosomal regions of shared genetic inheritance by 
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looking at recombination blocks based on clustering shared polymorphisms across all of the 
input genomes. Chromosomes are painted based on blocks of shared sequence. Chromosome 
painting of these Type II strains readily visualized recombined sequence haploblocks of distinct 
ancestry. For instance, the North American strains, TgGoatUs2 and 2987, had similar SNP 
density fingerprints (Figure 4B), and both share a large haploblock on chromosome Ia with Type 
I strains that is not present in the other Type II strains, indicating that these two strains are of 
mixed ancestry. Type II strains that share the most ancestry are indicated by the bolder 
connecting lines. Interestingly, one North American isolate, TgVvUs1, appears to have 
haploblocks of sequence in common with multiple lineages of Type II from diverse global 
populations. This mixed inheritance within a Type II strains strongly supports recombination 
occurring within the Type II clade as the inheritance of discrete haploblocks of shared ancestry 





Figure 2-4: Characterization of genomes of Type II strains via SNP density and PopNet shows diversity is 
inherent across the Type II strains and indicates diverse haploblocks are recombining across the Type II 
genomes. 
A) Pairwise SNP diversity plots of the Type I and III clonal lineages as well as a number of representative strains of 
Type II. These plots were created from WGS SNPs mapped to ME49. Each row displays the genome of one strain of 
Type II. Columns separate the chromosomes based on chromosome length. Each vertical bar represents the number 
of SNPs in 100 kbp window of sequence with the tallest bars representing areas in this strain which contain the 
highest quantity of SNPs that differ from the Type II ME49 reference strain sequencing, representing greater 
diversity in that area of the genome. B) SNP density plots for all Type II strains grouped by geographical isolation of 
the strains. Y-axes are constrained to 0-20 SNPs per window to allow better visualization of Type II strains. C) 
PopNet analysis of the WGS of the Type II and X strains with Type I, III, and X strains for reference. All 
chromosomes of these strains are concatenated into a single circular representation of the genome. Chromosomes 
are painted based on their shared ancestry within groups of strains. These clusters are shown via the color of the 
circle behind the strain which indicates the clustering of the majority of its genome (Type II-green, Type X-purple, 
Type I-cyan, Type III-blue). Lines between strains indicate interrelatedness between these particular strains with 




SNP Fingerprinting Displays Type II Diversity and Recombination Between Strains 
 
 After observing genetic admixture of distinct haploblocks from geographically isolated 
strains within a single North American Type II genome, further investigation of the TgVvUs1 
haploblocks was necessary to understand the extent of chromosomal recombination across this 
strain. A subset of 7 representative isolates from across the geographic range of sequenced 
strains were interrogated to characterize the origin of these discrete haploblocks. The SNP 
fingerprint of specific TgVvUs1 haploblocks were compared with fingerprints of other analyzed 
strains to show that the TgVvUs1 SNP density pattern across the length of chromosome IX was 
shared with the South American strain TgNgBr1. This pattern of inheritance was not observed in 
other North American isolates, indicating that this haploblock is not common in North America 
but has likely admixed into the TgVvUs1 genome via sexual recombination between North and 
South American Type II strains. The SNPs in this chromosome were extracted from the WGS of 
all strains previously characterized in this study and were analyzed in a maximum likelihood tree 
(Supplemental Figure 2A). Both strains clustered on the same 100 bootstrapped tree branch, 
which supported the finding that chromosome IX of TgVvUs1 was genetically most similar to 
chromosome IX of the South American isolate. As expected for a North American strain, the last 
1,400,000 bp of chromosome XI shared ancestry with other North American strains 
(Supplemental Figure 2D). However, the middle portion of the chromosome from 4.2-5.4 Mbp 
displayed inheritance consistent with African isolates such as TgDogEg11 (Supplemental Figure 
2C). TgVvUs1 also displayed some unique evolution at the proximal end of Chromosome XI 
where the sequence grouped separately from all other Type II strains, both in SNP density and 
phylogenetic analysis (Supplemental Figure 2B), which may be evidence of ongoing mitotic drift 
or introgression of another ancestry. 
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 The Type III Toxoplasma strain, VEG, is known to be the product of a sexual cross 
between a Type II strain and another distinct ancestry previously referred to as b (Boyle et al. 
2006). To determine the ancestry of the type II haploblocks present in VEG, a SNP diversity plot 
was generated, and the SNP fingerprinting pattern was similar to that observed for TgVvUs1 
(Figure 5B). The proximal 3.8 Mbp of chromosome VIII possessed a Type II haploblock and the 
maximum likelihood tree generated in this region claded with Eurasian Type II strains 
(Supplemental Figure 3A/B). Conversely, SNP fingerprint analysis and maximum likelihood 
trees supported the entirety of chromosome XI as most similar to North American Type II strains 
(Figure 5B and Supplemental Figure 3C). However, the VEG chromosome XII had a mixed 
heritage (Figure 5B). In the 3.6-4.6 Mbp region it was most closely related to the Eurasian strains 
(Supplemental Figure 3D) whereas the distal 6.5-7.1 Mbp of the chromosome grouped more 
tightly with North American Type II strains (Figure 5B and Supplemental Figure 3E) suggesting 
that the b parent likely crossed multiple times with different Type II lines, or once with a 




Figure 2-5: Recombination observed across haploblocks of SNP density identified in both Type II and Type 
III strains. 
A subset of the SNP density fingerprints shown in Figure 4A are highlighted here to display recombination that has 
occurred across the genomes of the Type II TgVvUs1 strain, isolated from a North American fox, and the Type III 
VEG strain. SNP density plots are shown using a sliding 10 kbp window to allow for better resolution of discrete 
haploblocks of SNP density on the selected chromosomes. Y-axes are restricted to 0-10 SNPs to resolve the low 
frequency of divergence within the Type II clade. Representatives strains of each geographical isolation are included 
for reference to the isolate being interrogated. Strains were colored as previously based on geographical isolation 
(North America, South America, Eurasia, Africa, Australia). A) North American strain, TgVvUs1 SNP density 
fingerprint across chromosomes IX and XI compared to geographically representative strains. Chromosome IX 
highlighted in yellow mirrors the SNP density of South American strain TgNgBr1. Chromosome XI highlights the 
mixed inheritance pattern in TgVvUs1. The last 1.4 Mbp of chromosome XI (highlighted in pink) has a shared 
ancestry with North American strains, whereas the region from 4.2-5.4 Mbp (highlighted in green) has a shared 
ancestry with African strains (e.g., TgDogEg11). Purple highlights the haploblock region from 1.2-1.8 Mbp where 
TgVvUs1 appears to have a distinct ancestry from all other Type II strains assayed. Chromosomal trees supporting 
these inheritances are shown in Supplementary Figure 2. B) VEG SNP density fingerprint across chromosomes VIII, 
XI, and XII compared to geographically representative strains. The first 3.8 Mbp of chromosome VIII (highlighted 
in blue) has a SNP density fingerprint similar to the Eurasian DEG strain whereas the entirety of chromosome XI 
(highlighted in pink) shares ancestry with North American Type II strains such as TgGoatUs19. Chromosome XII 
identifies recombination between different ancestries. Specifically, the SNP density from 3.6-4.6 Mbp (blue) 
encodes a divergent Type II ancestry that is most closely related to the Eurasian PRU strain, whereas the region 
from 6.5-7.1 Mbp (pink) shares ancestry with North American Type II strains (e.g., TgGoatUs19). Chromosomal 








Toxoplasma and the Clonal Theory of Expansion  
 
Sexual recombination is known to alter biological potential within a parasitic population, 
allowing selection for advantageous adaptations that are maintained cryptically and when 
sexually recombined can confer on the progeny new combinations of virulence genes that 
enhance transmissibility and extend a parasites host range. This adaptability is especially 
important for generalist parasites, like Toxoplasma. Provided the opportunity to sexually mate, 
Toxoplasma can produce upwards of 800 million highly-infectious, genetically recombinant 
progeny, all of which are capable of productively infecting any warm-blooded animal (Torrey 
and Yolken 2013). This fecundity would suggest that the sexual cycle of Toxoplasma should aide 
in the ability of this parasite to expand across a broad host range. However, previous work has 
suggested that the Toxoplasma population is expanding primarily asexually, which would limit 
punctuated adaptations that could be rapidly recombined within the population by its sexual 
cycle. The apparent clonality of the Toxoplasma population led to the clonal theory of 
propagation; a theory proposing that Toxoplasma strains propagate in nature exclusively by 
asexual expansion, and that sexual recombination was sufficiently rare to not impact the clonal 
population structure (Sibley and Ajioka 2008; Tibayrenc and Ayala 2002, 2014).  The clonal 
theory of propagation states that mitotic drift is occurring due to polymerase error during 
replication, but that sexual recombination is not sufficient to break up the clonal population 
structure. The theory was based largely on a limited set of genetic markers that were in linkage 
disequilibrium and suggested the existence of widespread identical genotypes. In the age of 
genome sequencing, it is possible to revisit the theory of clonal propagation to test the 
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sufficiency of the model, when virtually an entire genome of markers are interrogated. This 
thesis assayed at full genome resolution a collection of strains from the globally distributed Type 
II clonal lineage to determine the extent to which isolates within this lineage, are expanding 
asexually or sexually. The Type II clade was selected to address the possibility that 
Toxoplasma’s clonal lineages may possess greater diversity than previously envisaged, using 
higher resolution markers and whole genome sequencing to determine the contribution of the 
sexual and asexual lifecycles in shaping the clonal population structure of Toxoplasma.   
 
Diversity Inherent in Typing Markers of the Type II Clonal Lineage 
 
 Work shown here tested the sufficiency of the current set of typing markers to accurately 
predict strains that belong to a clonal clade. The Type II clade is defined by a restriction digest 
pattern at ten ToxoDB PCR-RFLP characterization markers. We selected 17 strains that were 
known to be in linkage disequilibrium and genotyped as Type II strains by PCR-RFLP analyses. 
The first test was to expand the number of markers and DNA sequence both the PCR-RFLP 
markers as well as 4 additional typing markers that were selected because they were under either 
neutral, homogenizing and diversifying selection. Our results indicated that within the Type II 
clade, multiple, genetically distinct Type II sub-groups were present across the globe once 
analyzed by whole genome DNA sequencing. This genetic diversity may begin to explain the 
differences observed in clinical disease within the Type II clade.  
 The diversity within the Type II clade was not entirely unexpected as this clade is known 
to be comprised of two distinct PCR-RFLP genotypes grouped into one clade of strains. The one 
known SNP difference is in the maternally-inherited apicoplast organellar genome marker 
(APICO) which is not nuclear-encoded, and hence was not considered in the Type II lineage 
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designation (Su, Zhang, and Dubey 2006). In this study, DNA sequencing of the full 35kb 
apicoplast genome on which APICO is located identified considerable genetic diversity within 
the maternally inherited, organellar genome. Genomic diversity using the expanded set of 
sequenced nuclear encoded markers within our cohort of 17 Type II strains suggested greater 
diversity among Type II strains (Ajzenberg et al. 2009; Verma et al. 2015). Based on marker 
sequencing, five distinct haplotypes were identified within the Type II strains examined and 
these preliminary results indicated that whole genome sequencing would be needed to determine 
the true extent of diversity within the Type II clade.  
 
Incongruence Between Nuclear and Organellar Genomes Indicates Sexual Recombination 
Occurs Within the Type II Clade 
 
Diversity within these strains could be from polymerase error during mitotic replication 
(genetic drift) or from recombination, which admixes sequence haploblocks bearing distinct 
ancestries and can cause incongruence between the apparent ancestries of nuclear-meiotically 
dividing and organellar-mitotically dividing genomes. To investigate the degree to which isolates 
within the Type II clade were expanding asexually versus sexually, a phylogenetic analysis was 
carried out to determine whether incongruence among tree topologies existed between the 
nuclear and organellar genomes of Type II. The apicoplast is thought to evolve exclusively by 
mitotic drift and does not participate in meiotic sexual recombination, hence, an incongruence 
between the nuclear versus the organellar genome would indicate that these genomes have 
sexually recombined. The network analysis for the genomes of these strains (Figure 2A) displays 
known clonal lineages on individual branches with individual isolates of these lineages clustered 
closely together at the end of each branch, as expected for lineages with a small degree of mitotic 
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variation (Lorenzi et al. 2016). Type II strains all claded together on a single branch, supporting 
their close genetic relationship. However, despite the apparent clonality of the Type II strains 
(Figure 2A), the mapping of these strains onto the apicoplast genome identified 10 haplotypes 
that resolved into six well-supported (with >60% bootstrap support) apicoplast genomes. 
Interestingly, the six apicoplast genomes did not all clade with the same five groups that were 
defined by the sequencing the nuclear encoded typing markers. The only way that this 
incongruence could occur is by genetic hybridization which admixes nuclear genomes but does 
not affect the maternal inheritance of the apicoplast genome which undergoes mutation by 
genetic drift (Ferguson et al. 2005).  
To determine whether the Type II strains are undergoing unisexual expansion (intra-clade 
genetic recombination) and reshuffling diversity within the Type II clade, as suggested by the 
typing markers, WGS was performed on 17 strains Type II strains to better resolve the allelic 
diversity discovered and determine whether this diversity is distributed in large haploblocks 
synonymous with genetic hybridization. In fact, the majority of the typing markers possessed at 
least one novel allele that closely resembled the ME49 canonical Type II allele but was 
considered sufficiently different to be evolving independently based on bootstrap support greater 
than 60%, a cut-off that was previously used to differentiate the Type II and X clades. 
Furthermore, the novel II-related alleles were limited and did not possess strain-specific SNPs as 
would be expected if these alleles were ancestral and accumulating mutations by polymerase 




Type II Strains Display Geographical Inheritance and Sexual Recombination Across the 
Genome  
 
 SNP density plots established that the Type II strains resolved into several discrete 
subgroups based on their geographic origin. However, both the Eurasian and North American 
groups had at least one strain that contained SNP diversity fingerprints not seen in the rest of the 
geographic group. North American strains were the most widely sampled and also the most 
diverse geographic group within the analysis. Correspondingly, the North American Type II 
isolates (such as 3131 and TgGoatUs2) displayed more in-group SNP fingerprint diversity than 
the other geographic groups, indicating that there existed multiple subgroups of Type II within 
North America. Prevalent haploblock recombination across these North American sub-groups 
indicated that sexual recombination as well as mitotic drift was shaping the Type II population. 
Indeed, the geographical subgroups observed by the SNP diversity analyses were supported by 
the PopNet chromosome painting analysis.   
  The North American strain TgVvUs1 was a good example of full genome admixture 
between different clades of Type II. TgVvUs1 was shown to share sequence haploblocks that 
were either of South American, African, or North American descent, indicating that this isolate 
has undergone several unisexual genetic hybridizations with a diverse array of geographically 
isolated groups within the Type II clade. Importantly, the majority of the genome’s SNP 
fingerprint clades with the North American Type II sub-group, and this strain has a limited 
number of recombination points that are readily observed across the genome, which is not 
parsimonious with this strain evolving from a common ancestor but is rather a product of 
multiple genetic hybridization events between divergent strains of Type II. Although only 17 
strains were sampled across the global Type II population, and at least four of these (CZ1, 
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TgVvUs1, 3131, TgCatEg51) were found via SNP density fingerprinting and phylogenetic 
verification to be recombined progeny from unisexual crosses between Type II strains, indicating 
that sexual recombination is likely more prevalent than has previously been characterized, 
especially since no previous study has interrogated any clonal lineage at whole genome 
resolution (Sibley et al. 2009; Grigg and Sundar 2009). Recombination within a clade masks the 
frequency of recombination within the Toxoplasma population, especially because the frequency 
of sexual crossing is generally assayed by a limited set of PCR-RFLP markers that were 
designed to distinguish the original three clonal lineages rather than distinguishing intra-lineage 
diversity (Shwab et al. 2014; Khan, Dubey, et al. 2011; Boyle et al. 2006; Minot et al. 2012). It is 
likely that further interrogation of the Type II clade will yield additional diversity and evidence 
of recombination across this clade of strains, especially with the addition of more South 
American isolates where sexual recombination is known to be an integral part of population 
transmission dynamics (Khan, Dubey, et al. 2011). 
The diversity observed within the Type II clade is recapitulated within the Type II 
regions of the Type III strain VEG. Type III strains are progeny of an ancient cross between an 
unknown b ancestor and a Type II ancestral strain (Boyle et al. 2006). SNP density 
fingerprinting of the Type II haploblocks within the Type III VEG strain showed inheritance of 
both North American and Eurasian ancestry. Based on the limited diversity and strong 
segregation of the Type II haploblocks, the mixed inheritance of the Type II ancestry within the 
Type III clade was likely derived from sexual crossing between a mixed North 
American/Eurasian Type II strain and an unknown b strain rather than subsequent interbreeding 
with multiple Type II strains. The mixed inheritance of the Type II strain agrees with previous 
studies where Type III strains contained two distinct sub-groups of the Type II lineage based on 
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sequence comparisons of haploblocks across the population (Minot et al. 2012). Recombination 
within the Type III clade as well as the Type II clade supports a model whereby genetic 
hybridization is shaping the population structure of Toxoplasma, at least since VEG was derived 
~5000 years ago (Boyle et al. 2006). Additionally, this ancient recombination indicates that 
sexual recombination between the Type II isolates is not a recent adaptation of this clade. 
Whether this diversity of genomic inheritance would be recapitulated in other clonal lineages 
would inform the mechanisms by which Toxoplasma maintains its apparently clonal population 
structure.  
 
Sexual Recombination is Frequent yet Biased Within Type II Strains, and Likely the 
Toxoplasma Population 
 
Work done herein indicates that the clonal expansion theory of Toxoplasma evolution is 
insufficient to characterize the population dynamics of this generalist pathogen. The Type II 
clade of strains is not solely expanding asexually, but rather replicates via a combination of 
asexual propagation and unisexual mating (between closely related strains) which work in 
tandem to maintain a population structure that appears clonal when surveyed by limited 
resolution markers. The clonal expansion model misrepresents the dynamic adaptability of the 
Toxoplasma population as a whole. In fact, unisexual expansion is more frequently utilized by 
Toxoplasma than previously envisaged for the Type II clade. The lack of outcrossing observed 
within the Type II strains characterized here may indicate a preference toward similar sexual 
partner mating. This preference needs to be further interrogated as the specifics of sexual 
recombination in the feline host are still unclear. With Toxoplasma, although sexual 
recombination is optional for replication, it increases biological potential and infective capacity 
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and allows for the diversification of the population across the host range even when avirulent 
parents are recombined (Grigg, Bonnefoy, et al. 2001). An inaccurate estimation of the 
frequency of sexual recombination across the Toxoplasma population skews the expected 
population dynamics and alters estimates of times of divergence from a common ancestor 
significantly. This is especially true for Toxoplasma, where the calculated Plasmodium mutation 
rate, which has an obligate sexual cycle of replication, is used to estimate divergence from a 
common ancestor (Boyle et al. 2006; Fux et al. 2007; Shwab et al. 2014). Low marker resolution 
is the most likely cause of this underestimation of diversity within the Toxoplasma population. 
Using low-resolution genetic typing, unisexual expansion between closely-related strains, such 
as between Type II isolates, has been erroneously mistaken for asexual expansion in the absence 
of other genomic hallmarks of recombination. This misclassification of how Toxoplasma is 
expanding in nature underestimates the contribution of felines in the expansion, evolution and 
transmission potential of this highly successful protozoan pathogen. To determine the respective 
contributions of genetic hybridization by unisexual or uniparental mating within the population, 
an investigation of an isolated population of strains needs to be done over a time course with 
whole genome sequencing performed on all strains isolated to determine the contribution of each 




Materials and Methods 
 
Toxoplasma Strain Collection Typing 
 
Seventeen Toxoplasma gondii strains initially characterized as part of the Type II lineage 
were collected from unique geographical locations across the globe (Supplemental Figure 1). 3 
Type I, 2 Type III, 5 Type X, and 8 outgroup strains were also included in this collection (Figure 
1A) (Lorenzi et al. 2016). All strains had previously been typed by the laboratory in which they 
were isolated using a the standard ToxoDB Su genotyping PCR-RFLP typing markers (Su, 
Zhang, and Dubey 2006; Su et al. 2012). Strains were grown on human foreskin fibroblast (HFF) 
monolayers fed on Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS), 2mM glutamine, and treated with gentamicin and penicillin/streptomycin. 
Tachyzoites were harvested at time of HFF monolayer lysis and filtered through a 3.0-micron 
polycarbonate filter to remove host cell contamination (Khan, Dubey, et al. 2011). DNA from the 
filtered parasites was extracted using Qiagen’s Blood and Tissue DNeasy extraction kit. DNA 
was used to genotype strains using the standard ten PCR-RFLP markers (SAG1, SAG2, SAG3, 
BTUB, GRA6, L358, PK1, c22-8, c29-2 and APICO) to characterize new strains into the 
ToxoDB PCR-RFLP groups (Figure 1A) (Shwab et al. 2014; Su, Zhang, and Dubey 2006; 
Sundar et al. 2008). Further classification was done using additional PCR markers common to 
the Grigg laboratory (UPRT, EF1, BAG1, and SRS2) (Supplemental Table 1) (Fux et al. 2007; 
Parameswaran et al. 2010). Each marker was first amplified by PCR using Taqman Ampli-Taq 
polymerase and an Eppendorf thermocycler as previously described (Parameswaran et al. 2010; 
Su, Zhang, and Dubey 2006). The PCR products were then run on a 1% agarose gel to verify 
amplification of the correct product. All PCR products were restriction enzyme digested as 
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described previously (Su, Zhang, and Dubey 2006; Grigg and Sundar 2009; Parameswaran et al. 
2010). The PCR products were Sanger sequenced and sequences analyzed using DNASTAR’s 
Lasergene software version 14. 
 
Whole Genome Sequencing of Type II Strains 
 
DNA collected from Toxoplasma strains was sent to Rocky Mountain Laboratories and 
whole genome sequenced on a HiSeq machine using Illumina technology. All Type II strains 
were reference mapped to the ToxoDB Version 8.2 ME49 assembled genome or the ME49 
assembled apicoplast genome KE138841.1. This was done according to best practices (as 
recommended by BWA and GATK) using BWA 0.7.5a to align the raw reads and GATK 3.7 
with Picard 1.131 to quality control and filter the reads into a genome alignment (Van der 
Auwera et al. 2013). Strains whose average coverage across the genome was less than 5X using 
the VCFtools 0.1.8a genome coverage command were not included in subsequent analyses 
(Danecek et al. 2011). This coverage density was necessary to investigate sequence diversity 
across closely related strains, such as within the Type II clade. SNPs from whole genome 
sequenced strains were identified using the gVCF combination method in GATK (Van der 
Auwera et al. 2013). Briefly, a stand_call_conf of 30.0 and nct of 10 in GATK was used to call 




Phylogenetic Tree Creation from Markers and Genomes 
 
Sequences of the typing markers and the apicoplast genomes were aligned using Clustal 
X 2.1 with default settings (Larkin et al. 2007). For each marker, the alignment was input into 
MEGA 7 to create a maximum likelihood tree using Tamura-Nei model distance analysis with 
uniform rates of substitution across all sites, and 1000 bootstrap support for all branch points 
(Tamura et al. 2013). Bootstrap support equal to or greater than 60% distinguished novel alleles 
from mitotically drifted alleles because this level of bootstrap differentiation differentiates the 
closely related Type X and Type II lineages on single marker phylogenetic trees (Khan, Dubey, 
et al. 2011). All typing marker trees were rooted on the most genetically diverse strain included 
in this analysis, VAND. Phylogenetic trees of only the Type II and X strains were rooted on 
COUG, a known ancestor to the Type II clade (Minot et al. 2012).  
Maximum likelihood trees for whole and partial chromosomes were created in much the 
same manner as those created for typing markers. Genetic variants determined from reference 
mapping were parsed according to their genomic location and a custom script was used to create 
fasta sequences containing only locations where a polymorphism was present in one or more 
strains. Due to the manner of their generation from an aligned genome sequence, these fasta files 
did not require alignment and were input directly into MEGA 7 to create maximum likelihood 
trees. Tree parameters are as described above, but only 100 bootstrap replicates were used 
because the extended sequence lengths and previous genomic alignment ensured the accuracy of 
these comparisons without the additional bootstrap support given to shorter marker alignments. 
 98 
To create a NeighborNet tree based solely on the genomic SNPs, genomic polymorphism 
fasta files derived above were input into SplitsTree4 and default program parameters were used 
with 1000 bootstrap support for branch length (Huson and Bryant 2006). 
 
SNP Density Fingerprint Analysis of Closely Related Strains of Toxoplasma 
 
 Using GATK and VCFtools, a VCF file containing SNP covering the whole genome for 
all whole genome sequenced strains was converted to tabular format containing only biallelic 
SNPs with no long insertions or deletions (Van der Auwera et al. 2013; Danecek et al. 2011). A 
series of custom R scripts were generated based off of the scripts used to map the location of the 
sinefungin resistance gene (Behnke, Khan, and Sibley 2015). If any, one strain in the VCF 
analysis has a polymorphism at a set locus, all strains nucleotide sequence is recorded at that 
locus, regardless of if they are identical to the reference strain at that location. These custom 
scripts extracted SNP positions and identities where the strain in question differs from the 
reference sequence, such that the data from each strain only contains positions where the strain is 
non-reference. The number of SNPs within each strain of Toxoplasma was counted in a specified 
window, of 10 or 100 kbp length. The number of SNPs across a strain over a set genomic 
distance was given a limited y-axis (0-10 bp for 10 kbp windows, 0-20 bp for 100 kbp windows) 
to better display the SNP diversity inherent in Type II lineages. A larger scale as for more 
divergent strains such as VEG was not used because it would have eclipsed the number of Type 
II SNPs that differ within a window. Genomic region diversity or similarity was grouped based 
on geographic isolation of the strains and then on visual similarity of the SNP density plots 
which were confirmed by phylogenetic analysis of the region. 
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PopNet Analysis of Shared Inheritance Across the Type II Strains 
 
All 17 Type II, 5 Type X (ARI, DAG, WTD, TgSkunk, and 3133), 3 Type I (RH-88, RH-
JSR, and GT1), and 2 Type III (VEG and CTG) strains were selected for comparison and were 
included from the WGS VCF created from all the strains (detailed above) for analysis by 
PopNet. The SNP VCF of these strains was input into the PopNet program and run on previously 
determined parameters for Toxoplasma strains to determine their interrelatedness. This analysis 





Supplemental Figure 2-1: Strain isolation information 
A) Strains used here are listed with PCR-RFLP typing designation, isolation host and location, and their sequencing identification number. B) Global isolation 
location is shown for all strains utilized here. Strains are represented by their PCR-RFLP typing designation as shown by dots in the legend with Type I-red, 
Type II-green, Type III-blue, Type X-purple, Outgroup strains-yellow. 
Strain	ID Group	by	RFLP Region Sub-Region Host RML	ID GPIS
GT1 I USA MD Goat SRR516419
RH-88 I USA OH Human SRR521957
RH-JSR I USA OH Human SRR521559
Goat	TAS II Australia Goat 8206
TgNgBr1 II Brazil 6591
CZ1 II Czech	Republic Human 3893
TgCatEg45 II Egypt Cat 6544
TgCatEg51 II Egypt Cat 6588
TgDogEg11 II Egypt Dog 6590
76K II France Tours 4818
DEG II France Limoges Human 7595
PRU II France Limoges Human SRR350739
2987 II USA CA Sea	Otter 4808
3131 II USA CA Sea	Otter 4809
DAG II USA Human 8476
TgGoatUs19 II USA MD Goat 4824
TgGoatUs2 II USA MD Goat 4820
TgVaUs4 II USA AK Fox 4828
TgVvUs1 II USA AK Fox 4829
3142XB7_1 II	(ME49) USA CA Sheep 6135
VEG III USA CA Human SRR516406
CTG III USA NH Cat 6562
TgSkunk X Canada Skunk TgSK2
3133 X USA CA 4810
3671 X USA CA Sea	Otter 3891
3675 X USA CA Sea	Otter 4814
ARI X USA Human SRR350724
WTD-1 X USA AL Deer 6190
TgCatBr5 Brazil SRR350742
TgCatBr9 Brazil SRR350728
COUG Canada BC SRR350733
MAS France Nice Human SRR094469 (Brazilian	travel)
VAND French	Guiana SRR094467
B41 USA PA Bear SRR350721








Supplemental Table 2-1: Strain genotyping across the expanded Grigg sequence typing markers 
14 sequenced markers across the genomes of 17 strains of Type II, 3 Type I, 2 Type III, 5 Type X, and 8 outgroup 
strains are characterized by their sequence. All sequences were compared in individual marker maximum likelihood 
phylogenetic trees. New alleles are determined based on 60% or greater bootstrap support of tree branching. Four 
representative genomes (I-RH, II-ME49, III-VEG, X-WTD) are utilized to characterize the alleles seen on the 
phylogenetic trees. A) Type II sequence typing markers colored. 17 Type II and the 3 representative genomes (I-RH, 
II-ME49, III-VEG, X-WTD) are shown here. Colors represent the allele characterization from the phylogenetic trees 
as described above with I-red, II-green, III-blue, and X-purple. Shades of colors (such as light green versus dark 
green) differentiate discrete genetic alleles that possess less than 60% bootstrap support differentiation from known 
alleles. Pink and yellow alleles represent novel alleles found within the Type II strains. B) Allele characterizations of 
all strains used here at all markers. All 35 isolates representing the diversity of Toxoplasma strains are characterized 
at 14 markers across the nuclear and organellar genome. ToxoDB genotype is shown where it matches the observed 
typing of these strains. Alleles are determined as in A by phylogenetic divergence on maximum likelihood trees. 




Supplemental Figure 2-2: Phylogenetic trees support the recombination across the genome of TgVvUs1 in 
Figure 5A 
 SNPs from the WGS of all strains were extracted in either whole chromosomes or portions of the chromosome as 
determined by SNP density fingerprinting patterns. Maximum likelihood trees of these SNPs were generated using 
100 bootstrap support. Type II strains were colored based on geographical isolation as previously (North America, 
South America, Eurasia, Africa, Australia). An asterisk denotes the TgVvUs1 strain. A) Maximum likelihood tree of 
all SNPs in chromosome IX. B) Maximum likelihood tree of SNPs in chromosome ChrXI from 1.2-1.8 Mbp. C) 
Maximum likelihood tree of SNPs in chromosome ChrXI from 4.2-5.4 Mbp. D) Maximum likelihood tree of SNPs 





Supplemental Figure 2-3: Phylogenetic trees support the inheritance of different Type II geographically 
defined haploblocks in the genome of VEG seen in Figure 5B 
SNPs from the WGS of all strains were extracted in either whole chromosomes or portions of the chromosome as 
determined relevant by SNP density fingerprinting patterns. Maximum likelihood trees of these SNPs were 
generated using 100 bootstrap support. Type II strains were colored based on geographical isolation as previously 
(North America, South America, Eurasia, Africa, Australia). An asterisk denotes the Type III VEG and CTG strains. 
A) Maximum likelihood tree of SNPs in chromosome ChrVIII from 1.0-2.0 Mbp. B) Maximum likelihood tree of 
SNPs in chromosome ChrVIII from 2.0-3.2 Mbp. C) Maximum likelihood tree of all SNPs in chromosome ChrXI. 
D) Maximum likelihood tree of SNPs in chromosome ChrXII from 3.6-4.6 Mbp. E) Maximum likelihood tree of 
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How successful microbes maintain reservoirs of virulent strains in nature is understudied 
and is an important paradigm of infectious diseases. While many studies document how 
microbial pathogens acquire or admix genetic material to influence their pathogenicity, relatively 
less is known about how emergent strains are selectively maintained in nature. It is well 
established that viruses utilize reassortment to rapidly produce admixture genomes that possess a 
range of altered biological potential, including virulence (Twiddy and Holmes 2003; 
Vijaykrishna et al. 2011). Bacteria transfer mobile plasmid elements via conjugation that encode 
pathogenicity islands and confer an altered virulence potential on those strains that receive them 
(Bellanger et al. 2014; Schneider et al. 2011; Trevors 1998; Wardal et al. 2014; Heitman 2010). 
Among both fungi and protozoa, genetic hybridization by sexual recombination is a potent way 
to produce genomic variation or new admixture lines that have increased virulence and are 
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capable of causing disease outbreaks or altering host range (Ni et al. 2011; English, Adomako-
Ankomah, and Boyle 2015; Grigg, Bonnefoy, et al. 2001). What is less clear are the mechanisms 
at play that allow highly prevalent pathogens to maintain virulent strains cryptically in nature. 
Work shown herein sought to test whether generalist pathogens, such as the protozoan parasite 
Toxoplasma gondii, leverage their broad range of intermediate hosts to selectively partition 
parasite genotypic diversity and virulence potential. 
Toxoplasma gondii is a highly successful and prevalent protozoan pathogen that infects a 
wide range of wildlife, livestock and 30-80% of humans worldwide (Boothroyd and Grigg 2002; 
Boyer et al. 2011; Dubey et al. 2011). Its success in nature is largely attributed to its highly 
flexible life cycle. It can be propagated asexually by carnivory among all warm-blooded 
vertebrates (via orally infectious tissue cysts), sexually within its definitive felid host by self-
mating (when a single parasite undergoes fertilization and sexually clones itself), or by out-
crossing (producing as many as 108 genetic admixture hybrids that are transmissible as 
environmentally stable, highly infectious oocysts). Genetic hybridization has been previously 
shown to produce genotypes that possess a wide spectrum of biological potential, including 
altered virulence or a capacity to expand as successful epidemic clones (Boyle et al. 2006; Grigg, 
Bonnefoy, et al. 2001; Wendte, Miller, Lambourn, et al. 2010). Importantly, parasite clones 
possess a broad spectrum of disease states that are highly dependent on both parasite genetics 
and the animal species infected (Boothroyd 2009; Boothroyd and Grigg 2002; Howe and Sibley 
1995; Lorenzi et al. 2016). In rodents, low dose inoculums of Type I Toxoplasma strains are 
uniformly lethal to laboratory mice (Sibley and Boothroyd 1992) whereas Type II strains are 
considerably less virulent and routinely establish chronic, transmissible infections (Howe and 
Sibley 1995). In contrast, wild-derived CIM mice that encode resistant alleles of immunity-
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related GTPases (IRGs) confer resistance to virulent Type I strains by inactivating parasite-
specific secreted kinases (ROP18/ROP5) that control mouse susceptibility to infection (Lilue et 
al. 2013; Steinfeldt et al. 2010; Gazzinelli et al. 2014). The end result of this host-parasite genetic 
interplay determines the potential for a disease-producing virulent clone to expand or be 
maintained cryptically within a strain-specific, or host species-specific, manner, but this has not 
yet been demonstrated in natural populations and has only been inferred from laboratory studies. 
Likewise, laboratory rats are resistant to Type I infections and fail to transmit parasites, but again 
this is entirely rat species-dependent (Cavailles et al. 2006). The molecular basis for this 
resistance is an allele-dependent activation of the NLRP1 inflammasome resulting in 
macrophage pyroptosis and the inhibition of parasite growth in Lewis (LEW) and Sprague 
Dawley (SD) rats, but not in Brown Norway (BN) or Fischer CDF rats, which go on to establish 
chronic, transmissible infections of mouse-virulent Type I strains (Cirelli et al. 2014; Ewald, 
Chavarria-Smith, and Boothroyd 2014; Gorfu et al. 2014). While these laboratory studies suggest 
the possibility that virulent strains can be maintained cryptically across the pathogen’s host range 
(Dubey et al. 1999), this phenomenon has not been systematically investigated nor demonstrated 
to occur in a natural setting.  
Between 1998 and 2004, Toxoplasma gondii emerged as a significant disease in 
California sea otters (Enhydra lutris nereis), a federally listed threatened species (Conrad et al. 
2005; Miller et al. 2004). Full necropsies performed on each stranded sea otter identified a wide 
spectrum of disease sequelae among Toxoplasma-infected otters, ranging from chronic 
asymptomatic infection to fatal meningoencephalitis at time of death (Miller et al. 2004). 
Importantly, the majority of sea otters were found to be infected by a single outbreak clone, 
referred to as Type X (or HG12) (Conrad et al. 2005). Based on multi-locus PCR-DNA 
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sequencing (MLST) using a limited set of genotyping markers, Type X was defined as the fourth 
clonal lineage in the US (Khan, Dubey, et al. 2011) and was shown to be highly prevalent in 
sylvatic niches as chronic, subclinical, or mild infections in 47% of US wildlife (Dubey et al. 
2011; VanWormer et al. 2014). The range of disease sequelae detected in sea otters, however, is 
not consistent with infection by a single clone. Other possibilities proposed to explain variation 
in disease susceptibility have included co-infection (Gibson et al. 2011), exposure to 
environmental pollutants, or toxins that cause immunosuppression (Kreuder et al. 2003). More 
recently, WGS performed on Toxoplasma isolates has called into question whether MLST 
analysis is sufficiently resolved to predict clonotypes because it fails to capture extant genetic 
heterogeneity (Lorenzi et al. 2016). Indeed, a previous study concluded that Type X is comprised 
of at least two genotypes (Sundar et al. 2008), suggesting that strain variation may likewise play 
a contributing role in sea otter disease in this novel host-parasite interaction.   
 To test for this and to determine the true extent of genetic diversity among naturally 
circulating Type X isolates, a wide selection of linked and unlinked markers were sequenced 
here across the nuclear and organellar genomes for 53 isolates collected longitudinally from 
infected sea otters across a seven-year period. Based on these results, we selected 16 isolates for 
WGS. Analysis of our data support a model whereby Type X exists as a recombinant clade of 
strains that resemble F1 progeny from a natural cross between a Type II strain and a novel 
genotype that has not been identified previously in nature. One sea otter genotype was shown to 
be widely distributed and had expanded to cause the majority of infections in sea otters, most of 
which were subclinical and consistent with a strain that has been naturally selected in this 
mustelid host. This genotype, however, was highly pathogenic to laboratory mice and a 
population level, forward genetic approach using WGS mapped the mouse virulence gene to the 
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novel parasite-specific secreted kinase ROP33. This natural population dataset argues that 
Toxoplasma leverages its broad range of intermediate hosts to partition genetic diversity. Further, 
that intermediate hosts play a central role in the natural selection, expansion and maintenance of 
cryptically virulent strains in a host species-specific manner and demonstrated that these infected 




Genetic Characterization of Toxoplasma gondii Strains Isolated from Sea Otters 
 
In the late 1990s, an increasing number of sea otters stranded along the California coast 
with protozoal encephalitis due to Toxoplasma gondii (Miller et al. 2004; Miller et al. 2008; 
Sundar et al. 2008; VanWormer et al. 2014). An initial genetic analysis performed on a subset of 
35 T. gondii isolates established that 21 were a new genetic type, referred to as Type X, but this 
conclusion was limited to sequence typing at a single locus, GRA6 (Miller et al. 2004). Here was 
developed a multi-locus (MLST) PCR-DNA sequence-based typing scheme using an additional 
4 unlinked markers (BSR4, BAG1, SAG3, and ROP1) that possess a wide-range of phylogenetic 
strength, including markers under neutral (BSR4), diversifying (GRA6, SAG3, ROP1), and 
purifying (BAG1) selection to determine the molecular genotypes of 53 T. gondii isolates 
collected longitudinally over a seven-year period between 1998-2004 from fresh, beach-cast 
California sea otters. Isolates were obtained throughout the California sea otter range 
(Supplemental Figure 1). Antibody titers against Toxoplasma (when available), stranding 
location, co-infection status with other protozoal agents, and whether brain inflammation was 
associated with infection was recorded for 52 of the sea otters (Supplemental Figure 1). 
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Point-source Outbreak of Type II Strains Infecting Sea Otters  
 
To determine the T. gondii genotypes among the sea otter isolates, the 5 locus MLST was 
applied. Typing at just the GRA6 marker identified three sequence types, either a Type II allele 
in 16 (30%) isolates, or two non-archetypal alleles, previously identified as X or A (Miller et al. 
2004; Sundar et al. 2008), in 25 (47%) and 12 (23%) isolates, respectively. Expanding the 
genetic analysis across five markers showed that 2 of 16 isolates with a Type II allele at GRA6 
were predicted to be recombinant strains, because they possessed non-archetypal alleles at ROP1 
(3675) or BSR4 and BAG1 (3671), confirming that these strains are not Type II (Figure 1A). Of 
the 14 otters infected with Type II strains, 12 (86%) were identified within a restricted 
geographic range, a 40 mile stretch off the California coast line containing Moss Landing and 
Monterey Bay, which is consistent with a point source outbreak of a Toxoplasma strain that is 
found most frequently infecting human and domestic livestock in the USA. The other two Type 
II infected otters were recovered from Pismo Beach in Central California. Further, the majority 
of Type II infected otters (9/14; 64%) were collected during the first half of the study 
(Supplemental Figure 1), and only males were predominantly infected with this genotype. 




Type X is a Recombinant Clade of Strains 
 
Of the remaining 39 (74%) Toxoplasma isolates, collectively referred to as Type X or A by 
the allele present at GRA6, a maximum of only three alleles were identified at the additional 
sequenced loci, either a canonical Type II allele or one of two genetically distinct alleles, 
referred to as “g” or “d”, that appeared to segregate independently across the isolates (Figure 
1A). In total, 8 distinct haplotypes designated A-H were resolved based on their differential 
inheritance of the limited alleles, consistent with recombination between a Type II strain and a 
mosaic of two distinct ancestries as the most plausible explanation for the genetic relationship 
among the non-Type II strains. The Type X haplotype designated A was dominant (19/39; 49%). 
It was widely distributed across the entire geographic range of the Southern sea otter 
(Supplemental Figure 1), and it was isolated in every year except 2000. Importantly, this 
genotype expanded during the time frame of the study period and was responsible for the 
majority of infections by 2003 (Figure 1B). 
 
Acute Virulence in Mice is Dependent on Type X Haplotype 
 
 Mouse virulence is highly dependent on Toxoplasma genotype (Grigg, Bonnefoy, et al. 
2001; Saeij, Boyle, and Boothroyd 2005; Sibley and Boothroyd 1992). To further characterize 
the otter isolates, 18 strains, including two Type II and at least one isolate representing each of 
the 8 distinct Type X haplotypes, were tested for their mouse virulence phenotype. Isolates were 
selected based largely by their ability to expand in vitro in human foreskin fibroblasts. Virulence 
was assayed in CD-1 outbred female mice using a low-dose, 50 tachyzoite, intra-peritoneal 
injection model. At this inoculum, mouse avirulent strains (e.g. Type II) establish chronic, 
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transmissible infections whereas mouse virulent strains (e.g. Type I) die acutely within 10-14 
days. 
 Among the otter isolates, three mouse virulence phenotypes were identified: virulent (red; 
all mice died acutely), intermediate virulent (blue; some mice survived acute disease), and 
avirulent (green; all mice survived acute infection and produced chronic disease). The two otter 
isolates that possessed a Type II MLST were avirulent (Figure 1C; green) and phenocopied the 
infection kinetics of two well studied Type II strains, ME49 and 76K. Among the Type X 
haplotypes, E and G were also avirulent. Three otter isolates from haplotype A, the genotype that 
had expanded to cause the majority of sea otter infections, were highly pathogenic, and all 
infected mice died acutely (Figure 1C; red). Haplotypes D and H were likewise highly virulent in 
mice. The three haplotype F otter isolates all possessed an intermediate virulence phenotype 
(Figure 1C; blue). Of particular note, the 5 isolates from haplotypes B and C were either 
avirulent or possessed an intermediate mouse virulence phenotype (Figure 1C). Because the 
Type X isolates displayed a range of virulence phenotypes, the data collectively support a model 
whereby Type X represents a clade of recombinants from a genetic admixture of a mouse 
avirulent Type II strain with at least one other parent that is mouse virulent, rather than an 
expansion of a clonal lineage. Furthermore, not all isolates within each subgroup displayed 
equivalent virulence kinetics, in particular isolates from the B and C haplotypes were either 
avirulent or possessed intermediate virulence, suggesting that the 5 marker MLST was 
insufficiently resolved to fully capture total genetic and phenotypic diversity among the isolates 
infecting Southern sea otters.  
To explore this possibility, the 18 isolates assayed through mice plus 3 additional 
isolates, one each from haplotypes A, C and D, were further genotyped at 18 markers (17 
 115 
nuclear-encoded single copy gene loci plus one microsatellite marker) representing an expanded 
set of linked and unlinked loci across the genome. Additionally, 2 markers, one each from the 
organellar genomes of the apicoplast and mitochondria, were included to determine the ancestry 
of each maternally inherited genome. This represents a significant increase in the number of 
markers that were previously used to conclude that Type X (also referred to as HG12) is a clonal 
lineage (Khan, Dubey, et al. 2011; Dubey et al. 2011; Su et al. 2012). Altogether, the 20 marker 
MLST method provided 15,404 bp of sequence information to determine the genetic relationship 
among Toxoplasma strains isolated from Southern sea otters (Supplemental Table 1).  
 
Type X is Comprised of Twelve Distinct Haplotypes by an Expanded MLST Analysis 
 
 To establish the number of haplotypes among the 21 isolates, sequence data for the 17 
nuclear-encoded single copy gene loci was concatenated and analyzed using eBURST (Figure 
1D). eBURST resolves strains into clonal complexes (CC) that are in linkage disequilibrium. In 
this case, coded MLST data was used to identify strains that differ at one locus (or share 16 out 
of 17 markers). Isolates that differed by a single genetic locus were grouped together and 
connected by a line within each clonal complex. As expected, eBURST clustered the two Type II 
isolates (2987, 3131) into a single clonal complex with ME49 (CC1). Type X subgroup G isolate 
3675, originally identified by its allele at the microsatellite marker ROP1, was included within 
CC1 because it differed from Type II strains at only SAG4. For the remaining 18 Type X 
isolates, 15 clustered into 3 clonal complexes (designated CC2-CC4), and 3 unique haplotypes 
were resolved. This eBURST analysis failed to support a clonal lineage designation for Type X. 
Further, the increased resolution provided by the 17 markers subdivided the 8 distinct haplotypes 
defined using 5 loci in Figure 1A into 12 haplotypes (Figure 1D). One isolate each from 
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subgroups A (n=4; 3168), C (n=4; 3160), D (n=3; 4166) and F (n=3; 3387) was further resolved 



















Figure 3-1: Parasite diversity and mouse virulence within the Type X clade 
A) 53 isolates genotyped using 5 unlinked markers identified 9 distinct T. gondii genotypes infecting southern sea 
otters. Type I, II, and III alleles are represented by red, green, and blue, respectively. Sea otters were infected with 
T. gondii strains that possessed either a non-archetypal allele (purple or orange) or a Type II allele (green) at the loci 
examined. The number of sea otter infections (#SO) and percentage of total infections (%SO) is shown for each 
genotype group. Each group was comprised of the following isolates: A (3097, 3142, 3168, 3265, 3483, 3488, 3520, 
3637, 3659, 3744, 3786, 3821, 3865, 3947, 3950, 4003, 4045, 4071, 4151), B (3458, 3523, 3728, 3897), C (3026, 
3045, 3077, 3160, 4167), D (3133, 3178, 3183, 3451, 4166), E (3819), F (3387, 3429, 3503), G (3675), H (3671), II 
(2987, 2994, 3005, 3009, 3087, 3131, 3208, 3396, 3521, 3576, 3587, 3636, 3739, 4181). B) Total Sea Otter Deaths: 
number of sea otter deaths between 1998-2003 are charted according to their 5-marker type designation of Type II 
(green) or sub-types of Type X (range of purples). Type II infections not only clustered geographically (not shown) 
but also temporally while Type X infections are steady over time. Additionally, the Type X, sub-type A infections 
which were predominantly avirulent in sea otters show increased sea otter infections over time. C) CD1 mice were 
infected with 50 tachyzoites intraperitoneally with one of 18 isolates representing all singletons (E, G, H) and at 
least two isolates from each of the other 6 distinct genotypes (II, A, B, C, D, F) recovered from sea otters. Mouse 
seroconversion and survival was monitored for 30 days. At least two independent infection experiments were 
performed using 5 mice each for every strain tested. Results shown are for those mice that seroconverted or died 
acutely during infection. Strains are grouped and colored based on their genotype and virulence in mice. Red, mouse 
virulent, Blue, intermediate mouse virulent (some mice survived acute infection); Green, mouse avirulent (all mice 
survived acute infection). Number of mice infected by each genotype and their relative virulence is indicated. D) 
eBURST analysis to identify linkage disequilibrium across 17 nuclear-encoded linked and unlinked markers 
identified 4 clonal complexes and 3 unique Type X genotypes among 21 isolates selected from the 9 distinct clades 
in Figure 1A. Isolate colors represent the lineage Type from A: red (Type I), green (Type II), blue (Type III), and 
purple (Type X; all subgroups (A-H)). Dot size is proportional to the number of isolates with that genotype; larger 
dots are multi-isolate genotypes. Clonal complexes (CC) are indicated by lines connecting isolates and are 































































Type X Resembles a Recombinant Clade of F1 Progeny from a Natural Cross 
 
  eBURST, however, is insufficiently resolved to distinguish among isolates that are either 
variants within a clonal lineage but possess alleles that differ by only minor mutational drift or 
exist as admixtures that possess genetically distinct alleles derived from different parental types.  
Previous studies suggested that Type X (or HG12) is a clonal lineage infecting sea otters and 
wildlife in North America, and that HG12 represents an expanded clone from a sexual cross 
between a Type II strain and a new genetic lineage, that was referred to as “g”, but this was based 
largely on typing at just two loci, GRA6 or GRA7 (Conrad et al. 2005; Khan, Dubey, et al. 2011; 
Miller et al. 2004). To investigate if the genetic relationship among the 12 distinct haplotypes is 
supported by a model of genetic drift, or that of recombination, individual maximum likelihood 
trees were created for each of the 17 nuclear-encoded single gene copy loci, the microsatellite 
locus, and the two organellar loci (Supplemental Figure 1).  To differentiate between alleles 
undergoing minor mutational drift, from those that have evolved independently as distinct 
genetic outgroups, 1000 bootstrap replicates were run for each tree, and supported nodes above 
60% were indicated at each marker. For each tree, the 19 isolates identified as Type X were 
labeled in purple and isolates belonging to the clonal lineage I (n=1), II (n=3), and III (n=1) were 
labeled in red, green, and blue respectively (Figure 2). 
 At 5 genetic markers located on chromosomes Ib, II, III, XI, and XII, all 12 distinct Type 
X haplotypes possessed a canonical Type II allele (green), with no minor mutational drift 
detected, consistent with Type II being one of the parental genetic backgrounds for the Type X 
clade (Supplemental Table 1). At the L358 marker on chromosome V, however, all Type X 
isolates except 3675 possessed a Type I or “a” allele (red), indicating the presence of mixed 
ancestry. Further, at the BSR4 marker on chromosome IV, all Type X isolates except 3675 
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possessed an entirely novel allele that was readily differentiated from Type I, II and III strains 
with strong bootstrap support (Figure 2B). At all remaining loci, Type X isolates possessed either 
a Type II or one of 2 genetically distinct alleles, which could not be explained by minor 
mutational drift. Hence, across the 17 nuclear-encoded markers, each isolate possessed either a 
Type II allele, or an allele of distinct ancestry that was referred to as belonging to the “a” (red), 
“g” (purple) or “d” (orange) lineages.  
The maternally inherited organellar genome markers were likewise mixed. At the 
mitochondrial marker COX1, two alleles were identified, either an allele common to Type I, II 
and III strains or a novel allele designated “g” (Figure 2A). Further, 3 distinct alleles were 
identified at the apicoplast marker APICO: A Type I or “a” allele (red), a Type II allele (green) 
or a novel “g” allele (purple), supporting the mixed ancestry designation (Figure 2B). Each of the 
12 Type X haplotypes was therefore a mosaic of mixed ancestry that possessed some 
combination of Type II, Type I, or “g” alleles that had segregated independently across the loci 
investigated. The data are consistent with a sexual cross model in which Type X resembles a 
recombinant clade of F1 progeny that was recently derived, without sufficient time to develop 
minor mutational drift (Supplemental Table 1).  
In support of the sexual cross model, incongruity between phylogenies for each haplotype 
was readily observed between markers located in different portions of the genome. In Figure 2C, 
8 isolates shared the same ancestry between the two genetic loci located on separate 
chromosomes VIIa and VIIb (GRA7 and BAG1 respectively) and were shaded either green 
(Type II alleles at both loci) or purple (g lineage alleles at both loci). In contrast, 13 isolates had 
independently segregated chromosomes of mixed ancestry, colored orange and pink (to depict 
isolates that were discordant and possessed different ancestral alleles at each locus). The crossing 
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of orange and pink lines highlighted this lack of incongruence (Figure 2C). For example, isolate 
3671, had a g lineage allele at GRA7 but a d lineage allele at BAG1. Furthermore, recombination 
within a chromosome was similarly observed at linked markers for 18 strains (Figure 2D). For 
example, isolate 3387, had a g lineage allele at GRA7 but a d lineage allele at SAG4, whereas 
3675 had an II lineage allele GRA7 but a g lineage allele SAG4, formally establishing that 
recombination has occurred and supporting genetic hybridization as the most likely explanation 

















Figure 3-2: Phylogenic biallelism and allelic segregation between sequenced markers 
Maximum likelihood trees of sequenced markers. Isolates are colored based on their genotype from Figure 1A (I: 
red, II: green, III: blue, X: purple). A) Mitochondrial marker, COX1. B) Genomic loci BSR4. New alleles are 
classified by differentiation of greater than 60% bootstrap support. The g lineage is significantly different than Type 
II alleles and, on some markers, can also be distinguished from a second unique clade only observed in Type X 
isolates, dubbed d. C) Comparison of unlinked genomic markers GRA7 and BAG1. Chromosomal segregation 
between groups of isolates are highlighted. Isolates of d lineage that lack differential segregation are highlighted in 
purple, those that retain Type II lineage are green. Isolates that show lineage recombination via chromosomal 
segregation between II and g/d alleles are highlighted pink and orange depending on allelic combination. D) 
Comparison of linked genomic markers GRA7 and SAG4. Allelic recombination is highlighted within this 
chromosome. Isolates retain Type II lineage alleles are highlighted in green. Isolates that show recombination 











































































































































































































Type X is an Admixture Cross Between Type II and a Novel Genetic Background 
 
 A subset of Type X isolates, 2 each from haplotypes A (3142, 3265), C (3026, 3045), F 
(3503, 3429) and one each from D (3178) and H (3671) were hybridized against a 
photolithographic microarray that possessed 1517 polymorphic Type I, II and III strain-specific 
genotyping probes distributed genome-wide (Khan, Miller, et al. 2011). This was done to test 
whether the MLST genetic markers accurately predicted the presence of large genome-wide 
haplotype specific blocks, consistent with genetic hybridization. Each Type-specific SNP on the 
CGH array is represented as a dot colored either red, green or blue respectively for a hybridizing 
strain that possesses a Type I, II or III SNP at the probe position. Dots colored grey identify 
probes that fail to hybridize, consistent with a strain that does not possess a Type I, II or III 
specific SNP at the probe position. Hybridization with DNA from a Type I (GT1), Type II 
(ME49), and Type III (CTG) strain identified hybridization patterns consistent with genotype, 
indicating that all genotype-specific probes were functioning as expected (Figure 3A). 
Hybridization with the Type X isolates identified large, contiguous Type II haploblocks, as 
evidenced by hybridization of all Type II-specific probes present on Chr III, VI, VIIb and XII, 
for example. However, in other portions of the genome, the SNP diversity pattern was novel. The 
hybridization pattern in these regions either shared patch-work similarity with Type I (i.e., at Chr 
Ib, VI) or was highly divergent with large contiguous blocks of SNP probes colored grey that 
failed to hybridize, which was consistent with introgression of a non-Type I, II or III genetic 
ancestry, rather than minor mutational drift as the explanation for lack of reactivity (i.e., Chr IV, 
XI, right end of Chr VII, XII, left end of Chr VIII).  
 The pattern of hybridizing SNPs was unique for each of the seven Type X isolates 
examined, but it was only minimally different; either 3, 5, or 15 SNP differences were detected 
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in pairwise comparisons within haplotype A (3142, 3265), C (3026, 3045), and F (3503, 3429), 
respectively (Figure 3A). At this resolution, it was not possible to distinguish between CGH 
array hybridization efficiency, from that of minor mutational drift. Indeed, the CGH arrays each 
had approximately the same number of SNP differences (3-15) between haplotypes as they did 
within a haplotype, which is more consistent with hybridization efficiency as the probable 
explanation for these hybridization differences. It did, however, establish that 3671 is a distinct 
genetic admixture because it possessed a different Type II hybridization pattern at Chr Ia, left 
hand of Chr Ib, VI, XI and right side of Chr XII, which was different from all other Type X 
strains analyzed (Figure 3A). 
 
Type X is a Recombinant Clade at WGS Resolution 
 
The lack of resolution using the CGH array approach indicated that WGS is required to infer 
an accurate genetic history model for the Type X strains. Using genome-wide polymorphism 
data derived by identifying all variant SNP positions after reference mapping a Type I, II, III, 16 
Type X, and three previously WGS sequenced HG12 isolates (WTD-1, RAY, ARI) against the 
published ME49 genome, an unrooted NeighborNet tree was generated (Figure 3B). The 
NeighborNet analysis established that all Type X isolates, similar to Type I and III strains, 
shared definitive genome-wide ancestry with Type II, represented by the reticulated pattern of 
edge blocks that depict recombination events between Type II and the different genetic 
backgrounds within X, I, and III. However, NeighborNet analysis did not support the clonal 
lineage designation as the majority of Type X isolates appeared on separate branches (Figure 3B, 
Inset). Only clonal complexes 1 and 4 (CC1, Type II; CC4, 3045, 3160, 4167) were supported at 
WGS resolution, and 3 previously sequenced HG12 isolates from 2 people (ARI, RAY) and a 
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deer (WTD-1) formed well-supported clades with Type X isolates 4166 (WTD-1; RAY) and 
3168 (ARI) indicating that Type X has a wider distribution beyond sea otter infection. Outside of 
the reticulated network of edge blocks, the branch length for each Type X isolate was 
significantly less than that observed for Type I and III, synonymous with a more recent origin, 
without sufficient time to accumulate private SNPs by mutational drift. When murine virulence 
data for each genotype was mapped onto the NeighborNet tree (see inset, Figure 3B), a clear 
partitioning of the different virulence phenotypes was resolved along branches within the 
network, consistent with Type X isolates existing as sister progeny with only minor mutational 



















Figure 3-3: Genome-wide SNP typing of Type X displays haploblock recombination across the genome 
A) Microarray hybridization of Type X strains to clonal characterization probes across the genome of Type X 
isolates. SNPs are represented by a dot in one of three rows indicating where the isolate has hybridized to the 
microarray with hybridization characteristic of lineage Type I (red), II (green), or III (blue). Grey indicates no 
hybridization at this location. Chromosomes are represented as alternating grey and white bars. B) Type X linkage 
disequilibrium and network reticulation demonstrates recombination across the genomes of Type X. NeighborNet 
tree based on whole genome sequence identified 568,592 SNP variant positions across the 19 Type X strains 
reference mapped to ME49. Type I (red), II (green), III (blue), and X (purple) strains annotated in the box beside the 
group was based on the previous MLST designation. Two clusters of Type X strains were identified.  Strains in inset 




To identify the size, genome distribution, and total number of Type II admixed haploblocks 
introgressed into each Type X isolate, pairwise SNP diversity plots were generated for all Type 
X isolates, as well as reference Type I and III strains that are known to have recombined with 



















































block at the left side of Chr VIIa, and right end of Chr XI (Figure 4). As expected, the Type III 
VEG strain possessed many more ME49 admixture blocks distributed genome-wide than GT1, 
comprising ~40% of its genome (Minot et al. 2012). Only Type X haplotype H (3671) possessed 
haploblocks that were highly similar in sequence to ME49, on Chr Ia, II, III, VI, VIII, IX, XI, 
and XII (Figure 4). In other regions, however, 3671 shared regions clearly ME49-like, but that 
appeared to have diverged somewhat by mutational drift (average 3-5 SNPs per 10kb block) on 
Chr II or introgressed into Chr IV, V, VIIa, VIIb, VIII, IX, and XII. Intermixed within the Type 
II regions of the 3671 genome were a limited number of large haploblocks containing divergent 
SNP density synonymous with hybridization by the distinct g or d genetic ancestry (average of 
50-100 SNPs per 10kb block). When the pairwise SNP density analysis was expanded to 
different Type X haplotypes, isolates within each haplotype possessed highly similar patchwork 
mosaics of Type II-like or divergent (Type X) haploblocks that were specific to each haplotype. 
For example, haplotype A isolates 3142 and 3168 SNP density plots were highly similar to each 
other, and to haplotype C isolate 3045, but were readily distinguishable from isolates 4166 and 
3503, strains within haplotypes D and F, respectively (Figure 4). Specifically, isolate 3142 had a 
Type X haploblock inheritance pattern at the right end of Chr V, and in the middle of Chr Ib, 
VIIa, VIII, IX and XII whereas 4166, which was indistinguishable from a previously sequenced 
HG12 strain (RAY) recovered from a human patient, and possessed either Type II or 3671 
haploblocks in these regions (Figure 4). Although the haplotype F isolate 3503 was highly 
similar in genomic organization to 3142, it possessed a Type II haploblock at the right end of Chr 
V that readily distinguished it from haplotype A.  The pairwise SNP analysis established that the 
majority of Type X haplotypes possessed a genomic architecture that is strikingly similar, but 
different at a limited number of admixture blocks. Coupled with the low allelic diversity, the data 
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support a genetic history model whereby Type X resembles a sexual clade of recently-derived 




Figure 3-4: Whole genome SNP density displays clear recombination of haploblocks of II and g ancestry 
within the Type X strains.  
Isolates are reference mapped to the ME49 Type II strain and SNPs per 100 kbp window were graphed. Areas of 
higher SNP density are least like the Type II strain in that window. SNP density shows clear divisions of 
haploblocks of Type II and divergent SNP density haploblocks. 
 
  
PopNet Analysis Identifies Only Limited Admixture Blocks Among Type X Isolates 
 
While the NeighborNet analysis established that Type X exists as a recombinant clade of 
strains, it failed to predict the precise number of genetic ancestries, or how they had admixed 
positionally across the chromosomes.  PopNet was used to paint chromosomes according to their 


























































































































































































Type X Strains Mapped to ME49, 10 kb window
 128 
local inheritance patterns (Zhang et al. 2017). Included in the analysis were all sequenced Type 
X and II strains, as well as reference Type I and III strains, known to have admixed with Type II. 
PopNet identified 4 distinct ancestries and each genome was a mosaic of the different ancestries, 
supporting the admixture model. 
Within the circle depicting the Type X clade, 5 distinct subgroupings were identified based 
on the number and position of shared ancestral blocks; these were grouped together based on line 
thickness (Figure 5A). These same groupings were supported both by pairwise SNP plots and 
NeighborNet analysis, but the PopNet analysis showed which of the 5 ancestries had introgressed 
positionally across the mosaic genomes. Clear recombination blocks were readily resolved, and 
the genome architecture was remarkably similar between the groupings. A custom script 
designed to identify only major crossover points between the two parents (Type II and the 
mosaic ancestry of the g/d parent) identified either a limited number of single and double 
recombination events, or the inheritance of whole chromosomes of either Type II (Chr II) or g/d 
(Chr Ia, IV, XI) parental ancestry, consistent with this group of strains representing related sister 
progeny (Figure 5B). Because murine virulence plotted on the NeighborNet tree identified clear 
pathogenicity differences in mice that clustered based on parasite genotype, and because the 
recombinant clade of Type X strains resembled F1 progeny with only a limited number of 
crossover points, a forward genetic screen was attempted to determine whether genes 
contributing to the virulence trait could be mapped from the set of 18 natural isolates for which 
mouse virulence data existed (Figure 5C).  
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Figure 3-5: Whole genome sequencing demonstrates Type X is a unique clade of recombinant strains created 
from a cross between Type II parent and a unique g/d parent. 
A) PopNet analysis of the WGS strains from A. The genome of each strain is represented by a circle of concatenated 
chromosomes which are painted in haploblocks based on their shared ancestry. All strains were clustered into four 
distinct color groups based on degree of shared ancestry (Type II-green, Type X-purple, Type I-cyan, Type III-blue). 
Line thickness between strains indicates their interrelatedness, bolder lines indicate whole genome linkage 
disequilibrium, as shown between the 4167 and 3160 strains. B) Genetic model of Type X parental recombination of 
isolate 3142. Type II ancestry is shown in green and unknown unique g/d parent in black. C) Isolates are shown with 
their group identification via 5 loci MLST (Figure 1A), eBURST clonal complex identity (Figure 1D), 17 loci 























Isolate 5 loci CC 17 loci Mouse VIR
2987 II CC1 II -
3131 II CC1 II -
3142 A CC2 X1 +
3265 A CC2 X1 +
3947 A CC2 X1 n.d.
3168 A CC3 X2 +
3458 B CC3 X3 +/-
3523 B CC3 X3 -
3026 C CC4 X4 -
3045 C CC4 X4 -
4167 C CC4 X4 +/-
3160 C CC4 X5 n.d.
3133 D CC3 X6 +
3178 D CC3 X6 n.d.
4166 D - X7 +
3819 E - X8 -
3503 F CC2 X9 +/-
3429 F CC2 X9 +/-
3387 F CC3 X10 +/-
3675 G CC1 X11 -
3671 H - X12 +
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Natural Population-based QTL Identifies ROP33 as a Novel Murine Virulence Locus  
 
The Type X isolates recovered from sea otters resembled a natural clade of recombinant F1 
progeny from a cross between a Type II strain, which is avirulent in mice, and an unknown 
parent that is a mosaic of two distinct ancestries. Among the natural isolates, a range of murine 
virulence was observed (Figure 1C). We performed a genome scan to determine the log-
likelihood of association of discrete genome haploblocks with the acute virulence phenotype and 
identified four quantitative trait loci (QTL) peaks with logarithm of odds (LOD) scores 4.0 or 
greater on chromosomes V, VIIa, VIII, and X (Figure 6A).  The average size of the genomic 
regions spanned by the QTLs were in the range of 100-200kb, except for the one on chromosome 
V, which was >700 kb (Figure 6B). To identify candidate genes within the four peaks, the 
following inclusion criteria were assessed: presence of a signal peptide and/or transmembrane 
domain, gene expression, polymorphism, genome-wide CRISPR score for essentiality (Sidik et 
al. 2016) (Supplemental Table 2). ROP33 on chromosome VIIa stood out as the best candidate 
gene to target for reverse genetics as it was abundantly expressed during acute infection, it was 
predicted to be a functional serine-threonine protein kinase, and it was highly polymorphic. Of 
the shortlisted genes, one allele of ROP33 was strongly correlated with acute virulence 
(p=0.00031; fishers two-sided exact test) (Figure 6C).  
To determine if ROP33 is a murine virulence gene, the ROP33 locus was disrupted using 
targeted deletion by CRISPR-Cas9 facilitated double crossover homologous recombination in the 
mouse virulent RH∆ku80∆rop18∆hxgprt strain. This strain is virulent in mice (LD100=500 
tachyzoites) and was engineered to accept targeted replacement of the rop33 gene using an 
HXGPRT gene flanked by 30bp of homology just outside of the rop33 promoter and 3’UTR 
region. Following selection in mycophenolic acid (MPA) and xanthine (to select for the 
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HXGPRT gene), the population was screened for disruption of the rop33 gene by PCR. Mice 
were next infected with either the parent RH∆ku80∆rop18∆hxgprt strain or the Rop33 mutant to 
assess murine virulence. Groups of 5 outbred CD-1 mice were injected intraperitoneally with 500 
tachyzoites and the results shown are for one of two independent experiments. All mice infected 
with the parental RH strain succumbed to infection within 20 days (Figure 6D). Whereas, 
targeted deletion of the rop33 gene was protective, indicating that ROP33 is an acute virulence 
gene. No difference in parasite load was detected through acute infection by bioluminescence 
imaging, indicating that deletion of ROP33 does not affect parasite proliferation in vivo (data not 
shown). All surviving mice were confirmed to be positive by serology, indicating that they had 
been productively infected. These data strongly suggest that ROP33 is a potent virulence factor 
for murine infection that was identified using recombinant progeny from a naturally occurring 




Figure 3-6: QTL analysis identifies ROP33 associated with low-dose murine virulence in natural population 
of Type X infections 
A) WGS data from Type X strains was down-selected to one SNP every 5 kbp and analyzed via standard QTL 
methods with 1000 bootstrap support. LOD scores are shown across the chromosomes of these strains based on 
genetic association with low-dose murine virulence as shown in Table 1. B) Significantly associated peaks from the 
QTL were identified based on clusters SNP peaks as seen in the QTL analysis in A. The LOD scores of the tallest 
portion of the associated genomic region are listed. C) Maximum likelihood phylogenetic tree of ROP33 alleles 
from Type X strains displays that ROP33 allele correlates well with murine virulence. Colors correspond to murine 
virulence as listed in Figure 1C: virulent-red, intermediate virulent-blue, avirulent-green. D) ROP33 KO attenuates 




Chrm Start (bp) End (bp) LOD
V 1430036 2165042 4.091
VIIa 3815011 4085005 4.400
VIIb 3035265 3160030 3.680
VIII 6745008 6905157 4.194











































Here, we investigated a presumed epidemic outbreak of a clonal lineage (Type X) 
infecting sea otters to determine the genetic basis for this epizootic causing mortality in a 
federally listed, threatened species. Although Type X had previously been identified as the fourth 
clonal lineage in North America, work done here has shown that Type X is not a clonal lineage 
but rather a recombinant clade of strains that resemble F1 progeny from at least one sexual cross. 
DNA sequence analysis of a wide selection of linked and unlinked markers across the nuclear 
and organellar genomes of Type X isolates identified Type X to be a composite of Type II and an 
unknown mosaic of two distinct ancestries, referred to as g and d, that have recombined to 
produce a highly invasive clade of strains causing infection and mortality in threatened marine 
mammals, including the Southern sea otter. Data shown here suggest that Type X was derived 
from one or a limited number of crosses from two sets of highly related parental strains. This 
suggests that Toxoplasma’s sexual life cycle is facilitating the evolution of new strains capable of 
expanding into new ecological niches, such as near-shore marine mammals off the Eastern 
Pacific coastline.  
In previous studies, unknown strains having a distinct ancestry, referred to as a and b, 
were found to have crossed with Type II to create the Type I and Type III clonal clades 
respectively (Boyle et al. 2006). The pattern of recombined blocks inherited across the Type X 
strains is parsimonious with previously described models for the genetic history of Types I and 
III in which an unidentified ancestor (respectively a and b, and here designated g and d) sexually 
recombined with an ancestral Type II to create a new clade of strains (Figure 5B) (Fux et al. 
2007; Boyle et al. 2006). Additionally, it has previously been suggested that Type X is a product 
of genetic hybridization between a Type II lineage and an unknown g lineage, which has been 
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further refined in this analysis to be a mosaic of two distinct g and d ancestries (Miller et al. 
2004; Sundar et al. 2008). The g/d lineage has likely recombined at least once with Type II to 
create the Type X recombinant clade of strains. Currently, no single isolate has been found 
which could be defined as either g or d, similarly to the a and b lines thought to have admixed 
with Type II to produce the clonal lines I and III (Boyle et al. 2006; Fux et al. 2007).  
Previous work on Type X in wildlife samples using only a limited set of markers, 
identified Type X as the fourth clonal lineage in North America (Dubey et al. 2011; Khan, 
Dubey, et al. 2011). However, this designation was based on novel alleles identified at GRA6 
and GRA7, which was the original basis for defining the Type X lineage as a new genotype that 
shared ancestry with Type II but had undergone a hybridization event with a novel genotype 
(Miller et al. 2004). It is now well established that Type X commonly infects wildlife across 
North America (Sundar et al. 2008; Dubey et al. 2011; Gibson et al. 2011; Su et al. 2012; 
VanWormer et al. 2014; Howe and Sibley 1995). This study examined Toxoplasma strains 
collected longitudinally across a seven-year period solely from sea otter infections and was 
comprised of infections that ranged in disease presentation between either asymptomatic to the 
primary cause of death. Previous work had classified Type X as clonal, so it was unexpected to 
find a myriad of different disease states in the infected sea otters. This investigation was carried 
out to determine the genetic basis for sea otter pathogenicity and to control for strain genotype as 
a critical parameter in the severity of disease (Dubey et al. 2011; Khan, Dubey, et al. 2011; Su et 
al. 2012; Sundar et al. 2008). Genotyping studies were carried out using an expanded set of 
markers to confirm the predicted clonal population structure for Type X.  All genotyping 
markers used in this study were sequenced rather than examined strictly by PCR-RFLP analysis, 
as has been the standard for many previous studies. While the markers used herein only surveyed 
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a small part of the genome, they identified at least 12 distinct haplotypes within Type X, 
confirming that Type X is not a clonal population. Furthermore, at any given locus, only a Type 
II allele or one of two distinct alleles were identified indicating limited allelic diversity. Each of 
the 12 haplotypes possessed one of three allelic types at any one locus that had independently 
segregated across the markers examined. This result is parsimonious with the relationship 
between isolates as that of a recombinant clade of distinct ancestry. Our results were further 
confirmed both by CGH array of several genomes as well as whole genome sequencing and 
characterization. The misclassification as a clonal population appears to be the result of the low-
resolution genotyping analyses performed, and the placement of the markers in predominantly 
Type II regions of the genome (Ajzenberg et al. 2002; Dubey et al. 2011; Howe and Sibley 
1995). For this reason, future studies should use WGS to not only discriminate between 
haplogroups within the population, but also to determine the true clonality of each haplogroup. 
Toxoplasma population genetics would also greatly benefit from an increase in the number of 
isolates that are whole genome sequenced. WGS should be expanded to include both greater 
diversity of strains and a more in-depth analysis of the canonical clonal lineages.  
The Type I and III clonal lineages are thought to be derived from a limited number of sexual 
crosses, and all strains within these clonotypes share large haploblocks of Type II-like sequence 
(Boyle et al. 2006; Grigg and Sundar 2009; Minot et al. 2012; Khan et al. 2014). This finding 
also holds true for the Type X lineage. At all loci surveyed, Type X displayed at least one isolate 
with a Type II inherited allele, and the introgression of Type II haploblocks across the genomes 
was confirmed in the 19 strains that underwent WGS. In regions that did not clade with Type II, 
two different allelic types were identified. We concluded that these represented distinct 
ancestries that we referred to as g and d. This designation was supported by the inherent 
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reticulation of the clade, seen via the NeighborNet tree (Figure 3B) which possessed short branch 
lengths from the reticulated network with multiple strains on a single branch, rather than 
producing a star phylogeny with multiple alleles present at each major branch, the result of 
strain-specific SNPs that accumulated through genetic drift. In fact, the lack of genetic drift 
between these loci supported genetic hybridization as the explanation for the relationship 
between the Type X haplotypes.  
Sexual replication with genetic recombination is known to occur in South America at high 
frequency (Fux et al. 2007; Minot et al. 2012; Rajendran, Su, and Dubey 2012; Shwab et al. 
2014).  Additionally, recent studies on the population genetic structure of Toxoplasma has 
established extensive genetic hybridization at whole genome resolution for the vast majority of 
strains that represent the breadth of genetic diversity within Toxoplasma (Lorenzi et al. 2016; 
Zhang et al. 2017). Evidence of sexual recombination across the population as well as the 
evidence of sexual replication within the Type X clade shown here may indicate that sexual 
recombination is occurring with greater frequency than previously suspected within North 
America.  
Sexual recombination is known to readily occur in the laboratory, although there is no 
current understanding of the genetic factors regulating sexual replication in the felid host 
(Behnke, Khan, and Sibley 2015; Grigg, Bonnefoy, et al. 2001; Saeij et al. 2006; Saeij et al. 
2007; Taylor et al. 2006). It is unknown why sexual recombination does not appear to be 
occurring in North American wildlife as it is in South America, although it is possible that self-
mating within the population masks the detection of genetic outcrossing (Ferguson 2002; Grigg 
and Sundar 2009; Wendte, Miller, Lambourn, et al. 2010). Especially with closely related 
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isolates, unisexual mating would not be resolved by current analyses and would be mistaken as 
asexual expansion (Wendte, Miller, Lambourn, et al. 2010; Wendte, Miller, Nandra, et al. 2010).  
In order to expand its biological potential, Toxoplasma has been shown in the laboratory to 
utilize it sexual replicative life cycle to combine virulence alleles into new combinations that 
create enhanced virulence potential (Grigg, Bonnefoy, et al. 2001; Saeij et al. 2006; Taylor et al. 
2006). Since sexual recombination can reshuffle alleles into new combinations that can produce 
a range of altered biological potential, the intermediate host range is likely responsible for 
selecting Toxoplasma strain diversity within each intermediate host (Grigg, Bonnefoy, et al. 
2001; Saeij et al. 2006; Saeij et al. 2007; Taylor et al. 2006). Examples of this type of selection 
can be seen in murine hosts that have highly diversified IRG (immunity related GTPases) gene 
arrays. IRGs are the proteins primarily responsible for combatting Toxoplasma lysis of murine 
cells and Toxoplasma encodes a suite of highly polymorphic rhoptry kinase genes (ROPKs) 
whose primary function is to inactivate host IRGs (Fleckenstein et al. 2012; Hunn et al. 2011; 
Yamamoto et al. 2012). While laboratory mice are highly clonal, wild mice and their subsequent 
IRGs are more diverse, as are the ROPKs expressed by different Toxoplasma strains that are 
capable of infecting wild mice (Gazzinelli et al. 2014; Lilue et al. 2013). Similarly, TLR 11/12 is 
one of the primary rodent innate immune responses to detect infection by Toxoplasma. However, 
not all intermediate hosts share a functional combination of TLR11/12, thus, Toxoplasma strains 
that are selected for infection in mice need to bypass TLR11/12 recognition, whereas this is not a 
barrier to infection in a human cell, for example (Gazzinelli et al. 2014; Koblansky et al. 2013). 
Hence, reshuffling genetic diversity is one way in which the generalist parasite Toxoplasma finds 
the balance of fitness and infectious ability across its wide host range.  
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In sea otters, we have observed a host-virulence shift. The recombinant clade of Type X 
strains displays a wide spectrum of virulence within the sea otter host. One Type X subgroup 
(X9) causes severe myoencephalitis, and all otters infected with this sub-type die acutely. In 
contrast, another Type X subgroup (X1), that expanded in sea otters to represent greater than 
50% of otter infections across a space of seven years, established benign, sub-clinical disease.  
While the X1 strain is relatively avirulent in sea otters, it was however highly pathogenic to 
mice, with all mice dying in 10-15 days with an inoculum of just 50 tachyzoites. This data 
supports an admixture model for the expansion and propagation of Toxoplasma in nature, 
whereby Toxoplasma utilizes its sexual cycle to create a wide spectrum of novel genotypes that 
possess altered biological potential that can be selected across Toxoplasma’s vast host range for 
the best parasite-host symbiosis. Thus, natural selection among intermediate hosts allows 
Toxoplasma to maintain strains that possess a cryptic virulence potential for another host species. 
This cryptic virulence is necessary in order to maintain its ability to cause disease outbreaks or 
expand its host range and transmissibility into new ecological niches.  
In other protozoan parasites, when host partitioning occurs, it is synonymous with speciation. 
For example, Plasmodium parasites often partition by the mosquito host species they co-evolve 
with for parasite transmission (Mackinnon and Read 2004; Ariey et al. 2014; Bopp et al. 2013; 
Miotto et al. 2013; Arisue and Hashimoto 2014). Likewise, the apicomplexan parasite 
Sarcocystis largely maintains separate species for each intermediate-definitive host species 
combination to maintain its life cycle (Wendte, Miller, Lambourn, et al. 2010; Wendte, Miller, 
Nandra, et al. 2010; Barbosa et al. 2015). In contrast, Toxoplasma forms transmissible cysts in 
virtually all warm-blooded vertebrate hosts, and these are transmissible to the definitive host, as 
well as a large array of intermediate hosts. What is different, is that across the genetic diversity 
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of Toxoplasma strains, specific genotypes get selectively expanded in different intermediate 
hosts, and it is this fact that allows Toxoplasma to maintain cryptically virulent strains across its 
broad intermediate host range. Hence, the intermediate host is playing a central role in the 
natural selection, expansion, and maintenance of virulent strains across the broad host range of 
this generalist parasite. In effect, infected hosts act as reservoirs for the pathogenic or epidemic 
potential of the species. This study demonstrated that the sub-type of Toxoplasma that expanded 
to cause the majority of benign, chronic infections in sea otters was uniformly lethal to outbred 
laboratory mice. This is not unlike the expansion of Type I strains in birds that harbor 
asymptomatic infections of another highly pathogenic strain to laboratory mice (Miller et al, 
unpublished). Additionally, while Type II isolates are commonly found in domestic livestock in 
North America, Type X is more common in sylvatic hosts, leading others to propose that 
separate cycles exist within the Toxoplasma population that overlap solely in the feline definitive 
host (VanWormer et al. 2014; Wendte, Gibson, and Grigg 2011; Dubey et al. 2011).  
Finally, although the exact parents are unknown that crossed to produce the recombinant 
clade of Type X strains, only a limited number of crossovers was detected, and the pedigree of 
one of the parents was known which allowed analysis by QTL on an unmanipulated, natural 
population of genetic hybrids. This analysis identified multiple punctate QTL associated regions 
with differences in mouse virulence. Taking advantage of the high-resolution SNP map for all of 
the progeny, and the ability to score quantitative differences in murine virulence, the regions of 
the genome that were associated with the virulence trait were small, allowing us to identify only 
a limited number of candidate loci for reverse genetic follow-up. The serine-threonine protein 
kinase ROP33 stood out as the best candidate to influence pathogenicity, largely because other 
related ROP proteins, including ROP5, 16, 17, and 18 are known to hijack host immune 
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signaling pathway gene expression to alter Toxoplasma virulence during rodent infection. Of 
note, all Type X isolates investigated in this study, whether virulent or avirulent, only expressed 
avirulent allele combinations of the known ROP virulence factors (data not shown). ROP33 was 
identified to be an active protein kinase that is abundantly expressed and is highly polymorphic. 
Whether its sequence divergence is the result of immune selection, or functional selection for 
interaction with specific host proteins is unknown. Nor is it known what specific host immune 
signaling pathways ROP33 targets. Although ROP33 contributes to the acute virulence 
phenotype, previous genetic mapping studies failed to identify the QTL for this locus, even 
though it is polymorphic between the Type I, II and III strains for which genetic crosses have 
been performed. It is likely that the ROP5 and ROP18 virulence factors were dominant, and 
ROP33 is analogous to ROP17, another virulence factor that was only identified after the 
virulence enhancing capacity of ROP18 was removed (Etheridge et al. 2014; Zhang et al. 2014). 
Future work will dissect the host factors that ROP33 targets to influence parasite transmission 
and pathogenicity. 
 
Materials and Methods 
 
Parasite Culture of Toxoplasma Strains 
 
Fifty-three T. gondii strains were isolated from brain samples of stranded Pacific coast 
southern sea otters provided by Dr. Patricia Conrad as previously described (Miller et al. 2004). 
Cause of death was determined for each sea otter host from primary pathology reports done 
based on host necropsy (Kreuder et al. 2003; Miller et al. 2002). Toxoplasma isolates are 
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identified based on their ATOS (“as the otter swims”) numbers derived from sea otter host 
stranding location as previously described (Wendte, Miller, Nandra, et al. 2010).  
Parasite strains were cultured on human foreskin fibroblast (HFFs) monolayers at 5% 
CO2 at 37°C. These HFFs were grown in DMEM Complete Medium derived from Dulbecco’s 
Modified Eagle Medium (DMEM) enriched with 10% heat-inactivated fetal bovine serum (FBS), 
glutamine, and treated with gentamycin and penicillin-streptomycin as described previously 
(Pszenny et al. 2000). Toxoplasma strain tachyzoites were grown on host HFFs until monolayer 
lysis.  
 
Type X Mouse Virulence Assay 
 
To determine the virulence of these isolates in a mouse model, Type X strain virulence 
was characterized using low dose infection in outbred mice. Groups of five or more, 6-8 week-
old, female CD-1 mice from Charles River Laboratories  were intraperitoneally injected with 50 
T. gondii tachyzoites per strain suspended in 500 μl PBS (Su et al. 2002). Mice were weighed 
daily to measure infection-induced cachexia and mouse survival was assayed over 42 days. After 
14 days, mice were bled, and serum extracted to test for seroconversion via indirect fluorescent 
antibody test (IFAT) against ME49 tachyzoites (Fletcher 1965; Grigg, Bonnefoy, et al. 2001; 
Miller et al. 2002). Virulence in murine infection was defined as thus: Virulent strains killed all 
seropositive mice, avirulent strains killed none of the seropositive mice, and intermediate 
virulence strains killed around 50% of all seropositive mice infected per strain of Type X.  
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DNA Extraction and Type X Strain Preliminary Marker Typing 
 
Parasites were syringe lysed from host HFFs using a 27-gauge needle and filtered 
through a 3.0-micron polycarbonate filter to remove cellular debris. Cleaned tachyzoites were 
pelleted and rinsed with PBS. DNA was extracted from cell pellets using the Qiagen DNeasy 
Blood and Tissue kit (Qiagen).  
DNA from the 53 filtered isolates was typed using 5 previously described PCR-RFLP 
markers distributed across 5 chromosomes (Su, Zhang, and Dubey 2006; Grigg, Bonnefoy, et al. 
2001; Fazaeli et al. 2000; Howe and Sibley 1994; Miller et al. 2004). BSR4, BAG1, GRA6, 
ROP1, and SAG3 were amplified by PCR using Taqman Ampli-Taq polymerase and an 
Eppendorf thermocycler as previously described (Fazaeli et al. 2000; Su, Zhang, and Dubey 
2006; Sundar et al. 2008). PCR products were electrophoresed through a 1% agarose gel to 
verify size. The PCR product of ROP1 was restriction enzyme digested with DdeI for 1 hour at 
37°C, products were run on a 1% agarose gel, and compared to clonally representative strain 
digests to determine marker identity. The PCR products of BSR4, BAG1, GRA6, and SAG3 
were Sanger sequenced and sequences were analyzed using DNAStar’s Lasergene SeqMan Pro 
software version 14 to identify representative SNPs within these genes, detailed below. These 
five markers identified 10 unique genotypes within the Type X clade.  
21 strains representing these 10 unique genotypes were PCR amplified and Sanger 
sequenced at 20 genotyping markers across the parasite genomes: 18 markers were sequenced 
for all possible strains at both linked and unlinked genomic loci, encompassing 13 of the 14 
chromosomes, and 2 loci on organellar genomes (apicoplast and mitochondria) (see 
Supplemental Table 1). Only seven loci on different Type X strains (shown in gray) were unable 
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to be amplified and characterized. 15,430 bp of genome were sequenced from these makers with 
335 SNPs (~0.024% of the genome). Sequences were examined, and nucleotides verified using 
SeqMan Pro alignment software (Lasergene). Sequences for reference strains (ME49, GT1, and 
VEG) were downloaded from ToxoDB Version 8.2 (Gajria et al. 2008). Alleles at each locus 
were determined by phylogenetic tree analysis as detailed below.  
 
eBURST Clonal Complex Determination 
 
Alleles determined from the 17 nuclear encoded marker sequencing (excluding ROP1 
due to its classification as a microsatellite marker) were categorized based on phylogenetic 
analysis of the sequence at a given locus and given numerical designations to create a multilocus 
sequence-typing scheme suitable for eBURST (Feil et al. 2004). Default settings were used to 
evaluate the isolated strains’ alleles to detect clonal complexes within the population of strains. 
Strains sharing 16 of the 17 nuclear encoded markers were designated as clonal complexes and 
represented by connecting lines in the diagram shown.  
 
Phylogenetic Tree Creation and Marker Analysis 
 
Typing marker sequences from Sanger sequencing were aligned using Clustal X 2.1 with 
default settings (Larkin et al. 2007). For each marker, the alignment was input into MEGA 7 to 
create a maximum likelihood tree using Tamura-Nei model distance analysis with uniform rates 
of substitution across all sites, and 1000 bootstrap support for all branch points (Tamura et al. 
2013). Bootstrap support equal to or greater than 60% distinguished novel alleles from 
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mitotically drifted alleles. This cutoff value was determined based on previously characterized 
markers such as GRA6 that were initially used to separate the Type X clade from the closely 
related Type II clade using single marker phylogenetic trees (Khan, Dubey, et al. 2011). All 
typing marker phylogenetic trees were rooted the canonical Type II strain, ME49 due to its 
prediction to be ancestral to the Type X clade.  
Distinct parental lineages with bootstrap support greater than 60% are indicated on each 
tree, where II indicates the ancestral Type II lineage and g and d indicating the yet unidentified 
secondary parent(s) of the Type X strains. These novel alleles are indicated in purple and orange 
respectively on the 17 loci MLST in Supplementary Table 2.  
 
Genomic Hybridization to Affymetrix Arrays 
 
Genomic DNA was sheared, biotin labeled, and then hybridized to a custom T. gondii 
Affymetrix microarray as previously published (Khan, Miller, et al. 2011). High-fidelity SNPs 
were characterized via a custom R script to identify SNPs belonging to each of the three 
reference strains (I, II, and III) which are color coded according to allelic similarity to the 
reference strains. Three reference strains (GT1, ME49, and CTG) are shown to demonstrate ideal 
hybridization within canonical lineages. Sea otter Type X DNA isolate hybridizations are shown 
under these.  
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Characterization of Type X Whole Genome Diversity 
 
DNA from 16 isolates of Type X that grew best in culture and 3 representative Type X 
strains (ARI, RAY, and WTD1), for a total of 19 Type X strains, was collected and isolated as 
stated above. 1 ng of DNA from each of these 19 Type X strains was sent to Rocky Mountain 
Laboratories for whole genome sequencing using Illumina HiSeq technology. Fastq reads 
derived from Illumina sequencing were reference mapped against the ToxoDB version 8.2 ME49 
genome using BWA 0.7.5a to align the reads to the reference genome and GATK 3.7 in 
coordination with Picard 1.131 following best practices to quality control the mapped reads (Van 
der Auwera et al. 2013). Following mapping, the gVCF method of GATK was used to combine 
SNP calls using stand_call_conf of 30.0, nct of 10, and ploidy of 1 (for haploid genomes) to call 
568592 single nucleotide polymorphism positions across the whole genomes of these strains 
(Van der Auwera et al. 2013). The derived VCF formatted SNP file was curated using GATK 
and VCFTools to produce a tabular file containing only biallelic SNPs with no large insertions or 
deletions (Danecek et al. 2011).  
A custom script was utilized to convert this SNP file into a fasta file of strain 
polymorphic positions across the Type X and reference genomes. These SNP fastas were input 
into SplitsTree4 where the default parameters for BioNJ with 1000 bootstrap support was used to 
create a NeighborNet tree (Huson and Bryant 2006). Interconnected reticulation between strains 




SNP Density Fingerprint Analysis of Recombinant Progeny  
 
 The same tabular, biallelic SNP file used in the NeighborNet analysis was modified using 
a custom R script based on location mapping derived from Behnke et al. 2015 to isolate strain-
specific polymorphic locations from the tabular VCF. Further R scripts group these SNPs into 
100 kbp windows which are mapped across the genomes of these strains to display where 
diversity from the reference genome (ME49) is most apparent (Minot et al. 2012; Yin, Cook, and 
Lawrence 2012). The larger the number of SNPs in a particular window, the more divergent this 
strain is from the ME49 reference. Distinct haploblocks where genomic recombination has 
occurred are apparent in areas where haploblock diversity significantly varies from the 
surrounding regions on the same chromosome.  
 
PopNet Characterization of Strain Interrelatedness 
 
 The tabular, biallelic SNP file created from WGS of Type X and used to derive the SNP 
density plots and NeighborNet tree was input into PopNet using default parameters to assess the 
diversity and interrelatedness of strains (Zhang et al. 2017). The recombination and Markov 
clustering output were input into Cytoscape for visualization. Genomes are displayed in 
circularized format with chromosomes concatenated into a circular genome display. The 
background of each strain is painted to match the group that shares the most common ancestry 
over the entire genome with the strain shown. Chromosome painting is done on strain genomes 
such that haploblocks of 10 kbp of sequence are painted based on shared ancestry within the 
haploblock. For instance, a Type X genomic haploblock that is closely related to the ancestral 
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Type II haploblock at will be painted green to indicate inheritance. Strains that are more closely 
related have thicker connecting lines between the circles of the strain isolations. 
 
QTL Virulence Candidate Gene Identification 
 
To find novel virulence alleles, the tabular, biallelic SNP file used previously is utilized to 
run quantitative trait loci (QTL) analysis on these strains of Type X Toxoplasma (Behnke et al. 
2015). SNP calls were down-selected by a custom java script to include one SNP every 5 kb. 
This allows the QTL software to analyze the breadth of the WGS data in QTL, which was built 
to handle marker typing data without the depth inherent in WGS data. Custom scripts code the 
SNPs into reference (ME49) versus alternative (Type X’s g/d lineage which will substitute as the 
secondary parent) alleles. This down-selected marker dataset was combined with previously 
determine low-dose murine virulence for these strains. This data was then input into J/qtl and a 
one QTL genome scan was run using the default settings for the EM algorithm (maximum 
likelihood) with 1000 permutations to identify genomic locations significantly associated with 
the percentage of murine death with Type X infection (Smith et al. 2009).  
From the QTL calculations, four significantly associated regions were identified based on a 
LOD score of greater than 4.0. Within these genomic regions, 450 genes were predicted based on 
ToxoDB documentation. These potential genes were down-selected based on presence of a 
signal peptide and/or transmembrane domain, gene expression, polymorphism, and genome-wide 
CRISPR score for essentiality to identify 32 virulence candidate genes within the Type X strains. 
Of these, ROP33 was selected for further interrogation based on its high LOD score and 
similarity to previously identified virulence effector proteins. 
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ROP33 Knock-out and Virulence Assay 
 
WGS fastqs of the Type X strains and several reference strains were reference mapped to 
the ME49 allele of ROP33 downloaded from ToxoDB. SNPs within these strains were 
characterized as with WGS above, and using GATK and BEDTools, consensus sequences were 
called to create fastas of this virulence candidate gene in each strain (Quinlan and Hall 2010; 
Van der Auwera et al. 2013). These fasta files were compared to one another using SeqMan Pro 
14.0 and polymorphisms were used to characterize the allelic inheritance of these strains by 
creating phylogenetic trees as with the Sanger sequenced markers above.  
 ROP33’s effect on virulence was determined by knocking out the ROP33 gene in a 
ROP18 deficient Type I strain of Toxoplasma. ROP33 was deleted from the virulent 
RH∆ku80∆rop18∆hxgprt strain by CRISPR-Cas9 targeting using an HXGPRT gene flanked by 
30bp of homology just outside of the rop33 promoter and 3’UTR region. The resultant 
RH∆ku80∆rop18∆hxgprt∆rop33 population screened by PCR for deletion and was selected 
using mycophenolic acid (MPA) and xanthine followed by cloning to produce a clonal deletion 
of ROP33.  
 To assess the virulence of ROP33, groups of 5 outbred CD-1 female 6-8 week old mice 
were injected intraperitoneally with 500 tachyzoites were infected with either the parent 
RH∆ku80∆rop18∆hxgprt strain or the Rop33 mutant. Infectivity and virulence were assessed as 
above. Parasite dissemination and growth were assessed by bioluminescence imaging as 
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Supplemental Figure 3-1: Stranding location and probably cause of death of sea otter infections.  
A) Geographical map of all 53 Toxoplasma-infected sea otter stranding locations along the California coast line. 
Each sea otter is represented by a red dot located at stranding location. B) Isolates of Toxoplasma gondii used in this 
paper. Causes of death (COD) are listed based on pathology determination at date of necropsy. ATOS numbers and 





Isolate ATOS # 5 loci 17 loci Stranding Location
Necropsy 
Date Sex IFAT Primary COD Secondary COD Tertiary COD Infection
2994 249 II Santa Cruz 05/15/98 M
No 
Serum Shark Attack - Presumptive None None Tg
3739 264 II Santa Cruz 26th Ave Beach 06/12/02 M 2560 Meningoencephalitis - Protozoal Boat Strike Emaciation/Starvation Tg
3576 274 II New Brighton State Beach 09/05/01 M 20480 Shark Attack - Presumptive Meningoencephalitis - Idiopathic Myocarditis Tg
3587 281 II Rio Del Mar Beach 09/22/01 M 1280 Shark Attack - Presumptive Meningoencephalitis - Protozoal Ulcers - Gastric Tg
2987 291 II II Mannressa State Beach 05/11/98 F 1280 Shark Attack - Presumptive Meningoencephalitis Emaciation/Starvation Tg
4181 303 II Sunset State Beach 04/14/04 F 40960 Bacterial - Abcess Pneumonia - Bacterial Meningoencephalitis - Protozoal Sn/Tg
3009 321 II Elkhorn Slough 06/04/98 M 640 Boat Strike - Presumptive Bacterial - Abcess None Tg
3521 325 II Salinas River State Beach 05/19/01 M 2560 Hemorrhage - Brain Meningoencephalitis - Protozoal Cardiomyopathy - Idiopathic Tg
3208 357 II Monterey Bay 07/12/99 M 5120 Drowning - Presumptive Meningoencephalitis - Idiopathic None Tg
3636 376 II Del Monte Beach 12/27/01 M 80 Shark Attack - Presumptive Ulcers - Gastric Meningoencephalitis - Idiopathic Tg
3087 377 II Monterey Harbor 10/28/98 F 640 Acanthocephalan Peritonitis Mating Trauma Emaciation/Starvation Tg
3131 379 II II Monterey Bay 02/05/99 M 320 Cardiomyopathy Mating Trauma Emaciation/Starvation Tg
3005 928 II Pismo Beach 06/01/98 M 160
Domoic Acid Intoxication - 
Presumptive Ulcers - Gastric None Tg
3396 928 II Oceano Dunes 11/11/00 M 20480 Drowning - Presumptive Meningoencephalitis - Idiopathic None Tg
3097 84 A Dunes Beach, San Mateo 11/16/98 M 5120 Meningoencephalitis - Idiopathic Acanthocephalan Peritonitis Emaciation/Starvation Tg
3142 180 A X1 Ano Nuevo Island 02/24/99 F 320 Shark Attack - Presumptive Meningoencephalitis - Protozoal Ulcers - Gastric Tg
3786 180 A Ano Nuevo Island 09/20/02 M 2560 Shark Attack - Confirmed Systemic Protozoal Infection Ulcers - Gastric Sn
4045 260 A Seabright Beach 10/21/03 M 10240 Shark Attack - Presumptive None None Tg
3950 263 A Santa Cruz, 21st Street Beach 07/16/03 M 10240 Meningoencephalitis - Protozoal Cardiomyopathy Septicemia - Bacterial Sn/Tg
3520 306 A Sunset Beach 05/16/01 M 320 Acanthocephalan Peritonitis Enteritis Emaciation/Starvation Tg
3659 374 A Del Monte Beach 02/28/02 F 40 Intussusception Peritonitis - Septic Septicemia - Bacterial Tg
3265 426 A X1 Carmel Beach 09/28/99 F 10240 Acanthocephalan Peritonitis Septicemia - Bacterial Herniation Tg
3168 450 A X2 Monterey Bay 04/09/99 F 2560 Gastroenteropathy - Hemorrhagic Emaciation/Starvation Rhabdomyolysis/Necrososis Tg
3865 480 A Carmel River State Beach 04/03/03 F 10240 Intestinal Volvulus Mating Trauma Emaciation/Starvation Tg
3947 523 A X1 Pfieffer Burns Beach 06/26/03 F 20480 Nose Wound Septicemia - Bacterial Emaciation/Starvation Tg
4003 750 A Cambria 09/17/03 F 10240 Mating Trauma Meningoencephalitis - Idiopathic Emaciation/Starvation Tg
4071 807 A Cayucos, North of E Steet 12/03/03 F 2560 Nose Wound Septicemia - Bacterial Emaciation/Starvation Tg
3483 820 A Morro Strand 03/30/01 F 320 Hepatopathy Cerebral Edema Pneumonia - Bacterial Sn/Tg
4151 825 A Morro Bay 04/04/04 F >40960 Meningoencephalitis - Protozoal Myocarditis - Nonsuppurative Emaciation/Starvation Sn/Tg
3488 919 A Pismo Beach, ~400m North of Grand Ave 04/04/01 F 640 Cardiomyopathy - Idiopathic Emaciation/Starvation Encephalitis - Atypical Idiopathic Tg
3821 922 A Pismo Beach 01/06/03 M 2560 Meningoencephalitis - Protozoal Cardiomyopathy Drowning - Presumptive Tg
3744 924 A Pismo Beach 07/02/02 F 5120 Shark Attack - Confirmed None None Tg
3637 926 A Oceana Dunes 02/14/03 F No data Meningoencephalitis - Protozoal Myocarditis Septicemia - Bacterial Tg
3523 141 B X3 Pescadero Point 05/31/01 F 5120 Meningoencephalitis - Protozoal Acanthocephalan Enteritis None Sn/Tg
3458 422 B X3 Stillwater Cove 01/16/01 F <80 Meningoencephalitis - Protozoal Cardiomyopathy Emaciation/Starvation Tg
3897 435 B Pt Lobos State Reserve 04/22/03 F 10240 Mating Trauma Pyothorax Septicemia - Bacterial Tg
3728 1,445 B Ventura County (Pt Mugu St Pk) 05/29/02 M 320 Cardiac Dilation Endocarditis - Vegetative Domoic Acid Intoxication - Presumptive Tg
3077 145 C Bean Hollow, Half Moon Bay 09/27/98 M 1280 Shark Attack - Presumptive None None Tg
3045 808 C X4 Cayucas 07/09/98 F
No 
Serum
Domoic Acid Intoxication - 
Presumptive Heart Failure - Chronic Emaciation/Starvation Tg
3026 840 C X4 Morro Bay Sandspit 06/24/98 M 320 Domoic Acid Intoxication Blunt Trauma Coccidiomycosis Tg
4167 852 C X4 Morro Creek 04/09/04 M 10240 Meningoencephalitis - Protozoal Cardiomyopathy Bacterial - Abcess Sn/Tg
3160 933 C X5 Pismo Beach 03/29/99 M 320 Bacterial - Abcess Cardiac Dilation Meningitis - Idiopathic Tg
3178 321 D X6 Moss Landing Harbor 03/26/02 F 320 Advanced decomp-No histopath Advanced decomp-No histopath Advanced decomp-No histopath Tg
3183 816 D Morro Strand 05/04/99 F 640 Meningoencephalitis - Idiopathic Meningoencephalitis - Protozoal Acanthocephalan Peritonitis Tg
3133 818 D X6 Morro Strand Campground 02/04/99 M 20480 Emaciation/Starvation Meningoencephalitis - Protozoal Viral Infection Tg
4166 827 D X7 Morro Bay 04/09/04 M 40960 Meningoencephalitis - Protozoal Acanthocephalan Peritonitis Cardiomyopathy Sn/Tg
3451 836 D Morro Bay, Sandspit between port 3 & 4 11/29/00 M <80 Meningoencephalitis - Protozoal Cardiomyopathy None Tg
3819 732 E X8 San Simeon Bay 12/28/02 F 5120 Pneumonia - Bacterial Mating Trauma Peritonitis - Septic Tg
3429 827 F X9 Morro Bay 10/30/00 F 2560 Acanthocephalan Peritonitis Septicemia - Bacterial Herniation Tg
3387 922 F X10 Pismo Beach 07/19/00 F 1280 Meningoencephalitis - Idiopathic Meningoencephalitis - Protozoal Acanthocephalan Peritonitis Tg
3503 1,319 F X9 Rincon Pt., Ventura County 08/09/01 M 2560 Meningoencephalitis - Protozoal None None Tg
3675 435 G X11 Point Lobos 03/20/02 F 1280 Emaciation/Starvation Nose Wound Meningoencephalitis - Protozoal Tg
3671 321 H X12 Elkhorn Slough 03/13/02 M 640 Pneumonia - Bacterial Cardiomyopathy Meningoencephalitis - Protozoal Sn/Tg
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Supplemental Table 3-1: Expanded sequencing marker genotyping of Type X isolates reveals chromosomal 
segregation and recombination within chromosomes. 
21 isolates characterized at 17 nuclear markers (ROP1 was excluded as it is a microsatellite marker, and prone to 
elevated mutation rates) clade into 12 distinct Type X genotypes (X1-X12). Types I, II, III, g and d lineage alleles, 
as determined by phylogenetic comparisons, are colored red, green, blue, purple, and orange, respectively. Shades of 
colors represent genetic drift below the 60% bootstrap delineation from the canonical allele. White represents 









Supplemental Table 3-2: Potential virulence candidate genes derived from the QTL analysis. 
Chromosome peaks with LOD scores over 3 as shown in Figure 3B were interrogated via ToxoDB to select genes in 
these regions which have predicted signal sequences (Signal) and transmembrane (TM) domains in Toxoplasma. 




Chr Start (bp) End (bp) LOD TM Signal Gene ID Genomic Location(s) Product Description
5 1215032 2165042 4.09 Y Y TGME49_285870 TGME49_chrV:2,158,544..2,162,541(-) SAG-related sequence SRS20A
Y Y TGME49_285940 TGME49_chrV:2,123,872..2,135,543(-) hypothetical protein
Y Y TGME49_286180 TGME49_chrV:1,933,873..1,942,288(-) tRNA ligases class I (M) protein
Y Y TGME49_286450 TGME49_chrV:1,824,587..1,826,598(+) dense granule protein GRA5
Y Y TGME49_286530 TGME49_chrV:1,790,919..1,793,716(+) hypothetical protein
Y Y TGME49_286620 TGME49_chrV:1,754,511..1,762,820(-) S1 RNA binding domain-containing protein
Y Y TGME49_286630 TGME49_chrV:1,750,888..1,752,970(+) redoxin domain-containing protein
Y Y TGME49_286770 TGME49_chrV:1,682,413..1,683,569(+) hypothetical protein
7a 2615053 4085005 4.35 Y Y TGME49_201130 TGME49_chrVIIa:4,019,644..4,026,659(+) rhoptry kinase family protein ROP33
Y Y TGME49_201180 TGME49_chrVIIa:3,982,746..3,988,716(-) hypothetical protein
Y Y TGME49_201390 TGME49_chrVIIa:3,908,769..3,911,287(-) hypothetical protein
Y Y TGME49_201780 TGME49_chrVIIa:3,794,121..3,797,385(-) microneme protein MIC2
Y Y TGME49_201860 TGME49_chrVIIa:3,741,150..3,743,832(-) hypothetical protein
Y Y TGME49_202050 TGME49_chrVIIa:3,666,573..3,668,278(-) hypothetical protein
Y Y TGME49_202375 TGME49_chrVIIa:3,379,488..3,384,231(-) hypothetical protein
Y Y TGME49_202440 TGME49_chrVIIa:3,326,760..3,330,921(+) hypothetical protein
Y Y TGME49_202572 TGME49_chrVIIa:3,207,247..3,216,124(-) ribophorin i protein
Y Y TGME49_202620 TGME49_chrVIIa:3,164,535..3,167,304(-) hypothetical protein
Y Y TGME49_202630 TGME49_chrVIIa:3,149,594..3,162,966(-) ATP-dependent metallopeptidase HflB subfamily protein
Y Y TGME49_202650 TGME49_chrVIIa:3,120,640..3,134,651(+) hypothetical protein
Y Y TGME49_202780 TGME49_chrVIIa:3,033,153..3,037,960(-) rhoptry kinase family protein ROP25
Y Y TGME49_202800 TGME49_chrVIIa:3,017,549..3,023,257(-) cytochrome c oxidase assembly protein COX11 protein, putative
Y Y TGME49_202860 TGME49_chrVIIa:2,977,558..2,979,383(+) hypothetical protein
Y Y TGME49_202940 TGME49_chrVIIa:2,936,249..2,939,562(-) hypothetical protein
8 6470103 6905157 3.94 Y Y TGME49_200230 TGME49_chrVIII:6,753,611..6,755,422(-) microneme protein MIC17C
Y Y TGME49_200440 TGME49_chrVIII:6,883,172..6,887,049(+) hypothetical protein
10 7314 595006 3.95 Y Y TGME49_228110 TGME49_chrX:579,227..581,518(-) hypothetical protein
Y Y TGME49_228160 TGME49_chrX:528,230..538,369(-) acid phosphatase
Y Y TGME49_228170 TGME49_chrX:519,357..528,263(-) inner membrane complex protein IMC2A
Y Y TGME49_228310 TGME49_chrX:426,285..427,726(-) hypothetical protein
Y Y TGME49_228350 TGME49_chrX:381,741..397,668(+) elongation factor Tu GTP binding domain-containing protein
Y Y TGME49_228360 TGME49_chrX:376,764..379,771(+) peptidyl-prolyl isomerase FKBP12, putative
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Chapter 4 - Low Frequency Sexual Recombination in Toxoplasma 
Favors Clonal Expansion by Unisexual Mating 
 
Kennard, Andrea; Gregg, Beth; and Grigg, Michael E. 
 




 Toxoplasma gondii is a generalist parasite found worldwide and is capable of infecting 
any warm-blooded host. This parasite has a bimodal lifecycle that allows Toxoplasma to 
replicate both asexually and sexually. The asexual cycle propagates Toxoplasma between 
intermediate hosts either vertically by congenital infection or horizontally by carnivory. 
Conversely, sexual propagation of Toxoplasma within its definitive feline host promotes either 
genetic diversification via outcrossing to produce novel admixture strains or sexual expansion of 
a single clone by self-mating. Both outcomes produce up to 100 million infectious oocysts per 
feline. Novel admixtures can then be naturally selected within the parasite’s broad range of 
intermediate hosts to select for best-fit combinations between host and parasite that maximize 
transmissibility (Sibley et al. 2009). Given the fecundity of the Toxoplasma sexual cycle, the 
expectation was that its population genetic structure would be highly diverse. But this is not the 
case in North America and Europe which possesses a limited number of clonal haplogroups or 
clades that cause the majority of infections in people and livestock (Boyle et al. 2006; Minot et 
al. 2012; Howe and Sibley 1995; Khan, Dubey, et al. 2011; Shwab et al. 2014; Dubey et al. 
2014; Dubey et al. 2011; Su, Zhang, and Dubey 2006; Grigg and Sundar 2009). It was previously 
hypothesized that these clonal lineages may be the products of a recent selective sweep or 
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founder effect, whereby only a few parasite genotypes escaped a genetic bottleneck and founded 
the current clonal population structure (Bertranpetit et al. 2016; Fux et al. 2007; Khan, Miller, et 
al. 2011; Shwab et al. 2014). Alternatively, a population structure with limited genomic diversity 
could also be explained by parasites that are predominantly expanded asexually and only rarely 
outcross in nature (Grigg and Sundar 2009; Khan et al. 2006; Sibley and Ajioka 2008). However, 
this hypothesis is at odds with the high fecundity with which Toxoplasma laboratory strains 
undergo experimental outcrossing in the feline host. Recent work by Wendte et al, 2010 
established that Toxoplasma frequently undergoes either unisexual mating between two 
genetically similar strains from the same clade or self-mating, in which a single strain undergoes 
a full sexual cycle within the definitive host to produce clonal progeny (Wendte, Miller, 
Lambourn, et al. 2010). In this way, unisexual or self-mating allows successful clones of the 
parasite to expand their prevalence and host range within a geographical or ecological niche 
which serves to genetically homogenize diversity within a given population (Heitman 2010; 
Roach and Heitman 2014; Wendte, Miller, Lambourn, et al. 2010). 
The designation that Toxoplasma possesses a clonal genetic population structure in North 
America and Europe was established using solely low-resolution typing markers (Su, Zhang, and 
Dubey 2006; Ajzenberg et al. 2010; Blackston et al. 2001; Verma et al. 2015). Subsequent work 
has established that this low-resolution approach has led to the mis-categorization of whole 
clades. For example, the Type X clade was initially reported as part of the Type II clonal lineage 
but was later re-categorized as a separate clonal lineage based on a single typing marker (GRA6) 
(Khan, Dubey, et al. 2011). Further, the low-resolution markers also failed to predict all of the 
genetic diversity that can be identified among natural isolates of both Type I (Khan, Behnke, et 
al. 2009) and Type II strains (Verma et al. 2015; Parameswaran et al. 2010) which serves as the 
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basis for the in depth, genome-wide analyses that were pursued in this thesis. Our work 
sequencing the whole genomes of Type II and X strains (Chapter 2 and 3 respectively) has 
demonstrated that sexual propagation is occurring within these populations more frequently than 
previously predicted (Lorenzi et al. 2016; Minot et al. 2012; Shwab et al. 2014; Sibley and 
Ajioka 2008; Su, Zhang, and Dubey 2006). Further, the increased resolution provided by whole 
genome sequencing is redefining the population genetic structure of Toxoplasma. Chapter 3 
established that the Type X clade is comprised of a group of progeny derived from one or more 
sexual crosses between a Type II strain and an unknown g/d lineage. In comparison, the Type II 
clade was found to be comprised of closely related strains which had recently diverged from a 
single lineage. However, while these strains displayed genetic diversity within their genomes, 
SNPs were not randomly distributed as would be expected for strains that are expanding 
exclusively asexually. Rather, distinct haploblocks of genetic diversity within the Type II clade 
displayed evidence of intra-clade/unisexual recombination, as described in Chapter 2. Because 
unisexual expansion is virtually indistinguishable from asexual expansion at low-resolution 
typing, the genetic basis for the maintenance of highly successful clones within the Toxoplasma 
population structure requires analyses to be conducted using high resolution genomic typing in 
order to distinguish the relative contribution of each of these replicative cycles in maintaining the 
clonal structure in North America and Europe.   
While unisexual mating appears to play a central role in maintaining Toxoplasma’s clonal 
population structure, outcrossing between genetically diverse strains is key to the expansion of 
this generalist parasite’s biological potential and it ability to infect a broad range of intermediate 
hosts.  For example, genetic hybridization enables avirulent haploid parents to produce virulent 
progeny when different virulence genes are recombined into novel associations that alter the 
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parasites fitness or capacity to cause disease (Grigg, Bonnefoy, et al. 2001). Experimental 
crosses have identified a series of genetic factors that are maintained cryptically across the 
parasite’s genetic diversity. For example, the ROP5I/III allele was identified to be a virulence 
factor only when it was combined with the ROP18I/II allele (Niedelman et al. 2012; Saeij et al. 
2006). In Chapter 3, infection of mice with different Type X strains identified a range of 
virulence phenotypes among the natural population of sexually derived hybrids studied. Because 
Type X strains did not possess allele combinations of known virulent genes that predicted their 
murine virulence phenotypes, it was hypothesized that the mouse virulent Type X clones 
possessed novel virulence factors. To test this hypothesis, a series of sexual crosses were 
attempted between the mouse virulent Type X strains 3142 and 3133 and the mouse avirulent 
Type II B7 (ME49) clone. Only a few progeny could be recovered from the several independent 
sexual crosses that were attempted. Although too few recombinant progeny were obtained to 
perform a forward genetic QTL to identify putative virulence loci, a novel method was 
developed to determine the relative rates of self-mating versus outcrossing among the 
hybridizing strains.  
During the process of isolating cross progeny, subsequent analyses performed on the 
recovered progeny identified several limitations to the traditional approach used for 
experimentally isolating recombinant progeny. The traditional method involved 
enzymatic/mechanical release of sporozoites from sporulated oocysts that are doubly-drug 
selected to identify recombinant progeny within the population. This technique cannot determine 
the relative rates of self-mating versus outcrossing that occurs during the sexual cycle due to the 
selection biases inherent in the process. To more accurately assess the frequency with which self-
mating is occurring within the sexual cross, sporozoites were hatched from oocysts in a manner 
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that facilitates direct cloning prior to drug selection. To do this, macrophage-facilitated limiting 
dilution isolation was used to increase effective yields and generated significantly more cross 
progeny in less time using a safer isolation process than traditional excystation. Additionally, 
these improvements allowed for the isolation of individual progeny from the cross significantly 
reducing biases present in previous isolation methods. Due to these improvements, our results 
established that outcrossing between two parents is rare compared to self-mating within a 
definitive feline host, which provides a possible explanation for how these sexually fecund 




Traditional Excystation Methods Limit the Genetic Analyses of Sexual Crosses  
 
 Forward genetic approaches were employed to generate sexual cross progeny by 
backcrossing the mouse virulent Type X strains 3133 and 3142 with the avirulent Type II strain 
ME49 (clone B7 with is FUDR resistant) in order to identify novel virulence alleles within the 
Type X clade. In order to perform the genetic crosses, drug resistant isolates for each Type X 
cross parent were first generated via ENU-mutagenesis, followed by single drug (sinefungin) 
resistance selection. Resistant isolates were cloned, then used to produce bradyzoite cysts in the 
brains of mice. Sulfadiazine treatment was used to allow murine survival of acute infection of the 
virulent Type X strains 3133 and 3142 at a dose empirically determined to maximize murine cyst 
burden and survival. These cysts were fed orally to cats to allow both parental strains to undergo 
gametocytogenesis and fusion during the sexual phase of the life cycle. Oocysts shed from feline 
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feces were then collected, sporulated and excysted to generate sporozoites (Dubey and Frenkel 
1976) to be screened for the presence of recombinant progeny.  
 Using traditional excystation protocols (commonly referred to as oocyst hatching), 
oocysts are extensively manually manipulated, a process which typically takes 8-10 hours to 
complete. Once oocysts are excysted into sporozoites, they are plated as a pooled sample into a 
single flask of adherent foreskin fibroblasts where the sporozoites undergo competitive infection 
and growth cycles as a pooled population. The pooled sporozoites are then subjected to further 
growth pressure by double-drug selection to select for progeny resistant to both parental drug 
selections, and to thereby select for recombinant progeny. Individual progeny can then be 
isolated, but only after the host cell lysis has occurred under double-drug selection, which 
typically takes several weeks after the initial excystation. Several biases were observed in our 
results when using this traditional excystation method. The competitive growth of all excysted 
sporozoites in a single pooled sample created a de facto competitive growth assay in which faster 
growing sporozoites were over-represented in the pool. The competitive growth observed biased 
the derived pool of sporozoites from the initial pool of recombinant progeny. This was 
determined by PCR-RFLP analysis after single cell cloning which established that a single, 
dominate clone had expanded in the Cross 1 Hatch 1 pool from the 3133XME49 cross, whereas 
PCR-RFLP analysis of the non-drug selected pool as a whole showed a distinct pattern of 
sequence types (data not shown). Furthermore, double-drug selection biased the pool toward 
only those progeny that had recombined to inherit a drug resistance gene from each parent and 
excluded analysis of those progeny that had undergone recombination but did not inherit both 
drug resistance loci. In order to better interrogate the individual progeny from a sexual cross and 
to infer the ratio of uniparental versus outbred progeny that derived from this genetic 
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hybridization, several modifications were made to allow for an unbiased isolation of individual 
progeny.  
 
Limiting Dilution Isolation Removes Growth Biases and Macrophage-Facilitated Limiting 
Dilution Improves Yield of Individually Isolated Sporozoites 
 
Significant modifications to the traditional excystation method allowed for safer, more 
efficient, and unbiased selection of independently isolated sporozoites (Table 1A). In order to 
overcome the competitive growth bias that double-drug selected sporozoites experience, a 
limiting dilution isolation method was established. Immediately following excystation, 
sporozoites were plated into successively diluted, individual wells of host cells over several 96-
well plates in order to isolate individual progeny and thereby remove any implicit bias 
introduced by competitive growth in a pooled population. Wells were then interrogated after ten 
days of growth by plaque assay to identify wells that derived from a single sporozoite founder. 
Individual progeny were replica plated and analyzed under non-selective medium, single, or 
double drug selection to determine which individual progeny expanded under the various 
selection conditions and were thus probable recombinant progeny from the sexual cross. A 
number of individually isolated progeny were then selected for whole genome sequencing and 
further genetic characterization. The isolation of sporozoites immediately following oocyst 
excystation allowed for significant improvement, by at least 28%, in individual progeny isolation 
because immediate isolation eliminated the competitive growth between sporozoites that biased 
them toward those which grow best in culture (Table 1A). In the limiting dilution isolation 
method, all sporozoites isolated were independent progeny from the sexual cross rather than 
identical clones of the same progeny that exhibited a growth advantage under pool selection. In 
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addition to limiting dilution, a further improvement increased yields by utilizing a natural oocyst 
excystation method which improved safety over the traditional isolation method. This new 
technique was based on a recent study that examined murine subcutaneous oocyst infection and 
determined that systemic Toxoplasma infection of the murine host is facilitated by macrophage 
phagocytosis and excystation of infecting oocysts (Freppel et al. 2016). Although the mechanism 
by which macrophage phagolysosomes excysted oocysts in vivo was unclear, these experiments 
also showed that cell cultured, in vitro macrophages excyst oocysts and suggested that 
macrophage excystation could be utilized to excyst oocysts to produce viable sporozoites in 
culture. To overcome the low yields of sporozoites obtained by traditional chemical, enzymatic, 
and manual excystation methods, bone marrow derived macrophages were utilized to promote 
excystation of the sporozoites from sexual cross oocysts. Briefly, oocysts were incubated with 
cultured macrophages overnight to break the oocyst outer wall. Compared to manual methods, 
macrophage-facilitated excystation can be completed within 3 hours, rather than the 8-10 
demanded by traditional excystation. Importantly, the sporozoite yield derived from macrophage 
excysted, limiting dilution isolated crosses was significantly increased by at least 290% above 
those sporozoites yielded from traditional methods (Table 1A).  
To compare the improved isolation methods with traditional excystation methods, an 
equal oocyst starting concentration from a single cross of 3133 SNFR and ME49 FUDRR was 
hatched in parallel using both traditional and macrophage-facilitated oocyst excystation methods, 
followed by limiting dilution isolation. The resultant plaques were enumerated after ten days as a 
measure of sporozoite yield (Table 1A). Following traditional excystation, sporozoite plaques 
were found in 114 wells, 93 of which were singleton individual sporozoite isolates. In contrast, 
following macrophage-facilitated excystation, 250 wells contained too many sporozoite plaques 
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to count. In the 194 wells derived from macrophage-facilitated excystation that contained a 
countable number of sporozoite plaques, 119 contained singleton plaques of individual 
sporozoite isolates. This method produced a 290% or greater increase in the sporozoite progeny 
pools based on the number of growing wells (which underestimates the number of excysted 
sporozoites per well) after excystation. The true rate of recombination within a single sexual 
crossing event was next interrogated. Previously, the presence of recombinant progeny was 
estimated using only a limited number of low-resolution marker loci characterized from double 
drug-selected pools of excysted sporozoites. In this study, whole genome sequencing of 
individually isolated progeny was used from the sexual cross to empirically determine sexual 
cross recombination rates, which is not possible by the traditional excystation and pool method 
under double drug selection.  
 
Sexual Recombination is Biased Toward Uniparental Mating 
 
 For the four crosses pursued as part of this thesis, three used the parents 3133 x ME49, 
and the fourth used the parents 3142 x ME49.  For two of the four crosses, progeny were isolated 
in 4 separate hatching events. For each excystation, DNA was extracted from the sporozoite pool 
prior to single cloning. Sporozoite pool DNA was analyzed to determine the dominant parental 
genotype within each hatched pool (Supplemental Table 1). Traditionally, sporozoite pools that 
have undergone successful sexual recombination contain the presence of both parental alleles 
within the sporozoite pool immediately following excystation, but this is by no means a 
quantitative measurement, and is rather a binary observation that both parents produced oocysts 
within the single cat infection. Observation of both parental alleles in the pool cannot distinguish 
between both parental strains undergoing self-mating and successful sexual recombination 
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resulting in the production of recombinant progeny containing an admixture of parental alleles in 
the same genome. In previous studies, when only a single parental allele is detected at 
characterized loci by this low-resolution methodology, the cross was typically abandoned, under 
the assumption that only one parent had undergone sexual expansion by self-mating. In this 
study, the PCR-RFLP characterizations of the sporozoite pools were dominated by a single 
parental lineage and displayed no signs of recombination between the parents at any loci 
interrogated (data not shown). However, the dominant parent for each of the four crosses was not 
biased toward one particular parent across independent replications of these crosses using the 
three parental strains. Of the four crosses, the PCR-RFLP analysis identified that 3133 was the 
only parent detected for both Cross 1 and 2 of the 3133 x ME49 cross, whereas ME49 was the 
only parent detected for Crosses 3.  ME49 was the only parent detected for the only cross (Cross 
1) done between 3142 x ME49. Overall, an equal segregation of the parental types was found to 
have expanded by self-mating within the Type II x Type X sexual crosses, with 2 Type X and 2 
Type II strains dominating the genetic populations across the 4 cat experiments performed (Table 
1C). For each cross, independently isolated progeny were grown up and whole genome 
sequenced in the absence of drug selection. In all cases, the dominant parent in the sporozoite 
pool matched with the majority of individual progeny isolated (Supplemental Figure 1 and 2). 
Multiple factors may induce preferential self-mating such as growth rates of each parent, the 
viability of the parental bradyzoite cysts, and the capability of each strain to differentiate into 
merozoites and commit to gametocytogenesis in the feline gut. However, neither parental strain 
grew significantly better than the other in the murine hosts and all three parental strains were 
capable of producing viable oocysts by self-mating in cats. In fact, the dominant parental 
inheritance of each sexual cross was not as expected based on the in vitro culture of the 
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bradyzoite cysts used to produce the crosses. Although the bradyzoites used to generate the 
crosses were fed to the cats in approximately equal number, cell culture viability of the parental 
bradyzoites was not predictive of the dominant parental genotype present in the sporozoites. For 
instance, although the sporozoite pool from Cross 3 of 3133 x ME49 was dominated by the 
ME49 parental alleles, only the bradyzoites from the 3133 (non-dominant) parent grew in culture 
(data not shown).  
 To verify these observed sexual recombination biases, each cross was repeated in 
multiple felines. Additionally, oocyst excystation was repeated to encompass the true diversity of 
progeny within the sexual cross. Thirty-one progeny from the 3133 x ME49 cross and 48 
progeny from the 3142 x ME49 cross were individually isolated by limiting dilution immediately 
following excystation. To characterize progeny genotypes, each isolate was sent for whole 
genome sequencing. Although PCR-RFLP analysis of pooled sporozoites from both crosses 
indicated that self-mating of only a single parent had occurred (Table 1B), whole genome 
sequence analyses of individually isolated progeny indicated otherwise, that each of the sexual 
crosses yielded recombinant progeny, but with a low frequency (Supplemental Figure 1 and 2). 
The identification of recombinant progeny in each cross indicated that the parental strains did 
successfully undergo sexual outcrossing. Sequencing of isolated progeny indicated that the 
meiotic genetic recombination of progeny occurred at a much lower frequency (3.2% and 2.1%) 
(Table 1C) than previously published for sexual crosses (Pfefferkorn and Pfefferkorn 1980), 
which had a recovery frequency of 12.5%. In fact, traditional excystation with PCR-RFLP 
marker analysis would have deemed these crosses as failures, as the dominant parental strain 
from the initial sporozoite pool had appeared to preferentially self-mate, and none of the progeny 
would have been analyzed to determine if they were genetic hybrids between the two parents. 
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However, the work herein indicates that low rates of sexual recombination between two parents 




Table 4-1: Improvements to oocyst hatching and recombination frequencies of Type X by II crosses. 
A) Oocyst Hatching Improvements. Oocyst excystation of the 3133 SNFR x ME49 FUDRR and 3142 SNFR x ME49 
FUDRR crosses. Oocysts from 4 independent feline crosses were hatched at least once. Each Hatch represents a 
separate oocyst excystation. Method of hatch corresponds to procedures listed in the methods section. Wells plated 
indicate the number of 96-well plates used to seed the excysted progeny. Well lysed indicates the number of wells 
with either complete lysis of the host cells at the time of counting or containing plaques that were too numerous to 
count. These wells were not included in plaque well counts. Plaques were counted in singleton plaque wells and 
multi-plaque wells to determine the number of independent progeny derived from these methods. Cross 3, Hatch 1 
of 3133xME49 was hatched in parallel by both traditional and macrophage-facilitated excystation. Macrophage 
excystation yielded more growing wells of sporozoite progeny and more total countable plaques than the traditional 
excystation method. B) Parental biases enumerated across the sexual crosses. Sexual crosses from A were assayed 
by PCR-RFLP before and after sexual recombination and parental Toxoplasma contribution was identified. For each 
parental strain, 1000 tachyzoites (tz) were infected into murine hosts. The resultant bradyzoites (bz) were counted 
before sexual recombination occurred. Sporozoite (sz) bias was determined based on PCR-RFLP of both pooled 
sporozoites and unselected individually isolated progeny. C) Recombination frequencies based on whole genome 
sequencing of progeny from two distinct Type II by Type X crosses. Verified recombinant progeny are determined 
based on SNP density analysis (See supplemental Figures 1&2).  
 
3133XB7 Cross 3142XB7 Cross
B7 Selfing 0 47
Type X Selfing 29 0
Recombinant Progeny 1 1
Total Progeny 30 48
% Recombination 3.33% 2.08%
3133 SNF X ME49 FUDR
Cross Hatch Method of Hatch Cross Date Hatch Date Well Plated Well Lysed Plaque Wells Multi-plaques Singletons Total Plaques
1 1 Pool to Isolates 5/1/14 6/5/14 1056 0 112 16 105 121
1 2 Plate across 1 96-wells 5/1/14 6/19/14 80 0 80 647 0 647
1 3 Plate across 10 96-wells 5/1/14 5/27/15 864 0 9 0 9 9
1 4 Serial Dilution 4 96-wells 5/1/14 7/25/15 384 0 14 4 12 16
2 1 Serial Dilution 5 96-wells 12/22/15 1/11/16 480 96 384 2036 3 2039
3 1 Standard Serial Dilution 10 96-wells 11/1/16 12/15/16 960 0 141 114 93 207
3 1 Macrophage Serial Dilution 10 96-wells 11/1/16 12/15/16 960 250 194 206 119 325
3142 SNF X ME49 FUDR
Cross Hatch Method of Hatch Cross Date Hatch Date Wells Plated Wells Lysed Plaque Wells Multi-plaques Singletons Total Plaques
1 1 Pool to Isolates 5/1/14 6/5/14 960 0 299 120 239 359
1 2 Plate across 1 96-wells 5/1/14 6/19/14 84 0 84 334 7 341
1 3 Plate across 10 96-wells 5/1/14 5/27/15 96 0 1 0 1 1
1 4 Serial Dilution 4 96-wells 5/1/14 7/2/15 384 0 76 12 70 82
A
B
Parents Cross infected tz Type II bz Type X bz sz bias
3133 x ME49 1 1000 unknown 3000 3133
3133 x ME49 2 1000 375 0 apparent 3133
3133 x ME49 3 1000 0 apparent 0 apparent ME49




   
Improved Methods of Excystation Also Improve Interrogation of Recombinant Progeny  
 
Sexual recombination rates between parental strains were interrogated using 
independently isolated progeny from a sexual cross between the Type II and X clades. There are 
several steps of the excystation process that introduce biases affecting the isolation of 
recombinant progeny, and subsequently the true ratios of sexual recombination events that occur 
in the feline host. The discrimination between true ratios of outcrossing versus self-mating was 
resolved between the parental strains by improving the isolation method that eliminated several 
experimentally induced biases such as competitive growth and survival of manual isolation. 
Independently isolated sexual cross progeny derived using these methods allowed for the 
unbiased interrogation of sexual cross recombination rates. In addition to the computational 
power of these new excystation methods, the safety of excystation of oocysts was greatly 
improved. Previous methods of oocyst hatching required both specialized reagents and lengthy 
manipulation of highly infectious oocysts (Freyre and Falcon 2004; Khan et al. 2005). While 
handing the highly infectious oocysts, researchers must remain in full-body personal protective 
equipment and keep equipment and generated waste isolated to reduce the risk of laboratory and 
personnel contamination. Human virulence phenotypes of newly isolated progeny are unknown 
and cannot be readily predicted, as even avirulent strains have been shown to produce virulent 
progeny (Grigg, Bonnefoy, et al. 2001). Thus, it is best to limit potential exposure to oocysts as 
the methods described here do. The length of exposure to the oocysts was more than halved by 
utilizing bone marrow derived macrophages (BMDMs) to digest oocyst walls, and the recovery 
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of viable progeny was increased exponentially, facilitating single cell cloning to increase yields 
of cloned progeny for molecular characterization (Freppel et al. 2016).  
Although this macrophage-facilitated method may bias derived progeny toward those 
sporozoites that survive BMDM phagocytosis, macrophages are thought to be the preferred 
cellular host of Toxoplasma infection (Jensen et al. 2011; Melo et al. 2013; Suzuki et al. 1988). 
Additionally, macrophage-facilitated excystation combined with limiting dilution isolation 
produced, at the very minimum, a 28% increase in the number of individually isolated 
sporozoites available for interrogation. However, it is of note that individual progeny isolates are 
more heavily influenced by correct limiting dilutions than on any improvement in technique as 
wells with multiple plaques indicated that far more sporozoite progeny were obtained by the 
macrophage excystation technique than could be enumerated here. Thus, the true improvement 
using macrophage-facilitated excystation followed by limiting dilution of progeny from oocysts 
demonstrated in this study has significantly improved yields of independent sporozoite progeny 
isolates by at least 300%. In previous genetic hybridization studies recovery of between 20-35 
recombinant progeny was necessary to determine novel virulence alleles (Behnke et al. 2011; 
Behnke, Khan, and Sibley 2015; Saeij et al. 2006; Taylor et al. 2006). With the increased 
numbers of isolated progeny herein, even if some bias is shown in the derived progeny, a single 
hatch yields ten times more individually isolated progeny than was necessary for prior studies to 
characterize novel virulence alleles. Additional isolates have also allowed the distinction 




Biased Sexual Recombination is Common in Protozoan Parasites 
 
Macrophage-facilitated limiting dilution excystation permitted the examination of all 
individually isolated progeny derived from a single cross. Characterization of these progeny by 
WGS (Supplemental Figures 1&2) demonstrated that most progeny (96.8% in the 3133 by ME49 
and 97.9% in the 3142 by ME49 cross, Table 1C) were products of uniparental mating rather 
than outcrossing. These uniparental mating rates are extremely high in comparison to previously 
reported successful crosses, in which a high-frequency of genetic hybridization was reported and 
in which the crosses experienced rates of uniparental mating  around 50%  (Pfefferkorn and 
Pfefferkorn 1980). The disparity between the experimental crosses reported here and previously 
reported successful crosses is likely due to the elimination of progeny selection biases in our 
interrogation. A common recombination verification procedure uses PCR-RFLP to interrogate 
the pool of oocysts prior to excystation and the pool of excysted sporozoite progeny immediately 
following excystation to verify that sexual recombination has occurred. If biallelism or marker 
recombination is not observed within either pool, no sexual recombination is considered to have 
occurred, and no further analysis is done on the oocysts from that cross. However, as seen in this 
study, the traditional protocol lacks the inherent resolution to detect low-frequency 
recombination masked by highly prevalent self-mating. In fact, all crosses interrogated here 
would have previously been classified as failures. As a result, the number of successful crosses 
between Toxoplasma strains has likely been underestimated. It was demonstrated here that even 
crosses initially thought to be failures contain both low-frequency genetic progeny from 
outcrossing within a larger population of progeny derived from uniparental self-mating by one of 
the parents. Thus, genetic hybridization is likely more common than previously reported as many 
unreported crosses are characterized as failures, when only one parent appeared to have 
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expanded by uniparental mating. Despite previous reports from the analysis of successful sexual 
crosses within the Toxoplasma field, the potential for a parasite to preferentially self-mate is not 
a rare occurrence (Boothroyd 2009; Grigg and Sundar 2009; Minot et al. 2012; Su et al. 2003; 
Wendte, Miller, Lambourn, et al. 2010). Such a bias toward self-mating has also been seen in 
Cryptococcus neoformans as well as other protozoan parasites, including Leishmania where 
hybrid progeny only accounted for 14% or less of all progeny isolated (Billmyre et al. 2014; Sun 
et al. 2014; Inbar et al. 2013). For Toxoplasma, this uniparental bias within sexual mating has 
been enumerated and defined in the studies herein for the first time.  
Host and parasite factors are likely co-operating to promote uniparental mating. The 
bradyzoite cysts used for feline infections have variability in the number of parasite bradyzoites 
contained within a single host tissue cyst and have variable viability across different host-strain 
combinations. This variability has the potential to affect parasite numbers that can participate in 
sexual recombination within the definitive host. Additionally, differential seeding capacity of 
parasites inside the feline intestinal tract has been observed in other parasites, such as the 
gregarine apicomplexans, S. terebellae and S. melongena n. sp. (Tenter 1995; Wakeman, 
Heintzelman, and Leander 2014). Toxoplasma is known to display differential host partitioning 
during co-infections of more than one Toxoplasma strain, which segregate differentially 
throughout the bodies of their hosts (Verma et al. 2017). In the feline host, bradyzoites may have 
a strain-specific ability to differentiate into gametes in different locations and with differential 
maturation rates inside the feline intestine. If so, gametes produced closer together both 
biologically and temporally would be more likely to merge into a zygote to produce oocysts. In 
order to characterize these differences, more controlled studies of the sexual cycle within the 
feline gut are necessary. 
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Biased Sexual Recombination Shapes the Population Structure of Toxoplasma 
 
Sexual recombination in nature has been classified as a rare event for Toxoplasma (Sibley 
and Ajioka 2008; Wendte, Miller, Lambourn, et al. 2010). However, careful examination of 
Type II strains has indicated that sexual recombination may be hidden within lineages as a result 
of same-clade/unisexual mating (Chapter 2). Sexual recombination is an important mechanism 
by which Toxoplasma retains the capability to diversify its genome while still maintaining 
virulence genes cryptically in its genome (Wendte, Miller, Lambourn, et al. 2010). Uniparental 
mating may drive clonality even in cases of co-infection, where outcrossing is predicted to be 
prevalent. To determine if uniparental and/or highly-similar unisexual mating (mating within a 
clade) is preferred over sexual outcrossing, more sexual crosses would need to be examined 
using the new, unbiased techniques of macrophage-facilitated excystation followed by limiting 
dilution isolation of sexual progeny detailed here. Furthermore, there are several factors to 
consider in experimental crosses that may bias the outcome. For example, bradyzoite viability 
and associated gamete differentiation and propagation should be assessed within the feline 
intestine. While it is currently standard to infect a feline with approximately equal bradyzoites 
per strain, not all bradyzoite cysts contain the same number of bradyzoites thus accounting for 
this disparity may be key in the standardization of feline infections. Therefore, these bradyzoite 
infections in cats would also need to be induced such that gamete production from the 
bradyzoites of each strain is optimized to produce sexual recombination between the maturing 
gametes of infecting parasites. Ideally, each strain would produce gametes at the same time in 
overlapping locations across the feline host gut to ensure the greatest likelihood of cross-strain 
gametes encountering and fusing to produce the hybrid zygotes that would yield recombinant 
sporozoites. In addition to the possible biological limitations in these studies, feline experiments 
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are expensive and more difficult to control. Unlike inbred mice, the host population of felines is 
not as tractable to repeat infections. As a result, the significance of these factors in facilitating 
uniparental mating over outcrossing currently remains a black box in the Toxoplasma field. 
Thus, isolation of oocysts from natural populations as well as repeated experimental crosses with 
more diverse strains, such as South American strains, may be the best approach to determine the 
true prevalence of outcrossing versus self-mating within a natural sexual cross.                                                                                                                                                               
 
Materials and Methods 
 
Culture and DNA Isolation of Toxoplasma Strains 
 
 Toxoplasma strains were cultured on human foreskin fibroblast (HFFs) monolayers at 5% 
CO2 at 37°C. These HFFs were grown in DMEM Complete Medium derived from Dulbecco’s 
Modified Eagle Medium (DMEM) enriched with 10% heat-inactivated fetal bovine serum (FBS), 
glutamine, and treated with gentamycin and penicillin-streptomycin.  
 Tachyzoites were grown until HFF monolayer lysis. Tachyzoites and lysed host cells 
were filtered using a 3.0-micron filter to remove host cellular debris. Clean tachyzoites were 
pelleted and rinsed with PBS. DNA was extracted from parasite pellets using the Qiagen DNeasy 
Blood and Tissue Kit. 1 ng of DNA was sent to Rocky Mountain Laboratories for whole genome 
sequencing as described below.  
 
Macrophage Growth for Oocyst Hatching 
 
Bone marrow derived macrophages (BMDMs) were made from 6-8 week old female 
C57BL/6 mice (Jackson Laboratories), as described (Trouplin et al. 2013). Briefly, bone marrow 
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was harvested from both mouse femurs and re-suspended in complete macrophage media 
(Dulbecco’s Modified Eagle’s Medium, 10% fetal bovine serum, glutamine, HEPES, and 
gentamicin) supplemented with 30% L929 cell supernatants. Cells were plated across non-
tissue culture treated Petri dishes and incubated at 37°C in 5% CO2. Media was exchanged on 
days 3 and 6, and adherent cells were harvested on day 8 by scrapping with a rubber policeman. 
Cells were washed with complete media and counted. Counted BMDMs were plated into five 
T25 flasks at 7 x 106 BMDMs/flask.  
 
Initial Characterization of Progeny from Sexual Crosses 
 
  Because the previous typing markers for Type X strains do not clearly distinguish Type X 
and II strains via restriction digest, a PCR-RFLP scheme was created to screen the progeny from 
the II by X sexual cross. To characterize recombinant progeny from the sexual crosses between 
the Type II and Type X parents, PCR-RFLP typing markers at BSR4, L358, GRA7, BAG1, 
SAG1, GRA6, ROP1, and SRS9 were developed to distinguish between the Type II and Type X 
alleles using the comparison of nucleotide sequences of typing markers known in our laboratory 
(Supplementary Table 1). Restriction enzymes were chosen that distinguish the Type II and X 
parental strain sequence at the chosen typing markers to create a PCR-RFLP map of progeny 
from the sexual crosses. Type X strains and sexual cross progeny were also characterized using 
these PCR-RFLP typing markers to allow the differentiation of the 3133 and 3142 Type X 
strains both from each other and from the ME49 Type II strain. Markers were amplified by PCR 
using Taqman Ampli-Taq polymerase and an Eppendorf thermocycler as previously described 
(Parameswaran et al. 2010; Su, Zhang, and Dubey 2006). PCR products were restriction enzyme 
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digested using the enzymes listed in Supplemental Table 1 for 1 hour at 37°C and products were 
run on a 1% agarose gel and compared to parental strain digest to verify marker identity.  
 
Characterization of Whole Genome Sequencing  
 
 1 ng of DNA from DNA extractions of each isolate was sent to Rocky Mountain 
Laboratories for whole genome sequencing using Illumina HiSeq technology. Fastq reads were 
reference mapped against the ToxoDB version 8.2 ME49 genome using BWA 0.7.5a to align the 
reads to the reference genome and GATK 3.7 in coordination with Picard 1.131 following best 
practices to quality control the mapped reads (Van der Auwera et al. 2013). Following mapping, 
the gVCF method of GATK was used to combine SNP calls using stand_call_conf of 30.0, nct of 
10, and ploidy of 1 (for haploid genomes) to call 568592 single nucleotide polymorphism 
positions across the whole genomes of these strains (Van der Auwera et al. 2013).The derived 
VCF formatted SNP file was curated using GATK and VCFTools to produce a tabular file 
containing only biallelic SNPs which excluded large insertions or deletions (Danecek et al. 
2011).  
 The tabular, biallelic SNP file was analyzed using a custom R script to display strain-
specific SNP locations (As seen in Chapters 2 and 3). SNPs were binned into 100 kbp windows 
across the genome(Minot et al. 2012; Yin, Cook, and Lawrence 2012). The larger the number of 
SNPs, the more divergent the strain was from the Type II ME49 reference strain.  
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Virulence Gene Characterization of Type X Strains 
 
Whole genome sequence fastqs derived above were reference mapped to known virulence 
genes within the Toxoplasma genome. The known sequences of virulence genes of ROP5, 
ROP18, ROP16, ROP17, and GRA15 were used to reference map the Type X strains (Saeij et al. 
2006; Saeij et al. 2007; Shwab et al. 2016; Taylor et al. 2006; Rosowski et al. 2011). SNPs 
within these strains were characterized as above, and using GATK and BEDTools, consensus 
sequences were called to create fastas of these known virulence alleles (Quinlan and Hall 2010; 
Van der Auwera et al. 2013). These fasta files were compared to one another using SeqMan Pro 
14.0 and polymorphisms were used to characterize the allelic inheritance of these strains.  
 
Sexual Crossing in Cats 
 
 N-ethyl-N-nitrosourea (Sigma-Aldrich) was used to derive mutant pools of drug resistant 
Toxoplasma from the Type X 3133 and 3142 strains. Mutagenized pools of Type X strains were 
selected for sinefungin resistance, following published protocols, to create 3133 SNFR and 3142 
SNFR (Khan et al. 2014; Behnke, Khan, and Sibley 2015). The Type II ME49 FUDRR strain has 
previously been published and was obtained from the Sibley lab (Khan et al. 2014). Cloned drug-
resistant strains were intraperitoneally infected into 8-week old female outbred CD-1 mice from 
Charles Rivers Laboratories at a dose of 1000 tachyzoites per mouse. To ensure murine survival, 
Type X infected mice were treated with 0.5 mg/ml of sulfadiazine (Sigma-Aldrich) in their 
drinking water on days 5-15 post-infection (Sibley 2009). Mice were monitored for survival and 
cachexia daily for 42 days. Serum was collected on day 20 post-infection and seroconversion 
was tested via IFAT (Miller et al. 2002). 42 days after infection, infected mice were euthanized, 
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and their brains were removed. Brains bearing bradyzoite cysts were resuspended in 1ml of 
sterile PBS and passed through 19G and 21G needles to homogenize. 20 microliters of 
homogenate containing bradyzoite cysts were counted on a slide schemer. Type II ME49 FUDRR 
and Type X SNFR brain homogenates were combined in approximately equal ratios. The mixed 
brain homogenates were sent to the USDA Dubey lab where they were fed to feline hosts for 
sexual recombination. Feces were collected from felines and oocysts separated via floatation in 
sucrose and sporulated and stored in sulfuric acid as previously published (Dubey 1995, 2001).  
 
Excystation of Sporozoites from Oocysts 
 
Oocyst can be stored at 4°C for several months in sulfuric acid, however the viability of 
the excysted progeny is severely reduced the longer the oocysts are stored. Thus, immediate 
oocyst excystation is recommended as soon as possible following oocyst isolation from feline 
feces. As oocysts are highly infectious and sexual recombination is known to increase virulence 
in murine hosts, personal protective equipment (double-gloves, face mask, safety glasses, 
disposable lab smock, and shoe covers) should be worn, lockable lids for centrifuge buckets 
used, work done in a biosafety hood, and hoods should be protected with disposable liners to 
reduce the risk of laboratory contamination. After all work is completed, sterilize all equipment 
with 70% ethanol, followed by fungicide, followed by 70% ethanol, and autoclave equipment 
which can be autoclaved. 
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Traditional Oocyst Excystation 
 
Traditional oocyst excystation was developed by both the Sibley and Dubey laboratories 
and is detailed below (Khan et al. 2014; Dubey 1995). 20 ml of sporulated oocysts from fecal 
extractions were pelleted at 1300 rpm for ten minutes in a 50 ml conical tube. Supernatant was 
discarded, and the pellet of oocysts was washed in PBS three additional times to neutralize the 
oocyst sulfuric acid storage buffer. The pellet was placed on wet ice and resuspended in 5 ml of 
PBS. 5 ml of 10% bleach in PBS was added to the solution to sterilize the bacteria in the pelleted 
oocysts and the resuspended oocysts were incubated on ice for 45 minutes. Bleach-treated 
oocysts were diluted to 50 ml with PBS and spun at 200 rpm for 5 minutes to remove large fecal 
debris in the resulting pellet from the oocysts. The supernatant was moved to a new 50 ml 
conical tube and spun at 2000 rpm for ten minutes. The resulting pellet containing the oocysts 
was resuspended in 50 ml of PBS and washed three times by spinning at 2000 rpm for ten 
minutes. The oocyst pellet was resuspended in 1 ml PBS in a 15 ml polystyrene conical tube. 2g 
of 450-600 micron glass beads (Sigma G-8772) were added to the resuspended oocysts. The 
bead-oocyst solution was vortexed on high for two minutes to break the outer oocyst wall and 
beads allowed to settle via gravity. The supernatant from the bead-oocyst solution was decanted 
and spun at 1500 rpm for ten minutes. The oocyst pellet was resuspended in 1 ml of 5% sodium 
taurodeoxycholate (bile salts to induce oocyst inner wall cracking) (Sigma T0875-5G) in RPMI 
and incubated at 37°C for exactly ten minutes. After ten minutes, the oocyst-bile salt solution 
was diluted with 10 ml of ice cold RPMI. The oocyst solution was spun at 2000 rpm for ten 
minutes. The resulting oocyst pellet was washed three times with 15 ml of RPMI and spun down 
at 2000 rpm for ten minutes. The resulting pellet contained the excysted sporozoites which were 
resuspended in 24 ml of DMEM Complete Medium and distributed evenly across 3-T25 flasks of 
 177 
HFFs. HFFs were allowed to grow for 1 week before drug-selecting. Following excystation and 
one week of growth on HFFs in culture, double drug selection of sporozoite parasites was done 
on the growth pool of sporozoites using SNF (24× 107 M) and fluorodeoxyuridine (FUDR, 24× 
105 M) as determined based on parental drug-selection. 
 
Limiting Dilution Isolation Following Oocyst Excystation 
 
Individual isolation of sporozoites improves the yield of traditionally obtained progeny of 
oocyst excystment (detailed above) by eliminating competitive growth. Instead, individual 
sporozoite progeny are isolated immediately following excystation rather than after drug 
selection. Rather than plating sporozoites in a pool within T25 flasks (as above), the excysted 
sporozoite pellet was re-suspended in 48 ml of Complete DMEM Medium. Half of this re-
suspension of sporozoites was plated across one 96-well plate of HFFs. The original pool was 
diluted back to 48 ml with Complete DMEM and the process repeated until ten 96-well plates of 
HFFs were plated with sporozoites, with the last plate being 256 times more dilute than the 
initial plate. As with a standard plaque assay, plates were allowed to grow for one week, after 
which individual wells were examined for plaques to identify individually isolated sporozoites. 
These individual sporozoites were grown until the all HFFs in the well lyse. Lysed 96-well plates 
were replica plated onto four 96-well HFF plates each. These growth replicates are used for 
single and double drug-selection (1 plate without drugs, 1 plate SNF selection, 1 plate FUDR 
selection, 1 plate SNF + FUDR selection) using SNF (24 × 107 M) and fluorodeoxyuridine 
(FUDR, 24 × 105 M) as determined based on parental drug-selection. Progeny were also 
characterized via PCR-RFLP and whole genome sequencing as described above 
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Macrophage-Facilitated Oocyst Excystation 
 
Macrophage-facilitated excystment of oocysts has been reported to occur in vivo in 
murine subcutaneous Toxoplasma infections (Freppel et al. 2016). A method has been developed 
for in vitro use here to provide a safer approach that requires less manual manipulation than 
traditional oocyst excystation methods. Here, in vitro BMDMs were used to excyst oocysts. The 
beginning of macrophage-facilitated excystment is the same as traditional excystation methods.  
20 ml of sporulated oocysts from fecal extractions were pelleted at 1300 rpm for ten minutes in a 
50 ml conical tube. Supernatant was discarded, and the pellet of oocysts was washed in PBS 
three additional times to neutralize the oocyst sulfuric acid storage buffer. The pellet was placed 
on wet ice and resuspended in 5 ml of PBS. 5 ml of 10% bleach in PBS was added to the solution 
to sterilize the bacteria in the pelleted oocysts and the resuspended oocysts were incubated on ice 
for 45 minutes. Bleach-treated oocysts were diluted to 50 ml with PBS and spun at 200 rpm for 5 
minutes to remove large fecal debris in the resulting pellet from the oocysts. The supernatant was 
moved to a new 50 ml conical tube and spun at 2000 rpm for ten minutes. The resulting pellet 
containing the oocysts was resuspended in 50 ml of PBS and washed three times by spinning at 
2000 rpm for ten minutes. The resulting bleach-treated oocyst pellet was diluted in 48 ml of 
Complete DMEM and plated across 5-T25s of BMDMs (prepared as above). The BMDMs and 
bleach-treated oocysts were incubated together for 24 hours at 37°C in 5% CO2. After 24 hours, 
culture medium was removed from BMDMs and phagocytosed sporozoites and 1 ml of trypsin 
was added to each T25. The BMDMs and sporozoites were scraped from the plates and pooled 
into 48 ml of Complete DMEM Medium. The pooled BMDM sporozoites were plated as with 
the limited isolation procedure above until ten 96-well plates of HFFs were inoculated with 




The use of animals in this study was done under the approval of the Animal Care and Use 
Committee of the National Institute of Allergy and Infectious Diseases, National Institutes of 








Supplemental Table 4-1: PCR-RFLP typing markers for the detection of cross progeny. 
Markers are listed by chromosome position, sequence length and RFLP enzyme. Marker identity for each typing 
marker is shown based on RFLP digestion of these strains by enzymes listed in the table. Markers were selected 









Supplemental Figure 4-1: (Following page) - SNP density plots of all WGS progeny from the 3142 by ME49 
cross. 
Isolated progeny from the 3142 (Type X) x ME49 (Type II) cross were mapped to the ME49 genome and plotted in 
10 kbp windows across the genome (row) in chromosomal segments (columns). SNPs per 10 kbp window are 


















Chromosome IV V VIIa VIIb VIII X XI
Length 1138 600 460 1917 700 758 960 600
RFLP NciI HaeIII,	NlaIII EcoRI,	XmnI BbvI,	AvaI,	MboI HaeIII AvaI DdeI MboI
Type	II II II II II II II II II
3133 X I II-like X II-like X X X
3142 X I X X II-like X II-like X
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3142XB7 Progeny Mapped to ME49, 10 kb window
 181 
Supplemental Figure 4-2: (Following page) - SNP density plots of all WGS progeny from the 3133 by ME49 
cross. 
Isolated progeny from the 3133 (Type X) x ME49 (Type II) cross were whole genome sequenced and mapped to the 
ME49 genome and plotted in 10 kbp windows across the genome (row) in chromosomal segments (columns). SNPs 
per 10 kbp window are plotted on 0-400 SNP scale as vertical bars. Progeny clones #31 and #32 are replicate clones 
from the same selected pool and are the only verified recombinant progeny from this cross.  
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3133XB7 Progeny Mapped to ME49, 10 kb window
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Chapter 5 - Conclusions: Sexual Recombination is Common and 
Frequent Within and Between Clades of Toxoplasma  
 
Recombination and Clonal Expansion of Toxoplasma gondii 
 
 Toxoplasma gondii is a generalist parasite that infects 30-80% of human populations, and 
30-50% of warm-blooded animals globally and is one of the leading causes of preventable 
blindness worldwide (Soheilian et al. 2005; Torrey and Yolken 2013; Dubey and Jones 2008; 
Dubey et al. 2011; Guo et al. 2016; Lopes et al. 2014). Despite the diversity of its hosts and its 
fecund sexual cycle, the Toxoplasma population genetic structure is relatively simple. This 
parasite’s population is dominated by a limited number of widely distributed clonal lineages, 
which typically cause asymptomatic infections in people and livestock (Howe and Sibley 1995; 
Khan, Dubey, et al. 2011; Khan et al. 2005). Genetically diverse strains are less widely 
distributed and are prominent in regions of the globe (such as South America) where they have 
been associated with outbreaks and different disease sequelae (Shwab et al. 2014; Su et al. 2012; 
Su, Zhang, and Dubey 2006).  
Sexual recombination is prevalent across the range of parasitic life including viruses, 
bacteria, and other protozoans such as Leishmania and Plasmodium in spite of the risk that 
recombination is just as likely to separate as to conjoin beneficial gene combinations (Heitman 
2010; Inbar et al. 2013; Ariey et al. 2014; Arisue and Hashimoto 2014; Miotto et al. 2013; 
Twiddy and Holmes 2003; Vijaykrishna et al. 2011). The sexual cycle of Toxoplasma has 
previously been shown to confer on F1 progeny an altered biological potential, such as virulence 
different from parental capabilities, and has been postulated to facilitate the success and 
expansion of the parasite’s host range, due in part to the high transmissibility of its extremely 
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infectious oocyst stage, the end product of the sexual cycle (Grigg, Bonnefoy, et al. 2001). 
However, current population datasets have identified predominantly clonal population structures 
which seemingly contradict the expected genetically diverse population structure for a sexually 
reproducing organism (Lehmann et al. 2006; Shwab et al. 2014; Sibley and Ajioka 2008; Su et 
al. 2012). Debates within the field  focus on the extent to which Toxoplasma propagates 
asexually versus sexually (Tibayrenc and Ayala 2002, 2014), whether dominant clones are the 
products of sexual self-mating (Wendte, Miller, Lambourn, et al. 2010) and the extent and 
frequency to which out-crossing produces new recombinant strains that possess altered 
biological potential (Grigg, Bonnefoy, et al. 2001).  A primary goal of the work presented herein 
was to determine the frequency of sexual recombination in nature, and the role of sexual 
recombination in shaping the genetic population structure of Toxoplasma. Additionally, these 
WGS datasets were used to test the sufficiency of the clonal theory that currently explains the 
clonal population structure found in nature. 
The main conclusion of this thesis is that sexual recombination plays a previously 
underappreciated role in shaping the population structure of Toxoplasma. Evidence for sexual 
recombination was found within previously designated clonal lineages, II and X, that 
predominate in North America. While the Type II clade is an ancient lineage that has undergone 
asexual diversification followed by unisexual (within clade) meiotic expansion, it resembles a 
clonal lineage when only limited markers are used for genotyping. In contrast, Type X is not a 
clonal lineage, but rather a clade of sexually related strains, that are also capable of expanding 
unisexually. Data in this thesis suggest that the Type X exists as a clade of F1 progeny from a 
cross between a Type II strain and a mosaic parent of two distinct ancestries (referred to as g/d). 
Combined, the Type II and X clades represent the majority of globally sampled strains. Thus, 
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evidence of recombination here demonstrates that sexual recombination is more prevalent than 
previously hypothesized, as it has been characterized to have occurred only rarely in nature 
(Shwab et al. 2014; Sibley and Ajioka 2008).  
In addition to its role in creating variation within the genetic population structure of 
Toxoplasma, sexual replication also plays a role in the amplification of particular clones. 
Unisexual (intra-clade) recombination was observed within the Type II clade, characterized by 
the inheritance of haploblocks of shared ancestry, unique to the Type II clade, that were 
independently admixed among the strains, indicating that these Type II strains were capable of 
undergoing sexual recombination between non-identical strains within the clade, but in a biased 
manner. Evidence for this bias was observed during four independent sexual crosses between 
Type II and X parents whereby progeny derived from sexual replication were observed to 
strongly bias toward a single parent yet also produce, at low frequency (2-5%) recombinant 
progeny. This sexual bias is likely one of the major factors that masks the identification of 
frequent sexual replication such that Toxoplasma appears to bypass its sexual cycle and maintain 
an apparently clonal population structure. Biased sexual recombination also supports the 
conclusion that sexual propagation is more common in nature than previously hypothesized.  
 
Type II Strains are Expanding Predominantly by Unisexual Mating  
 
 Type II is a globally-distributed clonal lineage that is highly successful in nature, 
establishing it as a model candidate clade for testing whether the clonal expansion theory holds 
up at whole genome resolution for parasitic protozoans (Shwab et al. 2014; Su et al. 2012; Su, 
Zhang, and Dubey 2006). It has previously been theorized that only asexual expansion would 
allow for the retention of such a widely distributed clonal population (Sibley and Ajioka 2008; 
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Tibayrenc and Ayala 2014). It has also been argued that sexual expansion by self-mating could 
likewise produce a highly clonal population structure (Wendte, Miller, Lambourn, et al. 2010). In 
fact, the only way to differentiate asexual expansion from sexual self-mating in this haploid 
parasite is to interrogate the genomes of these strains for hallmarks of sexual expansion, 
including changes in allelic diversity, differences in somy, genetic structural variation, and 
haploblock recombination. No previous study has examined a single clade of strains at whole 
genome resolution. All other studies have either focused on the global diversity of Toxoplasma 
strains (Lorenzi et al. 2016; Shwab et al. 2014; Su et al. 2012; Su, Zhang, and Dubey 2006) or 
have analyzed strains within a clade using only a limited suite of low-resolution markers that are 
unsuitable for genome-wide characterization because they fail to capture the true extent of 
diversity within a clade (Minot et al. 2012; Sibley et al. 2009; Su, Zhang, and Dubey 2006). This 
thesis presented an unprecedented, in-depth WGS examination of a single clonal clade of strains 
isolated from across multiple continents and host species.  
 Type II strains were compared using whole genome sequencing (WGS). Geographically 
distinct isolates of Type II were compared by marker, chromosomal, and whole genome 
sequencing and analyzed by phylogeny to compare Type II strains to other known clades of 
Toxoplasma. Although Type II strain-specific SNPs were relatively rare, allelic diversity was 
higher than would be expected for a clonal lineage. Based on phylogenetic comparisons and by 
SNP diversity mapping, a number of distinct haplotypes were found within the Type II clade. 
Importantly, all of these haplotypes were distinguished based on previously unknown, large, and 
phylogenetically distinct blocks of alleles of distinct ancestry that could be identified within 
Type II strains from different geographies. Importantly, several North American Type II strains 
were unique genome-wide admixtures that possessed haploblocks of sequence that originated 
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within either the North American Type II lines, or African Type II lines. Because asexual 
replication accumulates SNPs across the genome randomly, due to polymerase error during 
replication, these SNPs are generally evenly distributed across the genome rather than found in 
localized distinct haploblocks that track with a specific geographic region, which was observed 
among several of the Type II strains studied herein.  Shared haploblocks between strains with 
clear crossover points between them is a hallmark of sexual recombination and this was found to 
occur among several of these hybrid strains within the Type II clade.  Supporting evidence for 
sexual recombination was observed by the incongruence of phylogeny between the nuclear and 
apicoplast genomes within the Type II strains investigated. This only occurs when nuclear 
genomes undergo recombination during meiosis and the phylogeny of the maternally inherited 
apicoplast genomes (i.e., grouping with African strains) does not match with the phylogeny of 
the entire nuclear genome (i.e., grouping with North American strains). This evidence led to the 
conclusion that Type II is by no means a clonal population, but rather a closely related clade of 
strains that have unisexually recombined with one another.  
Although outcrossing has previously been reported to occur only rarely among natural 
isolates (Minot et al. 2012), there is abundant evidence that Type II has recombined with several 
other distinct ancestries to produce both the Type I and Type III strains (Boyle et al. 2006; Minot 
et al. 2012). In this thesis, the Type III strain VEG was sequenced and it was shown to be an 
admixture of at least two distinct Type II strains that introgressed into the Type III genome, one 
that was highly similar to the North American ME49, the other more similar to the European 
strain PRU. Thus, work herein has established that recombination is occurring among distinct 
haplotypes within the Type II clade. Further, at least three distinct Type II haplotypes have been 
identified to be highly prevalent within North American Type II strains. Indeed, sequence 
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analysis of the various Type II haplotypes found in North American strains indicates that several 
strains have intermixed with African Type II strains within the same clade. This recombination 
was previously missed because these strains were not interrogated against one another at whole 
genome scale. What has not been established is whether Type II strains are biased in their mate 
preference during sexual expansion. Finding Type II admixed into distinct genetic ancestries in 
Type I, III and X strains indicate that Type II lines are capable of outcrossing. But equally, the 
identification of intra-clade admixtures within the Type II clade indicates that Type II can also 
expand unisexually, rather than strictly via self-mating. Hence, experiments needed to be set up 
to investigate whether Toxoplasma “prefers” to self-mate in the presence of an extra-clade 
mating partner, which would indicate whether the recombination frequency of Type II crosses 
biases toward either self-mating or unisexual mating between a highly similar, same clade 
parental strain, which would allow for the expansion of a closely-related “clonal” population. In 
Chapter 4 experiments were set up to determine the ratio of outcrossing to self-mating in order to 
test whether biased mating is likely occurring in nature.  
The demonstration of high levels of sexual replication inherently disputes the clonal 
theory proposed to explain the clonal population dynamics of Toxoplasma. Furthermore, the 
genetic diversity within the Type II clade, the most prevalent of the presumed clonal clades, 
suggests that previous population studies have underestimated global genetic diversity, and failed 
to address unisexual mating as an alternative mechanism to generate seemingly clonal genetic 
population structures within the parasitic protozoans. The asexual expansion theory is predicated 
on utilizing only low-resolution typing markers to characterize Toxoplasma strains. Further, 
these PCR-RFLP typing markers are biased, as they were designed to distinguish only between 
SNPs that vary between the three major clonal lineages (I, II, and III). Thus, they underestimate 
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to the total diversity inherent within the genetic population structure of Toxoplasma (Su, Zhang, 
and Dubey 2006). Recombination of the unique Type II haploblocks between the strains of the 
Type II clade indicated that it was necessary to test whether intra-clade sexual replication was 
extant across the entire population structure of Toxoplasma. To further interrogate the extent of 
intra-clade/unisexual recombination across the population the analysis was extended to another 
clonal lineage, referred to as Type X, or HG12, and reported in Chapter 3.  
 
Type X Strains Resemble F1 Progeny from a Natural Sexual Cross 
 
The release of oocysts into unfiltered water supplies has previously been implicated in 
the cause of several toxoplasmosis outbreaks in humans (Boyer et al. 2011; Demar et al. 2007; 
Vaudaux et al. 2010). But, the demonstration of definitive infection by oocysts in hosts other 
than humans has never been observed. The outbreak of toxoplasmosis in sea otters examined 
here provided a unique opportunity to study an oocyst-derived Toxoplasma outbreak in a natural 
host population. Because sea otters are listed as threatened species under the Marine Mammals 
Protection Act, all deaths are recorded and necropsied for cause of death determination, which 
provided clinical and pathological insight into the disease sequelae associated with Toxoplasma 
infection in this well-studied host. Further, as sea otters are marine mammals that do not eat 
warm-blooded animals, their infection was the result of oocyst contaminated water and/or 
bivalve food sources. The first known Toxoplasma infection of a southern sea otters was 
discovered during an outbreak caused by a novel Toxoplasma strain, that has been referred to as 
Type X, that began in the mid-late 90’s (Miller et al. 2004; Kreuder et al. 2003; Cole et al. 2000). 
Type X strains, originally classified as drifted Type II strains based on a single SNP at 
SAG1 (Cole et al. 2000), were later described by Miller et al. 2004 to be a new genotype, 
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referred to as Type X, because they possessed a novel, genetically distinct allele at GRA6 (Miller 
et al. 2004), suggesting these strains were recombinants from a cross between a Type II strain, 
and something new, that was later referred to as the “g” lineage (Grigg and Sundar 2009). Type 
X was then sub-divided into Type X and Type A by a single SNP present at the GRA6 locus 
(Sundar et al. 2008). Type X was further re-classified as the fourth clonal lineage in North 
America (also known as HG12) based primarily on polymorphisms identified at GRA6 and 
GRA7 that distinguished Type X from Type II (Sundar et al. 2008; Khan, Dubey, et al. 2011).  
Type X are widespread globally, although work done here focuses predominantly on 
Type X isolates collected only from the western coast of the United States (Dubey et al. 2014; 
Dubey et al. 2011; Khan, Dubey, et al. 2011; Miller et al. 2004; Miller et al. 2008; Parameswaran 
et al. 2010; Sundar et al. 2008; VanWormer et al. 2014). The primary aim of this study, reported 
in Chapter 3, was to determine whether the fourth clonal lineage is likewise expanding largely 
sexually by some combination of unisexual or self-mating, as was observed for Type II  (Dubey 
et al. 2011; Khan, Dubey, et al. 2011; Miller et al. 2004; Miller et al. 2008; Sundar et al. 2008).   
PCR-DNA sequencing of 53 sea otter isolates at 20 linked and unlinked markers 
distributed throughout the genome established that for any given marker, either a Type II allele 
or one of two unique allelic types existed. Phylogenetic analyses performed at each of the typing 
markers indicated a total lack of strain-specific SNPs, suggesting insufficient time had elapsed to 
generate novel SNPs de novo by genetic drift derived from polymerase errors during mitotic 
replication. The designation of two unique allelic types was supported by bootstrap analyses 
performed on the phylogenetic trees and strains were classified as having either g or d ancestry 
alleles following the convention used for previously characterized a and b ancestry in the Type I 
and III clonal lineages (Boyle et al. 2006). Importantly, across both linked and unlinked markers, 
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incongruence among the tree topologies was observed, with at least 10 distinct haplotypes 
resolved within the Type X clade, parsimonious with the isolates existing as a recombinant clade 
of strains that arose either by a cross between a Type II strain with a mosaic parent of both g and 
d ancestry, or from two independent crosses between a Type II strain and strains bearing either g 
or d ancestry. The absence of genetic drift at each marker, and the recent emergence of the Type 
X clade of strains in sea otters is more consistent with a single natural cross with a mosaic g/d 
parent, as the strains resembled F1 progeny from one or a small number of recent limited crosses.  
To examine this possibility at finer resolution, whole genome sequencing was done on 21 
of the Type X strains that grew well in culture, with each of the 10 distinct haplotypes being 
represented by at least one strain. WGS analysis identified only a limited number of crossover 
points in support of recent recombination between a Type II parent and at least one other parent 
of mixed ancestry (Khan et al. 2014; Shaik et al. 2015). Hence, the data was consistent with 
Type X resembling a reticulated clade of strains that are related progeny from at least one sexual 
cross. However, the majority of haplotypes appeared to share similar crossover points, which 
could not be readily explained by the presence of recombination hotspots within the genome, as 
these are not predicted to exist within Toxoplasma (Khan et al. 2014). Limited haploblock 
crossing over combined with low levels of genetic drift are consistent with Type X strains being 
derived from a recent sexual event. This sexual event was likely followed by a limited period of 
either asexual replication or uniparental mating as relatively few strain-specific SNPs within the 
Type X strains were identified genome-wide prior to the sea otter outbreak. 
Strains isolated from the otters possessed a wide-range of disease sequelae, of which 
toxoplasmic encephalitis was described for only a subset of seropositive otters. To determine 
whether parasite haplotype correlated with disease, all sequenced strains were assessed for their 
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virulence phenotype in mice. Otter derived strains that possessed Type II genotypes were 
avirulent in mice, as expected. In contrast, only a subset of Type II by g/d recombinant strains 
were highly pathogenic to mice, and this pathogenicity segregated by haplotype. Importantly, the 
haplotype that had expanded in otters, comprising nearly 50% of otter infections (the majority of 
which had stranded for reasons other than protozoal encephalitis) was highly virulent in mice, 
suggesting that a host-shift adaptation had occurred.  
 
Type X Contains Novel Virulence Gene Alleles 
   
Type X strains examined in this thesis displayed three different virulence phenotypes in 
mice:  avirulent, intermediate virulent (in which approximately half of infected mice died of 
acute infection, and half survived), or highly virulent (in which all mice died within 15 days of 
infection). Virulence shifts among cross progeny, such as the natural cross described herein, have 
been observed previously to occur during sexual crosses (Saeij et al. 2006; Saeij et al. 2007; 
Taylor et al. 2006). Forward genetic experiments to associate parasite genes responsible for 
causing virulence shifts have identified a suite of parasite-derived, secreted polymorphic effector 
proteins that hijack host immune signaling pathways to favor parasite pathogenesis (Boothroyd 
2013; Dubremetz and Lebrun 2012).  The majority of these previously characterized virulence 
phenotypes have been attributed to the inheritance of certain alleles from two proteins, ROP5 
and ROP18, that in combination promote a virulence-enhancing effect in murine hosts (Behnke, 
Dubey, and Sibley 2016; Behnke et al. 2015). However, the allele combinations found in the 
Type X strains examined in this thesis, identified only avirulent allelic combinations suggesting 
that other virulence factors were responsible for regulating Type X murine pathogenesis. 
Because Type X strains resembled F1 progeny from a natural cross between two parents, they 
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were utilized to investigate whether it was possible to take a forward genetic approach using 
natural isolates of Toxoplasma to identify the Type X encoded murine virulence factors, or genes 
that resulted in the epistatic regulation of murine virulence factors. Additionally, because the 
Type X haplotype that was mouse-virulent had expanded as a chronic, largely benign infection in 
sea otter hosts, this work provided a rationale for how mouse virulence genes can be maintained 
cryptically in the parasite population, by allowing certain pathogenic strains of one animal host 
to expand as natural, chronic infections in another intermediate host.  
The majority of Toxoplasma virulence genes previously identified using forward genetic 
approaches utilized quantitative trait loci (QTL) analysis of F1 progeny from sexual crosses with 
known parental strains. Although one parent is known for the murine virulent Type X strain, the 
other parent can only be inferred in aggregate, by reconstructing a mosaic genome for it from 
among all Type X strains. Regardless, we tested whether the isolates could be screened as if they 
were F1 progeny from an experimental cross to identify candidate virulence genes via QTL 
analysis. We anticipated that the existence of strain-specific SNPs within each Type X isolate, 
although relatively few in number, had the potential to confound the confidence of finding a 
specific genomic region by recombination that was associated with murine virulence (Smith et 
al. 2009).  As expected, the QTL analysis of Type X strains produced many more virulence-
associated genomic regions than would be expected for true F1 cross progeny, but each region 
existed as a discrete peak, with very little background between each peak (Behnke et al. 2015; 
Behnke, Khan, and Sibley 2015; Shastri et al. 2014).  When top candidate genes from each 
genomic region were filtered based on their open reading frame, signal peptide prediction, and 
transmembrane domain, a manageable number of genes (i.e., <50) were identified to employ 
reverse genetic testing to determine whether the predicted gene was associated with murine 
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virulence. The top candidate identified was ROP33, selected based on previously predicted 
activity that it could influence murine virulence in vivo (Peixoto et al. 2010; Wang, Li, et al. 
2017). Targeted deletion of the ROP33 gene in a Type I strain engineered to be deficient in 
ROP18 expression established that ROP33 is a virulence locus. RH is a mouse virulent strain, 
and deletion of ROP33 resulted in significant attenuation of its virulence kinetics, with the 
majority of mice surviving acute infection, whereas mice infected with the parental RH strain all 
succumbed to acute infection by Day 15. 
Importantly, treating the Type X isolates as F1 progeny from a cross indicated that 
natural isolates can be utilized for QTL approaches to identify novel virulence alleles. Future 
work will undoubtedly test for additional candidate virulence-associated genes in the other 
genomic regions with high LOD scores that were identified by the QTL. Genome-wide 
association studies (GWAS) could likewise be done to narrow the list of putative virulence genes 
and it has the added benefit of statistically accounting for both meiotic and mitotic variation 
between strains. However, GWAS analysis traditionally requires a larger number of whole 
genome sequenced isolates than currently available within the Type X clade to increase the 
chance of finding significantly associated genes, so it is not currently a feasible to utilized 
GWAS with only the Type X strains to find additional virulence genes. (Pearson and Manolio 
2008; Penman et al. 2010). A more straight-forward approach to narrow the predicted number of 
genomic regions encoding virulence genes would be to perform experimental crosses between 
Type II and Type X strains to generate true F1 cross progeny. However, as discussed in Chapter 
4, too few recombinant progeny were recovered from the four crosses done to perform an 
accurate QTL analysis.  
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Given the success with performing a QTL using the naturally-derived population of T. 
gondii strains infecting sea otters to identify mouse virulence genes, it is conceivable to likewise 
identify virulence genes associated with sea otter virulence using the same approach. 
Identification of mustelid virulence factors could potentially identify new approaches to combat 
protozoal infection and facilitate the conservation of this threatened species. Additionally, as 
mortality of the critically endangered Hawaiian monk seal has also been causally linked to 
Toxoplasma infection, a vaccine could dramatically reduce mortality within other endangered 
species threatened by protozoal infection. Especially since these parasites are a major cause of 
reproductive loss (Barbieri et al. 2016; Honnold et al. 2005). However, there are several 
significant obstacles to the characterization of mustelid virulence genes. Whilst mustelid tissue 
culture could allow in vitro analysis of novel virulence alleles for this endangered host, it is not 
currently available. Furthermore, inactivating the gene product to make an attenuated strain, or 
using the gene, to vaccinate marine mammals is problematic. Only a single vaccine is currently 
available against this parasite and it is not without risk. Although sheep are readily vaccinated 
against Toxoplasma, some sheep die from the vaccine, so the mortality risk of the vaccine is not 
acceptable for application to an endangered species such as the southern sea otter (Zhang et al. 
2015; Verma and Khanna 2014). Thus, any derived virulence genes are unlikely to be able to be 
tested for efficacy within the intended mustelid hosts.   
 
Biased Mating May Explain the Distinct Clonality Apparent Globally 
 
 Due to methods used previously to hatch sporulated oocysts into sporozoites and select 
immediately using double drug regimens, it was impossible to determine the true recombination 
rate for Toxoplasma sexual crosses. This is because all previous studies isolated individual 
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progeny from pooled sporozoites that had been selectively expanded under double drug selection 
prior to limiting dilution to select for individual recombinant progeny.  A new, macrophage-
facilitated method of excystation was developed here to increase yield and independently isolate 
progeny from a sexual cross. These progeny were isolated without drug-selection or competitive 
growth. This novel procedure produced increased numbers of individually isolated progeny and 
reduced the hazards to researchers associated with excystation. Further, novel WGS of 
individually isolated progeny increased the depth of genomic resolution available and allowed 
for the unbiased determination of recombination rates within Toxoplasma. 
 Based upon whole genome sequence analysis of the progeny from four independent 
crosses, parental recombination rates were determined to have occurred at a significantly lower 
frequency than previously reported (Khan et al. 2014; Khan et al. 2005; Pfefferkorn and 
Pfefferkorn 1980; Saeij et al. 2007; Pfefferkorn, Pfefferkorn, and Colby 1977). This work is the 
first to examine progeny from a low-recombination frequency cross as all other crosses 
published displayed either a larger number of outcrossed progeny, or suggested that some strains, 
which failed to outcross and only produced detectable numbers of oocysts by self-mating, are 
mating incompetent. WGS of all individually isolated progeny allowed self-mating and 
outcrossing to be interrogated from a single experimental sexual cross and facilitated the 
determination that Toxoplasma is more likely to self-mate than outcross, even in co-infection.  
A bias in isolation techniques could skew the isolated progeny toward one parental strain, 
but this is unlikely for the isolations done here as excystations were done in parallel for the four 
independent crosses examined, and while the recombination frequencies were similar, the 
parental strain that was preferentially expanded by self-mating was different for each cross, and 
no skewing to one parental type was identified. The greatest risk for bias from previous studies 
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was due to the pooled competitive growth of strains under double drug selection during cellular 
culture prior to isolation, which was removed in the new excystation methods detailed in this 
work. These improved individual isolation techniques abrogated growth competition by 
separating progeny from one another before growth in culture. However, progeny must still grow 
in host cells, which could bias toward strains better suited to expand in cell culture (Boyle and 
Radke 2009).  
Growth in the feline gut prior to sexual replication could also alter recombination. The 
contribution of the feline microbiome to these crosses is unknown, and bacterial factors have 
been shown to be important in regulating gametocytogenesis in other eukaryotes, such as 
choanoflagellates (Woznica et al. 2016; Woznica et al. 2017). In Eimeria spp., strains that 
colonize the same region of the GI tract tend to cross with each other, and this phenomenon is 
the basis for speciation among the chicken coccidia (Walker et al. 2013). If different strains of 
Toxoplasma colonize different regions of the cat lumen in a strain-specific manner, this may 
impact outcrossing, and favor inbreeding, or self-mating, as more diverse strains are not in close 
proximity physically or temporally to fuse to produce oocysts. Macrogamete production could 
also contribute to a bias against outcrossing as there are not enough microgametes to ensure 
cross-fertilization within any given sexual cross (Ferguson 2002; Ferguson et al. 1974; Ferguson, 
Hutchison, and Siim 1975; West, Smith, and Read 2000). Mating-type loci have not been 
formally demonstrated to exist in Toxoplasma, but in fungi, they are important variables that 
determine sexual competency and mating compatibility (Feretzaki and Heitman 2013; Heitman 
2010; Ni et al. 2011; Sun et al. 2014).   
It is likely that biased recombination is more prevalent in Toxoplasma than previously 
predicted. In fact, the uniparental-biased recombination rate of 2-3% recombination determined 
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here for Toxoplasma is similar to recombination rates known from other protozoan parasites 
which possess non-Mendelian recombination frequencies. In Leishmania recombination rates can 
be as low as 6% where it has been hypothesized that biased recombination rates are highly 
dependent on the species of the sand-fly definitive host the parasite infects (Inbar et al. 2013; 
Romano et al. 2014). Based on the similarity of the genetic hybridization rates between these two 
parasites, it is possible that similar mechanisms are at play within the definitive felid host of 
Toxoplasma, which possesses a highly diverse genus, where these may influence the successful 
hybridization of gametes. 
Elucidation of the extent to which Toxoplasma undergoes outcrossing in nature or is 
expanding clonally by asexual division versus unisexual expansion by self-mating within a cat is 
important data to not only initiate transmission blocking interventions, but also shed light on the 
origin of the clonal population structure for Toxoplasma in Europe and North America. The 
geographic origin of clonality, especially between North and South America, is still under 
debate. Some studies indicate that North American strains were seeded by South American 
parasite migration (Bertranpetit et al. 2016; Walzer and Boyle 2012), while other studies 
determined that clonal strains originated in North America (established by ancestral migration 
from Europe) (Fux et al. 2007; Sibley et al. 2009). These models and all previous mutation rates, 
however, were predicted based on the known Plasmodium mutation rates at that time, which 
have since been shown to be incorrect (Rich et al. 1998; Joy et al. 2003). Furthermore, these 
earlier calculations are inherently inaccurate for Toxoplasma due to lifecycle differences between 
the two parasites. Plasmodium has a mandatory sexual replication cycle for propagation, whereas 
Toxoplasma can bypass its sexual cycle and remain dormant as bradyzoite cysts for extended 
periods of time and can expand between intermediate hosts asexually by carnivory. Further, self-
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mating in the definitive host phenocopies the asexual expansion model and causes difficulties in 
differentiating asexual and unisexual growth (Wendte, Miller, Lambourn, et al. 2010; Boyer et 
al. 2011; Jones and Dubey 2010). As evidenced in Chapter 4, the bias for uniparental expansion 
in the crossing experiments, as well as the unisexual mating observed between Type II strains, 
would produce a mainly clonal population structure, that would be indistinguishable from a 
parasite that expands exclusively asexually (Ferguson et al. 1974; West, Smith, and Read 2000; 
Grigg and Sundar 2009).  
It should be possible to calculate a meiotic replication mutation rate using the uniparental 
progeny isolated in Chapter 4. Meiotic mutation rates have not previously been calculated for 
Toxoplasma but are hypothesized to contribute to the maintenance of the apparently clonal 
population structure (Minot et al. 2012; Roach and Heitman 2014; Wendte, Miller, Lambourn, et 
al. 2010). Experiments on the mitotic mutation rate are currently in progress using in vitro serial 
passage of a self-mated strain based on the more precise experimental methodologies developed 
in Plasmodium (Bopp et al. 2013). Together, mutation rates for meiotic sexual self-mating and 
mitotic asexual reproduction should enable a more accurate mathematical model for the genomic 
rate of evolution for Toxoplasma (Bopp et al. 2013; Claessens et al. 2014).  
 
Toxoplasma has a Diverse Population Structure Prone to Biased and 
Unisexual Recombination, as well as Mitotic Drift 
 
Clonality has been observed within natural parasite populations. However, the frequency 
and effect of sexual recombination in shaping these clonal populations remains to be fully 
interrogated by WGS. Several protozoan parasites possess the genetic capacity to undergo 
meiotic recombination yet for unknown reasons their natural genetic population structure that is 
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predominantly clonal, such as Cryptococcus (Billmyre et al. 2014), Cryptosporidium (Awad-El-
Kariem 1999), and Neisseria (Budroni et al. 2011). Drug-resistance has been shown to select for 
clonality in Plasmodium (Ariey et al. 2014; Miotto et al. 2013; Walliker 1991). However, it is 
unknown if these populations are maintained once drug-selection is removed. 
In Leishmania, the sheer number of vector species that serve as definitive hosts for the 
variety of Leishmania strains and species may limit interbreeding, especially because many 
vector species do not share overlapping host ranges which could pose a significant barrier for 
mixing to occur and thereby promote the maintenance of clonal lineages. When outcrossing does 
occur, other mechanisms could also bias toward a clonal population structure such as copy 
number variation and aneuploidy (Iantorno et al. 2017) which have been proposed to purify 
genomic heterozygosity to actively facilitate genomic clonality (Inbar et al. 2013; Romano et al. 
2014; Ramirez and Llewellyn 2014). Felid diversity has likewise been proposed to influence 
what strains of Toxoplasma can be expanded in any one geographic region, which may 
contribute to clonal population genetic structures depending on the felid species present (Khan et 
al. 2006; Fux et al. 2007; Khan, Miller, et al. 2011).  
All previous population studies in Toxoplasma have focused on the genetic diversity 
identified across the population and not within a clonal lineage (Lorenzi et al. 2016). However, 
Toxoplasma clades are more genetically diverse within a clade than previously expected, as 
evidenced by the genomic diversity identified within both the Type II and X clades shown here. 
The elevated genetic diversity identified among Type II clones established that mitotic drift has 
positively influenced within-clade genetic diversity among circulating strains of Toxoplasma. 
Additionally, the intra-clade specific sexual recombination detected in some North American 
Toxoplasma isolates, that appeared to be mosaic admixtures with strains circulating in Europe or 
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Africa, identified a previously underappreciated rate of genetic hybridization within clonal 
lineages. Further, the inheritance of apicoplast sequences that were of European or African 
decent within these admixture lines isolated from North American animals supported this 
conclusion (Burrells et al. 2013; Grigg and Sundar 2009; Howe and Sibley 1995; Khan, Dubey, 
et al. 2011; Fux et al. 2007; Minot et al. 2012; Su et al. 2012).  
Sexual crossing has been shown to produce novel combinations of virulence genes that 
can alter the parasite’s pathogenesis and allow infection to occur in novel hosts (Adomako-
Ankomah et al. 2014; Boothroyd 2009; Grigg and Sundar 2009; Su et al. 2003; Grigg, Bonnefoy, 
et al. 2001; Fernandez et al. 2016; Hakimi, Olias, and Sibley 2017). It is likely that sexual 
recombination is the predominant mechanism used by generalist parasites to adapt to and infect 
new host species. Bringing virulence alleles into new combinations may allow for effective 
expansion of the parasite’s host range, facilitating host-shifts for generalist parasites like 
Toxoplasma. These host-shifts may explain how a mouse virulent Toxoplasma strain can expand 
cryptically in one animal host, such as a sea otter, yet possess just the right combination of 
virulence alleles to inactivate murine host immunity and cause acute epidemic disease. The host-
shift identified among the Type X progeny that expanded in sea otters is not an anomalous 
finding, as it has likewise been demonstrated that other murine virulent strains, such as Type I, 
which have selectively expanded as an avirulent infection in a variety of avian hosts (Miller, 
Grigg unpublished).   
The conclusions presented herein are based on whole genome sequencing, rather than the 
more traditional PCR-RFLP marker characterization. To determine if the diversity observed in 
the Type II and X clades is extant across the Toxoplasma population, WGS of additional isolates 
from other clonal lineages will be necessary (Pan et al. 2012; Parameswaran et al. 2010; Yang et 
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al. 2013; Ajzenberg et al. 2010). Ideally, strains would be sequenced and genomes de novo 
assembled. Although de novo assembly provides more accurate genomic comparisons, it requires 
both longer sequencing reads and higher read depth, making this technique prohibitively 
expensive for multiple strains. Comparison of Toxoplasma strains by reference mapping is not 
without its own inherent biases and these limitations must be considered when evaluating 
datasets. For example, as with many de novo assembled genomes, the common Toxoplasma 
reference strain (ME49) does not accurately annotate low-diversity tandemly arrayed genes, 
often stacking them rather than correctly assembling them as tandem repeats end-to-end (Matrajt 
et al. 1999; Adomako-Ankomah et al. 2014). These regions must be interpreted with caution. 
Additionally, genomic regions with known sequence gaps can lead to erroneous mapping of 
sequencing reads. Finally, genes with strain-specific indels longer than the sequencing reads, 
such as GRA15, are often incorrectly assembled during reference mapping, and can lead to an 
elevated SNP diversity that is not actually present between genomes (Rosowski et al. 2011). 
Despite these limitations, evaluating single nucleotide polymorphisms at the level of 
chromosomes lends computational clarity and evolutionary resolution to WGS strains beyond 
that provided by PCR-RFLP. Furthermore, aligning to a shared (Type II) reference biases all 
non-Type II strains equally. The benefits of increased genomic depth for characterization far out-
weigh the potential pitfalls of WGS characterization.  
 
Further Work on Toxoplasma Sexual Cycles is Necessary to Elucidate the 
Lifecycle Diversity and Cryptic Virulence of this Sexual Parasite 
  
Toxoplasma has a uniquely flexible lifecycle whereby it can undergo either sexual 
replication or asexual expansion in any order or combination. With the increased appreciation 
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that sexual recombination is occurring cryptically either via unisexual mating or with a bias 
toward self-mating when the parasite has the opportunity to out-cross, identifying an accurate 
mathematical model for the evolution of Toxoplasma is important to limit transmission and 
examine the evolution of new parasite lines. Evidence herein has shown that Toxoplasma is not 
expanding strictly asexually within clonal clades such as Type II and X. The fact that this 
parasite, when given the chance to out-cross, predominantly self-mates argues that barriers must 
exist that limit productive recombination. Whether mating types exist is certainly a possibility 
that has not been definitively disproven. But equally, sexual bias could be related to physical 
barriers that limit the ability of gametes from two different strains to find each other within the 
definitive host gut lumen.  While it remains to be tested whether mating preferences exist 
between distinct clades of Toxoplasma, this phenomenon would explain how sexual expansion of 
clones seem to preferentially self-mate given the opportunity to outcross.  How Toxoplasma 
parasites chose their partners for sexual recombination is currently unknown, in large part due to 
the black box that is the feline gut where gametocytogenesis and mating occurs. In yeast, sexual 
partner selection is determined by genomic mating types (Ni et al. 2011). However, Toxoplasma 
displays no evidence for mating types within their genomes. Other parasites, as well as a number 
of fungal species maintain similarly cryptic sexual replication cycles like Toxoplasma. It is 
possible that work examining the replication cycles of these fungi may elucidate conserved 
mechanisms for unisexual (or similar strain) mating that could provide perspective for the biased 
nature of sexual replication in Toxoplasma (Heitman 2010; Roach and Heitman 2014). 
As Toxoplasma infections have previously been shown to differentially respond to stress 
in the cellular environment, it is possible that Toxoplasma can switch between outcrossing and 
unisexual or self-mating based on an unknown signal within the feline enterocytes (Hakimi, 
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Olias, and Sibley 2017; Yang et al. 2015). Experiments to elucidate the activity of merozoites 
and derived oocysts in the feline definitive host are necessary to elucidate the host environmental 
signals involved in the biased production of Toxoplasma progeny.  Although the majority of 
strains in the Toxoplasma population are derived from the known “clonal” lineages, the more 
diverse strains are often the most problematic, giving rise to disease outbreaks following sexual 
crossing (Vaudaux et al. 2010). Thus, it is imperative that an improved understanding of the 
population dynamics of Toxoplasma be determined to better understand these divergent strains.  
Likely, these divergent strains of Toxoplasma contain novel virulence genes. Hence, 
sexual progeny between divergent and “clonal” strains are necessary to further elucidate novel 
virulence factors within the Toxoplasma population. Furthermore, because it is hypothesized that 
divergent strains are best suited for different hosts than the clonal clades, testing these progeny 
against an array of intermediate host species could elucidate virulence genes important to host-
shifts. A genetic mechanism favoring one host over another would verify that intermediate host 
selection is a driving factor for the evolution of this generalist parasite (Boothroyd 2009). 
Potential host-shift genes need to be elucidated and their functions characterized to understand 
how this generalist pathogen maintains its cryptic virulence to maintain the ability to invade and 





Adomako-Ankomah, Y., E. D. English, and JJ Danielson. 2016. 'Host Mitochondrial Association 
Evolved in the Human Parasite Toxoplasma gondii via Neofunctionalization of a Gene 
Duplicate', Genetics. 
Adomako-Ankomah, Y., G. M. Wier, A. L. Borges, H. E. Wand, and J. P. Boyle. 2014. 
'Differential locus expansion distinguishes Toxoplasmatinae species and closely related 
strains of Toxoplasma gondii', MBio, 5: e01003-13. 
Agrawal, A. F. 2006. 'Evolution of sex: why do organisms shuffle their genotypes?', Curr Biol, 
16: R696-704. 
Ajzenberg, D., A. L. Banuls, M. Tibayrenc, and M. L. Darde. 2002. 'Microsatellite analysis of 
Toxoplasma gondii shows considerable polymorphism structured into two main clonal 
groups', Int J Parasitol, 32: 27-38. 
Ajzenberg, D., F. Collinet, A. Mercier, P. Vignoles, and M. L. Darde. 2010. 'Genotyping of 
Toxoplasma gondii isolates with 15 microsatellite markers in a single multiplex PCR 
assay', J Clin Microbiol, 48: 4641-5. 
Ajzenberg, D., H. Yera, P. Marty, L. Paris, F. Dalle, J. Menotti, D. Aubert, J. Franck, M. H. 
Bessieres, D. Quinio, H. Pelloux, L. Delhaes, N. Desbois, P. Thulliez, F. Robert-
Gangneux, C. Kauffmann-Lacroix, S. Pujol, M. Rabodonirina, M. E. Bougnoux, B. 
Cuisenier, C. Duhamel, T. H. Duong, D. Filisetti, P. Flori, F. Gay-Andrieu, F. Pratlong, 
G. Nevez, A. Totet, B. Carme, H. Bonnabau, M. L. Darde, and I. Villena. 2009. 
'Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in 
immunocompromised patients and correlation with clinical findings', J Infect Dis, 199: 
1155-67. 
Alaganan, A., S. J. Fentress, K. Tang, Q. Wang, and L. D. Sibley. 2014. 'Toxoplasma GRA7 
effector increases turnover of immunity-related GTPases and contributes to acute 
virulence in the mouse', Proc Natl Acad Sci U S A, 111: 1126-31. 
Ariey, F., B. Witkowski, C. Amaratunga, J. Beghain, A. C. Langlois, N. Khim, S. Kim, V. Duru, 
C. Bouchier, L. Ma, P. Lim, R. Leang, S. Duong, S. Sreng, S. Suon, C. M. Chuor, D. M. 
Bout, S. Menard, W. O. Rogers, B. Genton, T. Fandeur, O. Miotto, P. Ringwald, J. Le 
Bras, A. Berry, J. C. Barale, R. M. Fairhurst, F. Benoit-Vical, O. Mercereau-Puijalon, and 
D. Menard. 2014. 'A molecular marker of artemisinin-resistant Plasmodium falciparum 
malaria', Nature, 505: 50-5. 
Arisue, N., and T. Hashimoto. 2014. 'Phylogeny and evolution of apicoplasts and apicomplexan 
parasites', Parasitol Int. 
Avelino, M. M., W. N. Amaral, I. M. Rodrigues, A. R. Rassi, M. B. Gomes, T. L. Costa, and A. 
M. Castro. 2014. 'Congenital toxoplasmosis and prenatal care state programs', BMC 
Infect Dis, 14: 33. 
Awad-El-Kariem, F. M. 1999. 'Does Cryptosporidium parvum have a Clonal Population 
Structure?', Parasitology Today, 15. 
Ayi, I., K. D. Kwofie, E. A. Blay, J. H. Osei, K. K. Frempong, R. Koku, A. Ghansah, M. Lartey, 
T. Suzuki, D. A. Boakye, K. A. Koram, and N. Ohta. 2016. 'Clonal types of Toxoplasma 
gondii among immune compromised and immune competent individuals in Accra, 
Ghana', Parasitol Int, 65: 238-44. 
 206 
Barbieri, M. M., L. Kashinsky, D. S. Rotstein, K. M. Colegrove, K. H. Haman, S. L. Magargal, 
A. R. Sweeny, A. C. Kaufman, M. E. Grigg, and C. L. Littnan. 2016. 'Protozoal-related 
mortalities in endangered Hawaiian monk seals Neomonachus schauinslandi', Dis Aquat 
Organ, 121: 85-95. 
Barbosa, L., C. K. Johnson, D. M. Lambourn, A. K. Gibson, K. H. Haman, J. L. Huggins, A. R. 
Sweeny, N. Sundar, S. A. Raverty, and M. E. Grigg. 2015. 'A novel Sarcocystis neurona 
genotype XIII is associated with severe encephalitis in an unexpectedly broad range of 
marine mammals from the northeastern Pacific Ocean', Int J Parasitol. 
Behnke, M. S., J. P. Dubey, and L. D. Sibley. 2016. 'Genetic Mapping of Pathogenesis 
Determinants in Toxoplasma gondii', Annu Rev Microbiol, 70: 63-81. 
Behnke, M. S., S. J. Fentress, M. Mashayekhi, L. X. Li, G. A. Taylor, and L. D. Sibley. 2012. 
'The Polymorphic Pseudokinase ROP5 Controls Virulence in Toxoplasma gondii by 
Regulating the Active Kinase ROP18', PLoS Pathog, 8: e1002992. 
Behnke, M. S., A. Khan, E. J. Lauron, J. R. Jimah, Q. Wang, N. H. Tolia, and L. D. Sibley. 2015. 
'Rhoptry Proteins ROP5 and ROP18 Are Major Murine Virulence Factors in Genetically 
Divergent South American Strains of Toxoplasma gondii', PLoS Genet, 11: e1005434. 
Behnke, M. S., A. Khan, and L. D. Sibley. 2015. 'Genetic Mapping Reveals that Sinefungin 
Resistance in Toxoplasma gondii Is Controlled by a Putative Amino Acid Transporter 
Locus That Can Be Used as a Negative Selectable Marker', Eukaryot Cell, 14: 140-8. 
Behnke, M. S., A. Khan, J. C. Wootton, J. P. Dubey, K. Tang, and L. D. Sibley. 2011. 'Virulence 
differences in Toxoplasma mediated by amplification of a family of polymorphic 
pseudokinases', Proc Natl Acad Sci U S A, 108: 9631-6. 
Bellanger, X., S. Payot, N. Leblond-Bourget, and G. Guedon. 2014. 'Conjugative and 
mobilizable genomic islands in bacteria: evolution and diversity', FEMS Microbiol Rev, 
38: 720-60. 
Bertranpetit, E., T. Jombart, E. Paradis, H. Pena, J. Dubey, C. Su, A. Mercier, S. Devillard, and 
D. Ajzenberg. 2016. 'Phylogeography of Toxoplasma gondii points to a South American 
origin', Infect Genet Evol, 48: 150-55. 
Billmyre, R. B., D. Croll, W. Li, P. Mieczkowski, D. A. Carter, C. A. Cuomo, J. W. Kronstad, 
and J. Heitman. 2014. 'Highly recombinant VGII Cryptococcus gattii population develops 
clonal outbreak clusters through both sexual macroevolution and asexual microevolution', 
MBio, 5: e01494-14. 
Blackston, C. R., J. P. Dubey, E. Dotson, C. Su, P. Thulliez, D. Sibley, and T. Lehmann. 2001. 
'High-Resolution Typing of Toxoplasma gondii Using Microsatellite Loci', Journal of 
Parasitology, 87: 1472-75. 
Bohne, W., J. Heesemann, and U. Gross. 1994. 'Reduced Replication of Toxoplasma-Gondii Is 
Necessary for Induction of Bradyzoite-Specific Antigens - a Possible Role for Nitric-
Oxide in Triggering Stage Conversion', Infection and Immunity, 62: 1761-67. 
Boothroyd, J. C. 2009. 'Expansion of host range as a driving force in the evolution of 
Toxoplasma', Mem Inst Oswaldo Cruz, 104: 179-84. 
———. 2013. 'Have it your way: how polymorphic, injected kinases and pseudokinases enable 
Toxoplasma to subvert host defenses', PLoS Pathog, 9: e1003296. 
Boothroyd, J. C., and J. F. Dubremetz. 2008. 'Kiss and spit: the dual roles of Toxoplasma 
rhoptries', Nat Rev Microbiol, 6: 79-88. 
 207 
Boothroyd, J. C., and M. E. Grigg. 2002. 'Population biology of Toxoplasma gondii and its 
relevance to human infection: do different strains cause different disease?' in, Curr Opin 
Microbiol (England). 
Bopp, S. E., M. J. Manary, A. T. Bright, G. L. Johnston, N. V. Dharia, F. L. Luna, S. 
McCormack, D. Plouffe, C. W. McNamara, J. R. Walker, D. A. Fidock, E. L. Denchi, 
and E. A. Winzeler. 2013. 'Mitotic evolution of Plasmodium falciparum shows a stable 
core genome but recombination in antigen families', PLoS Genet, 9: e1003293. 
Boyer, K., D. Hill, E. Mui, K. Wroblewski, T. Karrison, J. P. Dubey, M. Sautter, A. G. Noble, S. 
Withers, C. Swisher, P. Heydemann, T. Hosten, J. Babiarz, D. Lee, P. Meier, R. McLeod, 
and Group Toxoplasmosis Study. 2011. 'Unrecognized ingestion of Toxoplasma gondii 
oocysts leads to congenital toxoplasmosis and causes epidemics in North America', Clin 
Infect Dis, 53: 1081-9. 
Boyle, J. P., B. Rajasekar, J. P. Saeij, J. W. Ajioka, M. Berriman, I. Paulsen, D. S. Roos, L. D. 
Sibley, M. W. White, and J. C. Boothroyd. 2006. 'Just one cross appears capable of 
dramatically altering the population biology of a eukaryotic pathogen like Toxoplasma 
gondii', Proc Natl Acad Sci U S A, 103: 10514-9. 
Boyle, Jon P., and Jay R. Radke. 2009. 'A history of studies that examine the interactions of 
Toxoplasma with its host cell: Emphasis on in vitro models', Int J Parasitol, 39: 903-14. 
Brabin, B. J. 1985. 'Epidemiology of infection in pregnancy', Rev Infect Dis, 7: 579-603. 
Braun, L., M. P. Brenier-Pinchart, M. Yogavel, A. Curt-Varesano, R. L. Curt-Bertini, T. 
Hussain, S. Kieffer-Jaquinod, Y. Coute, H. Pelloux, I. Tardieux, A. Sharma, H. Belrhali, 
A. Bougdour, and M. A. Hakimi. 2013. 'A Toxoplasma dense granule protein, GRA24, 
modulates the early immune response to infection by promoting a direct and sustained 
host p38 MAPK activation', Journal of Experimental Medicine, 210: 2071-86. 
Budroni, S., E. Siena, J. C. D. Hotopp, K. L. Seib, D. Serruto, C. Nofroni, M. Comanducci, D. R. 
Riley, S. C. Daugherty, S. V. Angiuoli, A. Covacci, M. Pizza, R. Rappuoli, E. R. Moxon, 
H. Tettelin, and D. Medini. 2011. 'Neisseria meningitidis is structured in clades 
associated with restriction modification systems that modulate homologous 
recombination', Proc Natl Acad Sci U S A, 108: 4494-99. 
Burrells, A., P. M. Bartley, I. A. Zimmer, S. Roy, A. C. Kitchener, A. Meredith, S. E. Wright, E. 
A. Innes, and F. Katzer. 2013. 'Evidence of the three main clonal Toxoplasma gondii 
lineages from wild mammalian carnivores in the UK', Parasitology, 140: 1768-76. 
Butcher, B. A., B. A. Fox, L. M. Rommereim, S. G. Kim, K. J. Maurer, F. Yarovinsky, D. R. 
Herbert, D. J. Bzik, and E. Y. Denkers. 2011. 'Toxoplasma gondii rhoptry kinase ROP16 
activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent 
growth control', PLoS Pathog, 7: e1002236. 
Caffaro, C. E., and J. C. Boothroyd. 2011. 'Evidence for host cells as the major contributor of 
lipids in the intravacuolar network of Toxoplasma-infected cells', Eukaryot Cell, 10: 
1095-9. 
Carruthers, V. B., and L. D. Sibley. 1997. 'Sequential protein secretion from three distinct 
organelles of Toxoplasma gondii accompanies invasion of human fibroblasts', Eur J Cell 
Biol, 73: 114-23. 
Cavailles, P., P. Flori, O. Papapietro, C. Bisanz, D. Lagrange, L. Pilloux, C. Massera, S. 
Cristinelli, D. Jublot, O. Bastien, C. Loeuillet, D. Aldebert, B. Touquet, G. J. Fournie, 
and M. F. Cesbron-Delauw. 2014. 'A highly conserved Toxo1 haplotype directs 
 208 
resistance to toxoplasmosis and its associated caspase-1 dependent killing of parasite and 
host macrophage', PLoS Pathog, 10: e1004005. 
Cavailles, P., V. Sergent, C. Bisanz, O. Papapietro, C. Colacios, M. Mas, J. F. Subra, D. 
Lagrange, M. Calise, S. Appolinaire, T. Faraut, P. Druet, A. Saoudi, M. H. Bessieres, B. 
Pipy, M. F. Cesbron-Delauw, and G. J. Fournie. 2006. 'The rat Toxo1 locus directs 
toxoplasmosis outcome and controls parasite proliferation and spreading by macrophage-
dependent mechanisms', Proc Natl Acad Sci U S A, 103: 744-49. 
Cirelli, K. M., G. Gorfu, M. A. Hassan, M. Printz, D. Crown, S. H. Leppla, M. E. Grigg, J. P. 
Saeij, and M. Moayeri. 2014. 'Inflammasome sensor NLRP1 controls rat macrophage 
susceptibility to Toxoplasma gondii', PLoS Pathog, 10: e1003927. 
Claessens, A., W. L. Hamilton, M. Kekre, T. D. Otto, A. Faizullabhoy, J. C. Rayner, and D. 
Kwiatkowski. 2014. 'Generation of antigenic diversity in Plasmodium falciparum by 
structured rearrangement of Var genes during mitosis', PLoS Genet, 10: e1004812. 
Cole, R. A., D. S. Lindsay, D. K. Howe, C. L. Roderick, J. P. Dubey, N. J. Thomas, and L. A. 
Baeten. 2000. 'Biological and Molecular Characterizations Oftoxoplasma Gondiistrains 
Obtained from Southern Sea Otters (Enhydra Lutris Nereis)', Journal of Parasitology, 86: 
526-30. 
Conrad, P. A., M. A. Miller, C. Kreuder, E. R. James, J. Mazet, H. Dabritz, D. A. Jessup, F. 
Gulland, and M. E. Grigg. 2005. 'Transmission of Toxoplasma: clues from the study of 
sea otters as sentinels of Toxoplasma gondii flow into the marine environment', Int J 
Parasitol, 35: 1155-68. 
Cornelissen, A. W., and J. P. Overdulve. 1985. 'Sex determination and sex differentiation in 
coccidia: gametogony and oocyst production after monoclonal infection of cats with free-
living and intermediate host stages of Isospora (Toxoplasma) gondii', Parasitology, 90 ( 
Pt 1): 35-44. 
Danecek, P., A. Auton, G. Abecasis, C. A. Albers, E. Banks, M. A. DePristo, R. E. Handsaker, 
G. Lunter, G. T. Marth, S. T. Sherry, G. McVean, R. Durbin, and Group Genomes 
Project Analysis. 2011. 'The variant call format and VCFtools', Bioinformatics, 27: 2156-
8. 
Darde, M. L., B. Bouteille, and M. Pestre-Alexandre. 1992. 'Isoenzyme analysis of 35 
Toxoplasma gondii isolates and the biological and epidemiological implications', J 
Parasitol, 78: 786-94. 
Demar, M., D. Ajzenberg, D. Maubon, F. Djossou, D. Panchoe, W. Punwasi, N. Valery, C. 
Peneau, J. L. Daigre, C. Aznar, B. Cottrelle, L. Terzan, M. L. Darde, and B. Carme. 2007. 
'Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, 
clinical, and parasitological aspects', Clin Infect Dis, 45: e88-95. 
Derouin, F., H. Pelloux, and Escmid Study Group on Clinical Parasitology. 2008. 'Prevention of 
toxoplasmosis in transplant patients', Clin Microbiol Infect, 14: 1089-101. 
Dubey, J. P. 1995. 'Duration of immunity to shedding of Toxoplasma gondii oocysts by cats', J 
Parasitol, 81: 410-5. 
———. 1998. 'Toxoplasma gondii oocyst survival under defined temperatures', J Parasitol, 84: 
862-5. 
———. 2001. 'Oocyst Shedding by Cats Fed Isolated Bradyzoites and Comparison of Infectivity 
of Bradyzoites of the VEG StrainToxoplasma gondiito Cats and Mice', Journal of 
Parasitology, 87: 215-19. 
 209 
Dubey, J. P., and J. K. Frenkel. 1972. 'Cyst-induced toxoplasmosis in cats', J Protozool, 19: 155-
77. 
———. 1976. 'Feline toxoplasmosis from acutely infected mice and the development of 
Toxoplasma cysts', J Protozool, 23: 537-46. 
Dubey, J. P., L. T. Huong, N. Sundar, and C. Su. 2007. 'Genetic characterization of Toxoplasma 
gondii isolates in dogs from Vietnam suggests their South American origin', Vet 
Parasitol, 146: 347-51. 
Dubey, J. P., and J. L. Jones. 2008. 'Toxoplasma gondii infection in humans and animals in the 
United States', Int J Parasitol, 38: 1257-78. 
Dubey, J. P., A. N. Patitucci, C. Su, N. Sundar, O. C. Kwok, and S. K. Shen. 2006. 
'Characterization of Toxoplasma gondii isolates in free-range chickens from Chile, South 
America', Vet Parasitol, 140: 76-82. 
Dubey, J. P., S. K. Shen, O. C. Kwok, and J. K. Frenkel. 1999. 'Infection and immunity with the 
RH strain of Toxoplasma gondii in rats and mice', J Parasitol, 85: 657-62. 
Dubey, J. P., K. Van Why, S. K. Verma, S. Choudhary, O. C. Kwok, A. Khan, M. S. Behinke, L. 
D. Sibley, L. R. Ferreira, S. Oliveira, M. Weaver, R. Stewart, and C. Su. 2014. 
'Genotyping Toxoplasma gondii from wildlife in Pennsylvania and identification of 
natural recombinants virulent to mice', Vet Parasitol, 200: 74-84. 
Dubey, J. P., G. V. Velmurugan, C. Rajendran, M. J. Yabsley, N. J. Thomas, K. B. Beckmen, D. 
Sinnett, D. Ruid, J. Hart, P. A. Fair, W. E. McFee, V. Shearn-Bochsler, O. C. Kwok, L. 
R. Ferreira, S. Choudhary, E. B. Faria, H. Zhou, T. A. Felix, and C. Su. 2011. 'Genetic 
characterisation of Toxoplasma gondii in wildlife from North America revealed 
widespread and high prevalence of the fourth clonal type', Int J Parasitol, 41: 1139-47. 
Dubey, J. P., X. Q. Zhu, N. Sundar, H. Zhang, O. C. Kwok, and C. Su. 2007. 'Genetic and 
biologic characterization of Toxoplasma gondii isolates of cats from China', Vet 
Parasitol, 145: 352-6. 
Dubey, J.P. 2010. Toxoplasmosis of Animals and Humans, Second Edition (CRC Press). 
Dubremetz, J. F., and M. Lebrun. 2012. 'Virulence factors of Toxoplasma gondii', Microbes 
Infect, 14: 1403-10. 
Dunn, J. D., S. Ravindran, S. K. Kim, and J. C. Boothroyd. 2008. 'The Toxoplasma gondii dense 
granule protein GRA7 is phosphorylated upon invasion and forms an unexpected 
association with the rhoptry proteins ROP2 and ROP4', Infection and Immunity, 76: 
5853-61. 
Dupont, C. D., and C. A. Hunter. 2012. 'Guanylate-binding proteins: niche recruiters for 
antimicrobial effectors', Immunity, 37: 191-3. 
Eidell, K. P., T. Burke, and M. J. Gubbels. 2010. 'Development of a screen to dissect 
Toxoplasma gondii egress', Mol Biochem Parasitol, 171: 97-103. 
Elbez-Rubinstein, A., D. Ajzenberg, M. L. Darde, R. Cohen, A. Dumetre, H. Yera, E. Gondon, J. 
C. Janaud, and P. Thulliez. 2009. 'Congenital toxoplasmosis and reinfection during 
pregnancy: case report, strain characterization, experimental model of reinfection, and 
review', J Infect Dis, 199: 280-5. 
English, E. D., Y. Adomako-Ankomah, and J. P. Boyle. 2015. 'Secreted effectors in Toxoplasma 
gondii and related species: determinants of host range and pathogenesis?', Parasite 
Immunol, 37: 127-40. 
 210 
Etheridge, R. D., A. Alaganan, K. Tang, H. J. Lou, B. E. Turk, and L. D. Sibley. 2014. 'The 
Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that 
synergize to control acute virulence in mice', Cell Host Microbe, 15: 537-50. 
Ewald, S. E., J. Chavarria-Smith, and J. C. Boothroyd. 2014. 'NLRP1 is an inflammasome sensor 
for Toxoplasma gondii', Infection and Immunity, 82: 460-8. 
Fazaeli, A., P. E. Carter, M. L. Darde, and T. H. Pennington. 2000. 'Molecular typing of 
Toxoplasma gondii strains by GRA6 gene sequence analysis', Int J Parasitol, 30: 637-42. 
Feil, E. J., B. C. Li, D. M. Aanensen, W. P. Hanage, and B. G. Spratt. 2004. 'eBURST: Inferring 
Patterns of Evolutionary Descent among Clusters of Related Bacterial Genotypes from 
Multilocus Sequence Typing Data', Journal of Bacteriology, 186: 1518-30. 
Fekkar, A., D. Ajzenberg, B. Bodaghi, F. Touafek, P. Le Hoang, J. Delmas, P. Y. Robert, M. L. 
Darde, D. Mazier, and L. Paris. 2011. 'Direct genotyping of Toxoplasma gondii in ocular 
fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in 
France', J Clin Microbiol, 49: 1513-7. 
Feretzaki, M., and J. Heitman. 2013. 'Unisexual reproduction drives evolution of eukaryotic 
microbial pathogens', PLoS Pathog, 9: e1003674. 
Ferguson, D. 2002. 'Toxoplasma gondii and sex: essential or optional extra?', Trends Parasitol, 
18: 351. 
Ferguson, D. J., F. L. Henriquez, M. J. Kirisits, S. P. Muench, S. T. Prigge, D. W. Rice, C. W. 
Roberts, and R. L. McLeod. 2005. 'Maternal inheritance and stage-specific variation of 
the apicoplast in Toxoplasma gondii during development in the intermediate and 
definitive host', Eukaryot Cell, 4: 814-26. 
Ferguson, D. J., W. M. Hutchison, J. F. Dunachie, and J. C. Siim. 1974. 'Ultrastructural study of 
early stages of asexual multiplication and microgametogony of Toxoplasma gondii in the 
small intestine of the cat', Acta Pathol Microbiol Scand B Microbiol Immunol, 82: 167-
81. 
Ferguson, D. J., W. M. Hutchison, and J. C. Siim. 1975. 'The ultrastructural development of the 
macrogamete and formation of the oocyst wall of Toxoplasma gondii', Acta Pathol 
Microbiol Scand B, 83: 491-505. 
Ferguson, David J. P., and Jean-François Dubremetz. 2014. 'Chapter 2 - The Ultrastructure of 
Toxoplasma gondii.' in, Toxoplasma Gondii (Second Edition) (Academic Press: Boston). 
Fernandez, C., J. Jaimes, M. C. Ortiz, and J. D. Ramirez. 2016. 'Host and Toxoplasma gondii 
genetic and non-genetic factors influencing the development of ocular toxoplasmosis: A 
systematic review', Infect Genet Evol, 44: 199-209. 
Ferreira Ade, M., R. W. Vitor, A. C. Carneiro, G. P. Brandao, and M. N. Melo. 2004. 'Genetic 
variability of Brazilian Toxoplasma gondii strains detected by random amplified 
polymorphic DNA-polymerase chain reaction (RAPD-PCR) and simple sequence repeat 
anchored-PCR (SSR-PCR)', Infect Genet Evol, 4: 131-42. 
Ferreira, I. M., J. E. Vidal, T. A. Costa-Silva, C. S. Meira, R. M. Hiramoto, A. C. Penalva de 
Oliveira, and V. L. Pereira-Chioccola. 2008. 'Toxoplasma gondii: genotyping of strains 
from Brazilian AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP 
markers', Exp Parasitol, 118: 221-7. 
Figueiró-Filho, Ernesto Antonio, Alessandro Henrique Antunes Lopes, Flávio Renato de 
Almeida Senefonte, VG de Souza Júnior, Carlos Augusto Botelho, Mauro Silvério 
Figueiredo, and Geraldo Duarte. 2005. 'Toxoplasmose aguda: estudo da freqüência, taxa 
 211 
de transmissão vertical e relação entre os testes diagnósticos materno-fetais em gestantes 
em estado da Região Centro-Oeste do Brasil', Rev Bras Ginecol Obstet, 27: 442-9. 
Fleckenstein, M. C., M. L. Reese, S. Konen-Waisman, J. C. Boothroyd, J. C. Howard, and T. 
Steinfeldt. 2012. 'A Toxoplasma gondii pseudokinase inhibits host IRG resistance 
proteins', PLoS Biol, 10: e1001358. 
Fletcher, S. 1965. 'Indirect Fluorescent Antibody Technique in the Serology of Toxoplasma 
Gondii', J Clin Pathol, 18: 193-9. 
Fox, B. A., L. M. Rommereim, R. B. Guevara, A. Falla, M. A. Hortua Triana, Y. Sun, and D. J. 
Bzik. 2016. 'The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection', 
MBio, 7. 
Freppel, W., P. H. Puech, D. J. Ferguson, N. Azas, J. P. Dubey, and A. Dumetre. 2016. 
'Macrophages facilitate the excystation and differentiation of Toxoplasma gondii 
sporozoites into tachyzoites following oocyst internalisation', Sci Rep, 6: 33654. 
Freyre, A., and J. Falcon. 2004. 'Massive excystation of Toxoplasma gondii sporozoites', Exp 
Parasitol, 107: 72-7. 
Fritz, H. M., K. R. Buchholz, X. Chen, B. Durbin-Johnson, D. M. Rocke, P. A. Conrad, and J. C. 
Boothroyd. 2012. 'Transcriptomic analysis of toxoplasma development reveals many 
novel functions and structures specific to sporozoites and oocysts', PLoS One, 7: e29998. 
Fux, B., J. Nawas, A. Khan, D. B. Gill, C. Su, and L. D. Sibley. 2007. 'Toxoplasma gondii 
strains defective in oral transmission are also defective in developmental stage 
differentiation', Infection and Immunity, 75: 2580-90. 
Gajria, B., A. Bahl, J. Brestelli, J. Dommer, S. Fischer, X. Gao, M. Heiges, J. Iodice, J. C. 
Kissinger, A. J. Mackey, D. F. Pinney, D. S. Roos, C. J. Stoeckert, Jr., H. Wang, and B. 
P. Brunk. 2008. 'ToxoDB: an integrated Toxoplasma gondii database resource', Nucleic 
Acids Res, 36: D553-6. 
Gay, G., L. Braun, M. P. Brenier-Pinchart, J. Vollaire, V. Josserand, R. L. Bertini, A. Varesano, 
B. Touquet, P. J. De Bock, Y. Coute, I. Tardieux, A. Bougdour, and M. A. Hakimi. 2016. 
'Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-
dependent gene regulation and IFN-gamma-mediated host defenses', Journal of 
Experimental Medicine, 213: 1779-98. 
Gazzinelli, R. T., R. Mendonca-Neto, J. Lilue, J. Howard, and A. Sher. 2014. 'Innate Resistance 
against Toxoplasma gondii: An Evolutionary Tale of Mice, Cats, and Men', Cell Host 
Microbe, 15: 132-38. 
Gibson, A. K., S. Raverty, D. M. Lambourn, J. Huggins, S. L. Magargal, and M. E. Grigg. 2011. 
'Polyparasitism is associated with increased disease severity in Toxoplasma gondii-
infected marine sentinel species', PLoS Negl Trop Dis, 5: e1142. 
Gorfu, G., K. M. Cirelli, M. B. Melo, K. Mayer-Barber, D. Crown, B. H. Koller, S. Masters, A. 
Sher, S. H. Leppla, M. Moayeri, J. P. Saeij, and M. E. Grigg. 2014. 'Dual role for 
inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii', 
MBio, 5. 
Grigg, M. E., S. Bonnefoy, A. B. Hehl, Y. Suzuki, and J. C. Boothroyd. 2001. 'Success and 
virulence in toxoplasma as the result of sexual recombination between two distinct 
ancestries', Science, 294: 161-65. 
Grigg, M. E., J. P. Dubey, and R. B. Nussenblatt. 2015. 'Ocular toxoplasmosis: lessons from 
Brazil', Am J Ophthalmol, 159: 999-1001. 
 212 
Grigg, M. E., J. Ganatra, J. C. Boothroyd, and T. P. Margolis. 2001. 'Unusual abundance of 
atypical strains associated with human ocular toxoplasmosis', J Infect Dis, 184: 633-9. 
Grigg, M. E., and N. Sundar. 2009. 'Sexual recombination punctuated by outbreaks and clonal 
expansions predicts Toxoplasma gondii population genetics', Int J Parasitol, 39: 925-33. 
Gross, U., M. C. Kempf, F. Seeber, C. G. Luder, R. Lugert, and W. Bohne. 1997. 'Reactivation 
of chronic toxoplasmosis: is there a link to strain-specific differences in the parasite?', 
Behring Inst Mitt: 97-106. 
Guo, M., J. P. Dubey, D. Hill, R. L. Buchanan, H. R. Gamble, J. L. Jones, and A. K. Pradhan. 
2015. 'Prevalence and risk factors for Toxoplasma gondii infection in meat animals and 
meat products destined for human consumption', J Food Prot, 78: 457-76. 
Guo, M., A. Mishra, R. L. Buchanan, J. P. Dubey, D. E. Hill, H. R. Gamble, J. L. Jones, and A. 
K. Pradhan. 2016. 'A Systematic Meta-Analysis of Toxoplasma gondii Prevalence in 
Food Animals in the United States', Foodborne Pathog Dis, 13: 109-18. 
Hakansson, S., A. J. Charron, and L. D. Sibley. 2001. 'Toxoplasma evacuoles: a two-step process 
of secretion and fusion forms the parasitophorous vacuole', EMBO J, 20: 3132-44. 
Hakimi, M. A., P. Olias, and L. D. Sibley. 2017. 'Toxoplasma Effectors Targeting Host 
Signaling and Transcription', Clin Microbiol Rev, 30: 615-45. 
Harrell, M., and P. E. Carvounis. 2014. 'Current treatment of toxoplasma retinochoroiditis: an 
evidence-based review', J Ophthalmol, 2014: 273506. 
Hehl, A. B., W. U. Basso, C. Lippuner, C. Ramakrishnan, M. Okoniewski, R. A. Walker, M. E. 
Grigg, N. C. Smith, and P. Deplazes. 2015. 'Asexual expansion of Toxoplasma gondii 
merozoites is distinct from tachyzoites and entails expression of non-overlapping gene 
families to attach, invade, and replicate within feline enterocytes', Bmc Genomics, 16: 66. 
Heitman, J. 2010. 'Evolution of eukaryotic microbial pathogens via covert sexual reproduction', 
Cell Host Microbe, 8: 86-99. 
Hermanns, T., U. B. Muller, S. Konen-Waisman, J. C. Howard, and T. Steinfeldt. 2015. 'The 
Toxoplasma gondii rhoptry protein ROP18 is an Irga6-specific kinase and regulated by 
the dense granule protein GRA7', Cell Microbiol. 
Herrmann, D. C., P. Maksimov, A. Hotop, U. Gross, W. Daubener, O. Liesenfeld, U. Pleyer, F. 
J. Conraths, and G. Schares. 2014. 'Genotyping of samples from German patients with 
ocular, cerebral and systemic toxoplasmosis reveals a predominance of Toxoplasma 
gondii type II', Int J Med Microbiol, 304: 911-6. 
Hide, G. 2016. 'Role of vertical transmission of Toxoplasma gondii in prevalence of infection', 
Expert Rev Anti Infect Ther, 14: 335-44. 
Honnold, S. P., R. Braun, D. P. Scott, C. Sreekumar, and J. P. Dubey. 2005. 'Toxoplasmosis in a 
Hawaiian monk seal (Monachus schauinslandi)', J Parasitol, 91: 695-7. 
Howe, D. K., and L. D. Sibley. 1994. 'Toxoplasma gondii: analysis of different laboratory stocks 
of the RH strain reveals genetic heterogeneity', Exp Parasitol, 78: 242-5. 
———. 1995. 'Toxoplasma gondii comprises three clonal lineages: correlation of parasite 
genotype with human disease', J Infect Dis, 172: 1561-6. 
Hunn, J. P., C. G. Feng, A. Sher, and J. C. Howard. 2011. 'The immunity-related GTPases in 
mammals: a fast-evolving cell-autonomous resistance system against intracellular 
pathogens', Mamm Genome, 22: 43-54. 
Hunter, C. A., and L. D. Sibley. 2012. 'Modulation of innate immunity by Toxoplasma gondii 
virulence effectors', Nat Rev Microbiol, 10: 766-78. 
 213 
Huson, D. H., and D. Bryant. 2006. 'Application of phylogenetic networks in evolutionary 
studies', Mol Biol Evol, 23: 254-67. 
Iantorno, S. A., C. Durrant, A. Khan, M. J. Sanders, S. M. Beverley, W. C. Warren, M. 
Berriman, D. L. Sacks, J. A. Cotton, and M. E. Grigg. 2017. 'Gene Expression in 
Leishmania Is Regulated Predominantly by Gene Dosage', MBio, 8. 
Inbar, E., N. S. Akopyants, M. Charmoy, A. Romano, P. Lawyer, D. E. Elnaiem, F. Kauffmann, 
M. Barhoumi, M. Grigg, K. Owens, M. Fay, D. E. Dobson, J. Shaik, S. M. Beverley, and 
D. Sacks. 2013. 'The mating competence of geographically diverse Leishmania major 
strains in their natural and unnatural sand fly vectors', PLoS Genet, 9: e1003672. 
Jensen, K. D., A. Camejo, M. B. Melo, C. Cordeiro, L. Julien, G. M. Grotenbreg, E. M. Frickel, 
H. L. Ploegh, L. Young, and J. P. Saeij. 2015. 'Toxoplasma gondii Superinfection and 
Virulence during Secondary Infection Correlate with the Exact ROP5/ROP18 Allelic 
Combination', MBio, 6. 
Jensen, K. D., K. Hu, R. J. Whitmarsh, M. A. Hassan, L. Julien, D. Lu, L. Chen, C. A. Hunter, 
and J. P. Saeij. 2013. 'Toxoplasma gondii Rhoptry 16 Kinase Promotes Host Resistance 
to Oral Infection and Intestinal Inflammation Only in the Context of the Dense Granule 
Protein GRA15', Infection and Immunity, 81: 2156-67. 
Jensen, K. D., Y. Wang, E. D. Wojno, A. J. Shastri, K. Hu, L. Cornel, E. Boedec, Y. C. Ong, Y. 
H. Chien, C. A. Hunter, J. C. Boothroyd, and J. P. Saeij. 2011. 'Toxoplasma polymorphic 
effectors determine macrophage polarization and intestinal inflammation', Cell Host 
Microbe, 9: 472-83. 
Jones, J. L., and J. P. Dubey. 2010. 'Waterborne toxoplasmosis--recent developments', Exp 
Parasitol, 124: 10-25. 
Joy, D. A., X. Feng, J. Mu, T. Furuya, K. Chotivanich, A. U. Krettli, M. Ho, A. Wang, N. J. 
White, E. Suh, P. Beerli, and X. Z. Su. 2003. 'Early origin and recent expansion of 
Plasmodium falciparum', Science, 300: 318-21. 
Khairat, R., M. Ball, C. C. Chang, R. Bianucci, A. G. Nerlich, M. Trautmann, S. Ismail, G. M. 
Shanab, A. M. Karim, Y. Z. Gad, and C. M. Pusch. 2013. 'First insights into the 
metagenome of Egyptian mummies using next-generation sequencing', J Appl Genet, 54: 
309-25. 
Khan, A., M. S. Behnke, I. R. Dunay, M. W. White, and L. D. Sibley. 2009. 'Phenotypic and 
gene expression changes among clonal type I strains of Toxoplasma gondii', Eukaryot 
Cell, 8: 1828-36. 
Khan, A., U. Bohme, K. A. Kelly, E. Adlem, K. Brooks, M. Simmonds, K. Mungall, M. A. 
Quail, C. Arrowsmith, T. Chillingworth, C. Churcher, D. Harris, M. Collins, N. Fosker, 
A. Fraser, Z. Hance, K. Jagels, S. Moule, L. Murphy, S. O'Neil, M. A. Rajandream, D. 
Saunders, K. Seeger, S. Whitehead, T. Mayr, X. Xuan, J. Watanabe, Y. Suzuki, H. 
Wakaguri, S. Sugano, C. Sugimoto, I. Paulsen, A. J. Mackey, D. S. Roos, N. Hall, M. 
Berriman, B. Barrell, L. D. Sibley, and J. W. Ajioka. 2006. 'Common inheritance of 
chromosome Ia associated with clonal expansion of Toxoplasma gondii', Genome Res, 
16: 1119-25. 
Khan, A., J. P. Dubey, C. Su, J. W. Ajioka, B. M. Rosenthal, and L. D. Sibley. 2011. 'Genetic 
analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North 
America', Int J Parasitol, 41: 645-55. 
Khan, A., N. Miller, D. S. Roos, J. P. Dubey, D. Ajzenberg, M. L. Darde, J. W. Ajioka, B. 
Rosenthal, and L. D. Sibley. 2011. 'A monomorphic haplotype of chromosome Ia is 
 214 
associated with widespread success in clonal and nonclonal populations of Toxoplasma 
gondii', MBio, 2: e00228-11. 
Khan, A., J. S. Shaik, M. Behnke, Q. L. Wang, J. P. Dubey, H. A. Lorenzi, J. W. Ajioka, B. M. 
Rosenthal, and L. D. Sibley. 2014. 'NextGen sequencing reveals short double crossovers 
contribute disproportionately to genetic diversity in Toxoplasma gondii', Bmc Genomics, 
15. 
Khan, A., S. Taylor, J. W. Ajioka, B. M. Rosenthal, and L. D. Sibley. 2009. 'Selection at a single 
locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in 
mice', PLoS Genet, 5: e1000404. 
Khan, A., S. Taylor, C. Su, A. J. Mackey, J. Boyle, R. Cole, D. Glover, K. Tang, I. T. Paulsen, 
M. Berriman, J. C. Boothroyd, E. R. Pfefferkorn, J. P. Dubey, J. W. Ajioka, D. S. Roos, 
J. C. Wootton, and L. D. Sibley. 2005. 'Composite genome map and recombination 
parameters derived from three archetypal lineages of Toxoplasma gondii', Nucleic Acids 
Res, 33: 2980-92. 
Kim, K. 2006. 'Time to screen for congenital toxoplasmosis?', Clin Infect Dis, 42: 1395-7. 
Koblansky, A. A., D. Jankovic, H. Oh, S. Hieny, W. Sungnak, R. Mathur, M. S. Hayden, S. 
Akira, A. Sher, and S. Ghosh. 2013. 'Recognition of profilin by Toll-like receptor 12 is 
critical for host resistance to Toxoplasma gondii', Immunity, 38: 119-30. 
Kong, J. T., M. E. Grigg, L. Uyetake, S. Parmley, and J. C. Boothroyd. 2003. 'Serotyping of 
Toxoplasma gondii infections in humans using synthetic peptides', Journal of Infectious 
Diseases, 187: 1484-95. 
Kreuder, C., M. A. Miller, D. A. Jessup, L. J. Lowenstine, M. D. Harris, J. A. Ames, T. E. 
Carpenter, P. A. Conrad, and J. A. Mazet. 2003. 'Patterns of mortality in southern sea 
otters (Enhydra lutris nereis) from 1998-2001', J Wildl Dis, 39: 495-509. 
Larkin, M. A., G. Blackshields, N. P. Brown, R. Chenna, P. A. McGettigan, H. McWilliam, F. 
Valentin, I. M. Wallace, A. Wilm, R. Lopez, J. D. Thompson, T. J. Gibson, and D. G. 
Higgins. 2007. 'Clustal W and Clustal X version 2.0', Bioinformatics, 23: 2947-8. 
Lehmann, T., P. L. Marcet, D. H. Graham, E. R. Dahl, and J. P. Dubey. 2006. 'Globalization and 
the population structure of Toxoplasma gondii', Proc Natl Acad Sci U S A, 103: 11423-8. 
Li, X. L., H. X. Wei, H. Zhang, H. J. Peng, and D. S. Lindsay. 2014. 'A meta analysis on risks of 
adverse pregnancy outcomes in Toxoplasma gondii infection', PLoS One, 9: e97775. 
Lilue, J., U. B. Muller, T. Steinfeldt, and J. C. Howard. 2013. 'Reciprocal virulence and 
resistance polymorphism in the relationship between Toxoplasma gondii and the house 
mouse', Elife, 2: e01298. 
Lindsay, D. S., B. L. Blagburn, and J. P. Dubey. 2002. 'Survival of nonsporulated Toxoplasma 
gondii oocysts under refrigerator conditions', Vet Parasitol, 103: 309-13. 
Lindsay, D. S., and J. P. Dubey. 2009. 'Long-term survival of Toxoplasma gondii sporulated 
oocysts in seawater', J Parasitol, 95: 1019-20. 
Liu, Q., L. Singla, and H. Zhou. 2012. 'Vaccines against Toxoplasma gondii: Status, challenges 
and future directions', Hum Vaccin Immunother, 8: 1305-8. 
Lopes, A. P., J. P. Dubey, M. L. Darde, and L. Cardoso. 2014. 'Epidemiological review of 
Toxoplasma gondii infection in humans and animals in Portugal', Parasitology, 141: 
1699-708. 
Lorenzi, H., A. Khan, M. S. Behnke, S. Namasivayam, L. S. Swapna, M. Hadjithomas, S. 
Karamycheva, D. Pinney, B. P. Brunk, J. W. Ajioka, D. Ajzenberg, J. C. Boothroyd, J. P. 
Boyle, M. L. Darde, M. A. Diaz-Miranda, J. P. Dubey, H. M. Fritz, S. M. Gennari, B. D. 
 215 
Gregory, K. Kim, J. P. Saeij, C. Su, M. W. White, X. Q. Zhu, D. K. Howe, B. M. 
Rosenthal, M. E. Grigg, J. Parkinson, L. Liu, J. C. Kissinger, D. S. Roos, and L. David 
Sibley. 2016. 'Local admixture of amplified and diversified secreted pathogenesis 
determinants shapes mosaic Toxoplasma gondii genomes', Nat Commun, 7: 10147. 
Lykins, J., K. Wang, K. Wheeler, F. Clouser, A. Dixon, K. El Bissati, Y. Zhou, C. Lyttle, A. 
Rzhetsky, and R. McLeod. 2016. 'Understanding Toxoplasmosis in the United States 
Through "Large Data" Analyses', Clin Infect Dis, 63: 468-75. 
Ma, J. S., M. Sasai, J. Ohshima, Y. Lee, H. Bando, K. Takeda, and M. Yamamoto. 2014. 
'Selective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic 
dense granule protein GRA6', Journal of Experimental Medicine, 211: 2013-32. 
Mackinnon, M. J., and A. F. Read. 2004. 'Virulence in malaria: an evolutionary viewpoint', 
Philos Trans R Soc Lond B Biol Sci, 359: 965-86. 
Matrajt, M., S. O. Angel, V. Pszenny, E. Guarnera, D. S. Roos, and J. C. Garberi. 1999. 'Arrays 
of repetitive DNA elements in the largest chromosomes of Toxoplasma gondii', Genome, 
42: 265-9. 
Matsuzaki, M., T. Kikuchi, K. Kita, S. Kojima, and T. Kuroiwa. 2001. 'Large amounts of 
apicoplast nucleoid DNA and its segregation in Toxoplasma gondii', Protoplasma, 218: 
180-91. 
McLeod, R., K. M. Boyer, D. Lee, E. Mui, K. Wroblewski, T. Karrison, A. G. Noble, S. Withers, 
C. N. Swisher, P. T. Heydemann, M. Sautter, J. Babiarz, P. Rabiah, P. Meier, M. E. 
Grigg, and Group Toxoplasmosis Study. 2012. 'Prematurity and severity are associated 
with Toxoplasma gondii alleles (NCCCTS, 1981-2009)', Clin Infect Dis, 54: 1595-605. 
Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. 
V. Tauxe. 1999. 'Food-related illness and death in the United States', Emerg Infect Dis, 5: 
607-25. 
Meissner, M., M. S. Breinich, P. R. Gilson, and B. S. Crabb. 2007. 'Molecular genetic tools in 
Toxoplasma and Plasmodium: achievements and future needs', Curr Opin Microbiol, 10: 
349-56. 
Melo, M. B., Q. P. Nguyen, C. Cordeiro, M. A. Hassan, N. Yang, R. McKell, E. E. Rosowski, L. 
Julien, V. Butty, M. L. Darde, D. Ajzenberg, K. Fitzgerald, L. H. Young, and J. P. Saeij. 
2013. 'Transcriptional analysis of murine macrophages infected with different 
Toxoplasma strains identifies novel regulation of host signaling pathways', PLoS Pathog, 
9: e1003779. 
Miller, M. A., I. A. Gardner, A. Packham, J. K. Mazet, K. D. Hanni, D. Jessup, J. Estes, R. 
Jameson, E. Dodd, B. C. Barr, L. J. Lowenstine, F. M. Gulland, and P. A. Conrad. 2002. 
'Evaluation of an Indirect Fluorescent Antibody Test (Ifat) for Demonstration of 
Antibodies to Toxoplasma Gondii in the Sea Otter (Enhydra Lutris)', Journal of 
Parasitology, 88: 594-99. 
Miller, M. A., M. E. Grigg, C. Kreuder, E. R. James, A. C. Melli, P. R. Crosbie, D. A. Jessup, J. 
C. Boothroyd, D. Brownstein, and P. A. Conrad. 2004. 'An unusual genotype of 
Toxoplasma gondii is common in California sea otters (Enhydra lutris nereis) and is a 
cause of mortality', Int J Parasitol, 34: 275-84. 
Miller, M. A., W. A. Miller, P. A. Conrad, E. R. James, A. C. Melli, C. M. Leutenegger, H. A. 
Dabritz, A. E. Packham, D. Paradies, M. Harris, J. Ames, D. A. Jessup, K. Worcester, 
and M. E. Grigg. 2008. 'Type X Toxoplasma gondii in a wild mussel and terrestrial 
 216 
carnivores from coastal California: new linkages between terrestrial mammals, runoff and 
toxoplasmosis of sea otters', Int J Parasitol, 38: 1319-28. 
Minot, S., M. B. Melo, F. Li, D. Lu, W. Niedelman, S. S. Levine, and J. P. J. Saeij. 2012. 
'Admixture and recombination among Toxoplasma gondii lineages explain global 
genome diversity', Proc Natl Acad Sci U S A, 109: 13458-63. 
Miotto, O., J. Almagro-Garcia, M. Manske, B. Macinnis, S. Campino, K. A. Rockett, C. 
Amaratunga, P. Lim, S. Suon, S. Sreng, J. M. Anderson, S. Duong, C. Nguon, C. M. 
Chuor, D. Saunders, Y. Se, C. Lon, M. M. Fukuda, L. Amenga-Etego, A. V. Hodgson, V. 
Asoala, M. Imwong, S. Takala-Harrison, F. Nosten, X. Z. Su, P. Ringwald, F. Ariey, C. 
Dolecek, T. T. Hien, M. F. Boni, C. Q. Thai, A. Amambua-Ngwa, D. J. Conway, A. A. 
Djimde, O. K. Doumbo, I. Zongo, J. B. Ouedraogo, D. Alcock, E. Drury, S. Auburn, O. 
Koch, M. Sanders, C. Hubbart, G. Maslen, V. Ruano-Rubio, D. Jyothi, A. Miles, J. 
O'Brien, C. Gamble, S. O. Oyola, J. C. Rayner, C. I. Newbold, M. Berriman, C. C. 
Spencer, G. McVean, N. P. Day, N. J. White, D. Bethell, A. M. Dondorp, C. V. Plowe, R. 
M. Fairhurst, and D. P. Kwiatkowski. 2013. 'Multiple populations of artemisinin-resistant 
Plasmodium falciparum in Cambodia', Nat Genet, 45: 648-55. 
Molina-Cruz, Alvaro, and Carolina Barillas-Mury. 2014. 'The remarkable journey of adaptation 
of the Plasmodium falciparum malaria parasite to New World anopheline mosquitoes', 
Mem Inst Oswaldo Cruz, 109: 662-67. 
Mordue, D. G., N. Desai, M. Dustin, and L. D. Sibley. 1999. 'Invasion by Toxoplasma gondii 
establishes a moving junction that selectively excludes host cell plasma membrane 
proteins on the basis of their membrane anchoring', Journal of Experimental Medicine, 
190: 1783-92. 
Ni, M., M. Feretzaki, S. Sun, X. Wang, and J. Heitman. 2011. 'Sex in fungi', Annu Rev Genet, 
45: 405-30. 
Niedelman, W., D. A. Gold, E. E. Rosowski, J. K. Sprokholt, D. Lim, A. Farid Arenas, M. B. 
Melo, E. Spooner, M. B. Yaffe, and J. P. Saeij. 2012. 'The rhoptry proteins ROP18 and 
ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-
gamma response', PLoS Pathog, 8: e1002784. 
Olias, P., R. D. Etheridge, Y. Zhang, M. J. Holtzman, and L. D. Sibley. 2016. 'Toxoplasma 
Effector Recruits the Mi-2/NuRD Complex to Repress STAT1 Transcription and Block 
IFN-gamma-Dependent Gene Expression', Cell Host Microbe, 20: 72-82. 
Pan, S., R. C. Thompson, M. E. Grigg, N. Sundar, A. Smith, and A. J. Lymbery. 2012. 'Western 
Australian marsupials are multiply infected with genetically diverse strains of 
Toxoplasma gondii', PLoS One, 7: e45147. 
Parameswaran, N., R. C. Thompson, N. Sundar, S. Pan, M. Johnson, N. C. Smith, and M. E. 
Grigg. 2010. 'Non-archetypal Type II-like and atypical strains of Toxoplasma gondii 
infecting marsupials of Australia', Int J Parasitol, 40: 635-40. 
Paya, E., I. Noemi, R. Tassara, P. Catalan, and C. L. Aviles. 2012. '[Prophylaxis against 
Toxoplasma gondii disease in pediatric and adult patients undergoing solid organ and 
hematopoietic stem cells transplantation]', Rev Chilena Infectol, 29 Suppl 1: S37-9. 
Pearson, T. A., and T. A. Manolio. 2008. 'How to interpret a genome-wide association study', 
Jama-Journal of the American Medical Association, 299: 1335-44. 
Peixoto, L., F. Chen, O. S. Harb, P. H. Davis, D. P. Beiting, C. S. Brownback, D. Ouloguem, and 
D. S. Roos. 2010. 'Integrative genomic approaches highlight a family of parasite-specific 
kinases that regulate host responses', Cell Host Microbe, 8: 208-18. 
 217 
Pellegrini, E., A. Palencia, L. Braun, U. Kapp, A. Bougdour, H. Belrhali, M. W. Bowler, and M. 
A. Hakimi. 2017. 'Structural Basis for the Subversion of MAP Kinase Signaling by an 
Intrinsically Disordered Parasite Secreted Agonist', Structure, 25: 16-26. 
Penman, B., C. Buckee, S. Gupta, and S. Nee. 2010. 'Genome-wide association studies in 
Plasmodium species', Bmc Biology, 8. 
Pernas, L., Y. Adomako-Ankomah, A. J. Shastri, S. E. Ewald, M. Treeck, J. P. Boyle, and J. C. 
Boothroyd. 2014. 'Toxoplasma effector MAF1 mediates recruitment of host mitochondria 
and impacts the host response', PLoS Biol, 12: e1001845. 
Pfefferkorn, E. R. 1981. 'Toxoplasmagondii and the biochemistry of intracellular parasitism', 
TIBS. 
Pfefferkorn, E. R., and L. C. Pfefferkorn. 1979. 'Quantitative studies of the mutagenesis of 
Toxoplasma gondii', J Parasitol, 65: 364-70. 
Pfefferkorn, E. R., L. C. Pfefferkorn, and E. D. Colby. 1977. 'Development of gametes and 
oocysts in cats fed cysts derived from cloned trophozoites of Toxoplasma gondii', J 
Parasitol, 63: 158-9. 
Pfefferkorn, L. C., and E. R. Pfefferkorn. 1980. 'Toxoplasma gondii: genetic recombination 
between drug resistant mutants', Exp Parasitol, 50: 305-16. 
Piergili Fioretti, D. 2004. '[Problems and limitations of conventional and innovative methods for 
the diagnosis of Toxoplasmosis in humans and animals]', Parassitologia, 46: 177-81. 
Pszenny, V., S. O. Angel, V. G. Duschak, M. Paulino, B. Ledesma, M. I. Yabo, E. Guarnera, A. 
M. Ruiz, and E. J. Bontempi. 2000. 'Molecular cloning, sequencing and expression of a 
serine proteinase inhibitor gene from Toxoplasma gondii', Mol Biochem Parasitol, 107: 
241-9. 
Quinlan, A. R., and I. M. Hall. 2010. 'BEDTools: a flexible suite of utilities for comparing 
genomic features', Bioinformatics, 26: 841-2. 
Rajendran, C., C. Su, and J. P. Dubey. 2012. 'Molecular genotyping of Toxoplasma gondii from 
Central and South America revealed high diversity within and between populations', 
Infect Genet Evol, 12: 359-68. 
Ramirez, J. D., and M. S. Llewellyn. 2014. 'Reproductive clonality in protozoan pathogens-truth 
or artefact?', Mol Ecol, 23: 4195-202. 
Read, A. F., M. Anwar, D. Shutler, and S. Nee. 1995. 'Sex allocation and population structure in 
malaria and related parasitic protozoa', Proc Biol Sci, 260: 359-63. 
Rich, S. M., M. C. Licht, R. R. Hudson, and F. J. Ayala. 1998. 'Malaria's Eve: evidence of a 
recent population bottleneck throughout the world populations of Plasmodium 
falciparum', Proc Natl Acad Sci U S A, 95: 4425-30. 
Rico-Torres, C. P., J. A. Vargas-Villavicencio, and D. Correa. 2016. 'Is Toxoplasma gondii type 
related to clinical outcome in human congenital infection? Systematic and critical 
review', Eur J Clin Microbiol Infect Dis, 35: 1079-88. 
Roach, K. C., and J. Heitman. 2014. 'Unisexual reproduction reverses Muller's ratchet', Genetics, 
198: 1059-69. 
Rogers, M. B., T. Downing, B. A. Smith, H. Imamura, M. Sanders, M. Svobodova, P. Volf, M. 
Berriman, J. A. Cotton, and D. F. Smith. 2014. 'Genomic confirmation of hybridisation 
and recent inbreeding in a vector-isolated leishmania population', PLoS Genet, 10: 
e1004092. 
 218 
Roiko, M. S., N. Svezhova, and V. B. Carruthers. 2014. 'Acidification Activates Toxoplasma 
gondii Motility and Egress by Enhancing Protein Secretion and Cytolytic Activity', PLoS 
Pathog, 10: e1004488. 
Romano, A., E. Inbar, A. Debrabant, M. Charmoy, P. Lawyer, F. Ribeiro-Gomes, M. Barhoumi, 
M. Grigg, J. Shaik, D. Dobson, S. M. Beverley, and D. L. Sacks. 2014. 'Cross-species 
genetic exchange between visceral and cutaneous strains of Leishmania in the sand fly 
vector', Proc Natl Acad Sci U S A, 111: 16808-13. 
Rosowski, E. E., D. Lu, L. Julien, L. Rodda, R. A. Gaiser, K. D. Jensen, and J. P. Saeij. 2011. 
'Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma 
gondii dense granule protein', Journal of Experimental Medicine, 208: 195-212. 
Ryu, J. S., D. Y. Min, M. H. Ahn, H. G. Choi, S. C. Rho, Y. J. Shin, B. Choi, and H. D. Joo. 
1996. 'Toxoplasma antibody titers by ELISA and indirect latex agglutination test in 
pregnant women', Korean J Parasitol, 34: 233-8. 
Saeij, J. P., J. P. Boyle, and J. C. Boothroyd. 2005. 'Differences among the three major strains of 
Toxoplasma gondii and their specific interactions with the infected host', Trends 
Parasitol, 21: 476-81. 
Saeij, J. P., J. P. Boyle, S. Coller, S. Taylor, L. D. Sibley, E. T. Brooke-Powell, J. W. Ajioka, and 
J. C. Boothroyd. 2006. 'Polymorphic secreted kinases are key virulence factors in 
toxoplasmosis', Science, 314: 1780-3. 
Saeij, J. P., J. P. Boyle, M. E. Grigg, G. Arrizabalaga, and J. C. Boothroyd. 2005. 
'Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals 
dramatic differences between strains', Infection and Immunity, 73: 695-702. 
Saeij, J. P., S. Coller, J. P. Boyle, M. E. Jerome, M. W. White, and J. C. Boothroyd. 2007. 
'Toxoplasma co-opts host gene expression by injection of a polymorphic kinase 
homologue', Nature, 445: 324-7. 
Schluter, D., W. Daubener, G. Schares, U. Gross, U. Pleyer, and C. Luder. 2014. 'Animals are 
key to human toxoplasmosis', Int J Med Microbiol, 304: 917-29. 
Schneider, G., U. Dobrindt, B. Middendorf, B. Hochhut, V. Szijarto, L. Emody, and J. Hacker. 
2011. 'Mobilisation and remobilisation of a large archetypal pathogenicity island of 
uropathogenic Escherichia coli in vitro support the role of conjugation for horizontal 
transfer of genomic islands', BMC Microbiol, 11: 210. 
Schoondermarkvandeven, E., J. Galama, C. Kraaijeveld, J. Vandruten, J. Meuwissen, and W. 
Melchers. 1993. 'Value of the Polymerase Chain-Reaction for the Detection of 
Toxoplasma-Gondii in Cerebrospinal-Fluid from Patients with Aids', Clinical Infectious 
Diseases, 16: 661-66. 
Sedwick, C. 2014. 'MAF1 sequesters mitochondria for Toxoplasma gondii', PLoS Biol, 12: 
e1001846. 
Seeber, F., and S. Steinfelder. 2016. 'Recent advances in understanding apicomplexan parasites', 
F1000Res, 5. 
Selleck, E. M., S. J. Fentress, W. L. Beatty, D. Degrandi, K. Pfeffer, H. W. th Virgin, J. D. 
Macmicking, and L. D. Sibley. 2013. 'Guanylate-binding protein 1 (Gbp1) contributes to 
cell-autonomous immunity against Toxoplasma gondii', PLoS Pathog, 9: e1003320. 
Selmecki, A. M., Y. E. Maruvka, P. A. Richmond, M. Guillet, N. Shoresh, A. L. Sorenson, S. 
De, R. Kishony, F. Michor, R. Dowell, and D. Pellman. 2015. 'Polyploidy can drive rapid 
adaptation in yeast', Nature, 519: 349-52. 
 219 
Shaik, J. S., A. Khan, S. M. Beverley, and L. D. Sibley. 2015. 'REDHORSE-REcombination and 
Double crossover detection in Haploid Organisms using next-geneRation SEquencing 
data', Bmc Genomics, 16: 133. 
Sharma, P., and C. E. Chitnis. 2013. 'Key molecular events during host cell invasion by 
Apicomplexan pathogens', Curr Opin Microbiol. 
Shastri, A. J., N. D. Marino, M. Franco, M. B. Lodoen, and J. C. Boothroyd. 2014. 'GRA25 Is a 
Novel Virulence Factor of Toxoplasma gondii and Influences the Host Immune 
Response', Infection and Immunity, 82: 2595-605. 
Shobab, L., U. Pleyer, J. Johnsen, S. Metzner, E. R. James, N. Torun, M. P. Fay, O. Liesenfeld, 
and M. E. Grigg. 2013. 'Toxoplasma Serotype Is Associated With Development of 
Ocular Toxoplasmosis.' in, J Infect Dis. 
Shwab, E. K., T. Jiang, H. F. Pena, S. M. Gennari, J. P. Dubey, and C. Su. 2016. 'The ROP18 
and ROP5 gene allele types are highly predictive of virulence in mice across globally 
distributed strains of Toxoplasma gondii', Int J Parasitol, 46: 141-6. 
Shwab, E. K., X. Q. Zhu, D. Majumdar, H. F. Pena, S. M. Gennari, J. P. Dubey, and C. Su. 2014. 
'Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus 
PCR-RFLP genotyping', Parasitology, 141: 453-61. 
Sibley, L. D. 2009. 'Development of forward genetics in Toxoplasma gondii', Int J Parasitol, 39: 
915-24. 
Sibley, L. D., and J. W. Ajioka. 2008. 'Population structure of Toxoplasma gondii: clonal 
expansion driven by infrequent recombination and selective sweeps', Annu Rev 
Microbiol, 62: 329-51. 
Sibley, L. D., and J. C. Boothroyd. 1992. 'Virulent strains of Toxoplasma gondii comprise a 
single clonal lineage', Nature, 359: 82-5. 
Sibley, L. D., A. Khan, J. W. Ajioka, and B. M. Rosenthal. 2009. 'Genetic diversity of 
Toxoplasma gondii in animals and humans', Philos Trans R Soc Lond B Biol Sci, 364: 
2749-61. 
Sibley, L. D., A. J. LeBlanc, E. R. Pfefferkorn, and J. C. Boothroyd. 1992. 'Generation of a 
restriction fragment length polymorphism linkage map for Toxoplasma gondii', Genetics, 
132: 1003-15. 
Sidik, S. M., D. Huet, S. M. Ganesan, M. H. Huynh, T. Wang, A. S. Nasamu, P. Thiru, J. P. 
Saeij, V. B. Carruthers, J. C. Niles, and S. Lourido. 2016. 'A Genome-wide CRISPR 
Screen in Toxoplasma Identifies Essential Apicomplexan Genes', Cell, 166: 1423-35 e12. 
Silva, J. C. R., F. Ferreira, R. A. Dias, D. Ajzenberg, M. F. V. Marvulo, F. J. R. Magalhaes, Cdfl 
Filho, S. Oliveira, H. S. Soares, T. F. Feitosa, J. Aizawa, L. C. Alves, R. A. Mota, J. P. 
Dubey, S. M. Gennari, and H. F. J. Pena. 2017. 'Cat-rodent Toxoplasma gondii Type II-
variant circulation and limited genetic diversity on the Island of Fernando de Noronha, 
Brazil', Parasit Vectors, 10: 220. 
Silva, L. A., R. O. Andrade, A. C. Carneiro, and R. W. Vitor. 2014. 'Overlapping Toxoplasma 
gondii genotypes circulating in domestic animals and humans in Southeastern Brazil', 
PLoS One, 9: e90237. 
Skariah, S., M. K. McIntyre, and D. G. Mordue. 2010. 'Toxoplasma gondii: determinants of 
tachyzoite to bradyzoite conversion', Parasitol Res, 107: 253-60. 
Smith, R., K. Sheppard, K. DiPetrillo, and G. Churchill. 2009. 'Quantitative trait locus analysis 
using J/qtl', Methods Mol Biol, 573: 175-88. 
 220 
Soete, M., B. Fortier, D. Camus, and J. F. Dubremetz. 1993. 'Toxoplasma gondii: kinetics of 
bradyzoite-tachyzoite interconversion in vitro', Exp Parasitol, 76: 259-64. 
Soheilian, M., M. M. Sadoughi, M. Ghajarnia, M. H. Dehghan, S. Yazdani, H. Behboudi, A. 
Anisian, and G. A. Peyman. 2005. 'Prospective randomized trial of 
trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment 
of ocular toxoplasmosis', Ophthalmology, 112: 1876-82. 
Steinfeldt, T., S. Konen-Waisman, L. Tong, N. Pawlowski, T. Lamkemeyer, L. D. Sibley, J. P. 
Hunn, and J. C. Howard. 2010. 'Phosphorylation of mouse immunity-related GTPase 
(IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii', PLoS 
Biol, 8: e1000576. 
Striepen, B., M. J. Crawford, M. K. Shaw, L. G. Tilney, F. Seeber, and D. S. Roos. 2000. 'The 
plastid of Toxoplasma gondii is divided by association with the centrosomes', Journal of 
Cell Biology, 151: 1423-34. 
Su, C., D. Evans, R. H. Cole, J. C. Kissinger, J. W. Ajioka, and L. D. Sibley. 2003. 'Recent 
expansion of Toxoplasma through enhanced oral transmission', Science, 299: 414-6. 
Su, C., D. K. Howe, J. P. Dubey, J. W. Ajioka, and L. D. Sibley. 2002. 'Identification of 
quantitative trait loci controlling acute virulence in Toxoplasma gondii', Proc Natl Acad 
Sci U S A, 99: 10753-8. 
Su, C., A. Khan, P. Zhou, D. Majumdar, D. Ajzenberg, M. L. Darde, X. Q. Zhu, J. W. Ajioka, B. 
M. Rosenthal, J. P. Dubey, and L. D. Sibley. 2012. 'Globally diverse Toxoplasma gondii 
isolates comprise six major clades originating from a small number of distinct ancestral 
lineages', Proc Natl Acad Sci U S A, 109: 5844-9. 
Su, C., X. Zhang, and J. P. Dubey. 2006. 'Genotyping of Toxoplasma gondii by multilocus PCR-
RFLP markers: a high resolution and simple method for identification of parasites', Int J 
Parasitol, 36: 841-8. 
Sun, S., R. B. Billmyre, P. A. Mieczkowski, and J. Heitman. 2014. 'Unisexual reproduction 
drives meiotic recombination and phenotypic and karyotypic plasticity in Cryptococcus 
neoformans', PLoS Genet, 10: e1004849. 
Sundar, N., R. A. Cole, N. J. Thomas, D. Majumdar, J. P. Dubey, and C. Su. 2008. 'Genetic 
diversity among sea otter isolates of Toxoplasma gondii', Vet Parasitol, 151: 125-32. 
Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. 'Interferon-gamma: the 
major mediator of resistance against Toxoplasma gondii', Science, 240: 516-8. 
Tamura, K., G. Stecher, D. Peterson, A. Filipski, and S. Kumar. 2013. 'MEGA6: Molecular 
Evolutionary Genetics Analysis version 6.0', Mol Biol Evol, 30: 2725-9. 
Taylor, S., A. Barragan, C. Su, B. Fux, S. J. Fentress, K. Tang, W. L. Beatty, H. E. Hajj, M. 
Jerome, M. S. Behnke, M. White, J. C. Wootton, and L. D. Sibley. 2006. 'A secreted 
serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma 
gondii', Science, 314: 1776-80. 
Tenter, A. M. 1995. 'Current research on Sarcocystis species of domestic animals', Int J 
Parasitol, 25: 1311-30. 
Tenter, A. M., A. R. Heckeroth, and L. M. Weiss. 2000. 'Toxoplasma gondii: from animals to 
humans', Int J Parasitol, 30: 1217-58. 
Thompson, R. C. 2013. 'Parasite zoonoses and wildlife: One Health, spillover and human 
activity', Int J Parasitol, 43: 1079-88. 
Thompson, R. C., A. J. Lymbery, and A. Smith. 2010. 'Parasites, emerging disease and wildlife 
conservation', Int J Parasitol, 40: 1163-70. 
 221 
Tibayrenc, M., and F. J. Ayala. 1991. 'Towards a population genetics of microorganisms: The 
clonal theory of parasitic protozoa', Parasitol Today, 7: 228-32. 
———. 2002. 'The clonal theory of parasitic protozoa: 12 years on', Trends Parasitol, 18: 405-
10. 
———. 2014. 'New insights into clonality and panmixia in Plasmodium and toxoplasma', Adv 
Parasitol, 84: 253-68. 
Tilley, M., M. E. Fichera, M. E. Jerome, D. S. Roos, and M. W. White. 1997. 'Toxoplasma 
gondii sporozoites form a transient parasitophorous vacuole that is impermeable and 
contains only a subset of dense-granule proteins', Infection and Immunity, 65: 4598-605. 
Tonkin, M. L., M. Roques, M. H. Lamarque, M. Pugniere, D. Douguet, J. Crawford, M. Lebrun, 
and M. J. Boulanger. 2011. 'Host Cell Invasion by Apicomplexan Parasites: Insights from 
the Co-Structure of AMA1 with a RON2 Peptide', Science, 333: 463-67. 
Torrey, E. F., and R. H. Yolken. 2013. 'Toxoplasma oocysts as a public health problem', Trends 
Parasitol, 29: 380-4. 
Trevors, J.T. 1998. 'Review: Bacterial Population Genetics', World Journal of Microbiology and 
Biotechnology, 14: 1-5. 
Trouplin, V., N. Boucherit, L. Gorvel, F. Conti, G. Mottola, and E. Ghigo. 2013. 'Bone marrow-
derived macrophage production', J Vis Exp: e50966. 
Twiddy, S. S., and E. C. Holmes. 2003. 'The extent of homologous recombination in members of 
the genus Flavivirus', J Gen Virol, 84: 429-40. 
Vaishnava, S., and B. Striepen. 2006. 'The cell biology of secondary endosymbiosis--how 
parasites build, divide and segregate the apicoplast', Mol Microbiol, 61: 1380-7. 
Van der Auwera, G. A., M. O. Carneiro, C. Hartl, R. Poplin, G. Del Angel, A. Levy-Moonshine, 
T. Jordan, K. Shakir, D. Roazen, J. Thibault, E. Banks, K. V. Garimella, D. Altshuler, S. 
Gabriel, and M. A. DePristo. 2013. 'From FastQ data to high confidence variant calls: the 
Genome Analysis Toolkit best practices pipeline', Curr Protoc Bioinformatics, 11: 11 10 
1-11 10 33. 
VanWormer, E., T. E. Carpenter, P. Singh, K. Shapiro, W. W. Wallender, P. A. Conrad, J. L. 
Largier, M. P. Maneta, and J. A. Mazet. 2016. 'Coastal development and precipitation 
drive pathogen flow from land to sea: evidence from a Toxoplasma gondii and felid host 
system', Sci Rep, 6: 29252. 
VanWormer, E., M. A. Miller, P. A. Conrad, M. E. Grigg, D. Rejmanek, T. E. Carpenter, and J. 
A. Mazet. 2014. 'Using molecular epidemiology to track Toxoplasma gondii from 
terrestrial carnivores to marine hosts: implications for public health and conservation', 
PLoS Negl Trop Dis, 8: e2852. 
Vaudaux, J. D., C. Muccioli, E. R. James, C. Silveira, S. L. Magargal, C. Jung, J. P. Dubey, J. L. 
Jones, M. Z. Doymaz, D. A. Bruckner, R. Belfort, Jr., G. N. Holland, and M. E. Grigg. 
2010. 'Identification of an atypical strain of toxoplasma gondii as the cause of a 
waterborne outbreak of toxoplasmosis in Santa Isabel do Ivai, Brazil', J Infect Dis, 202: 
1226-33. 
Verma, Ramesh, and Pardeep Khanna. 2014. 'Development of Toxoplasma gondii vaccine', Hum 
Vaccin Immunother, 9: 291-93. 
Verma, S. K., D. Ajzenberg, A. Rivera-Sanchez, C. Su, and J. P. Dubey. 2015. 'Genetic 
characterization of Toxoplasma gondii isolates from Portugal, Austria and Israel reveals 
higher genetic variability within the type II lineage', Parasitology, 142: 948-57. 
 222 
Verma, S. K., A. R. Sweeny, M. J. Lovallo, R. Calero-Bernal, O. C. Kwok, T. Jiang, C. Su, M. 
E. Grigg, and J. P. Dubey. 2017. 'Seroprevalence, isolation and co-infection of multiple 
Toxoplasma gondii strains in individual bobcats (Lynx rufus) from Mississippi, USA', Int 
J Parasitol, 47: 297-303. 
Vijaykrishna, D., G. J. Smith, O. G. Pybus, H. Zhu, S. Bhatt, L. L. Poon, S. Riley, J. Bahl, S. K. 
Ma, C. L. Cheung, R. A. Perera, H. Chen, K. F. Shortridge, R. J. Webby, R. G. Webster, 
Y. Guan, and J. S. Peiris. 2011. 'Long-term evolution and transmission dynamics of 
swine influenza A virus', Nature, 473: 519-22. 
Vitaliano, S. N., H. S. Soares, A. H. Minervino, A. L. Santos, K. Werther, M. F. Marvulo, D. B. 
Siqueira, H. F. Pena, R. M. Soares, C. Su, and S. M. Gennari. 2014. 'Genetic 
characterization of Toxoplasma gondii from Brazilian wildlife revealed abundant new 
genotypes', Int J Parasitol Parasites Wildl, 3: 276-83. 
Wakeman, K. C., M. B. Heintzelman, and B. S. Leander. 2014. 'Comparative ultrastructure and 
molecular phylogeny of Selenidium melongena n. sp. and S. terebellae Ray 1930 
demonstrate niche partitioning in marine gregarine parasites (apicomplexa)', Protist, 165: 
493-511. 
Waldeland, H., and J. K. Frenkel. 1983. 'Live and killed vaccines against toxoplasmosis in mice', 
J Parasitol, 69: 60-5. 
Walker, R. A., D. J. Ferguson, C. M. Miller, and N. C. Smith. 2013. 'Sex and Eimeria: a 
molecular perspective', Parasitology, 140: 1701-17. 
Walliker, D. 1991. 'Malaria Parasites - Randomly Interbreeding or Clonal Populations', 
Parasitology Today, 7: 232-35. 
Walzer, K. A., and J. P. Boyle. 2012. 'A single chromosome unexpectedly links highly divergent 
isolates of Toxoplasma gondii', MBio, 3. 
Wang, J. L., T. T. Li, H. M. Elsheikha, K. Chen, W. N. Zhu, D. M. Yue, X. Q. Zhu, and S. Y. 
Huang. 2017. 'Functional Characterization of Rhoptry Kinome in the Virulent 
Toxoplasma gondii RH Strain', Front Microbiol, 8: 84. 
Wang, Z. T., S. K. Verma, J. P. Dubey, and L. D. Sibley. 2017. 'The aromatic amino acid 
hydroxylase genes AAH1 and AAH2 in Toxoplasma gondii contribute to transmission in 
the cat', PLoS Pathog, 13: e1006272. 
Wardal, E., K. Markowska, D. Zabicka, M. Wroblewska, M. Giemza, E. Mik, H. Polowniak-
Pracka, A. Wozniak, W. Hryniewicz, and E. Sadowy. 2014. 'Molecular analysis of vanA 
outbreak of Enterococcus faecium in two Warsaw hospitals: the importance of mobile 
genetic elements', Biomed Res Int, 2014: 575367. 
Wasmuth, J. D., V. Pszenny, S. Haile, E. M. Jansen, A. T. Gast, A. Sher, J. P. Boyle, M. J. 
Boulanger, J. Parkinson, and M. E. Grigg. 2012. 'Integrated bioinformatic and targeted 
deletion analyses of the SRS gene superfamily identify SRS29C as a negative regulator 
of Toxoplasma virulence', MBio, 3. 
Watts, E., Y. Zhao, A. Dhara, B. Eller, A. Patwardhan, and A. P. Sinai. 2015. 'Novel Approaches 
Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and 
Replicating Entities In Vivo', MBio, 6. 
Wendte, J. M., A. K. Gibson, and M. E. Grigg. 2011. 'Population genetics of Toxoplasma gondii: 
new perspectives from parasite genotypes in wildlife', Vet Parasitol, 182: 96-111. 
Wendte, J. M., M. A. Miller, D. M. Lambourn, S. L. Magargal, D. A. Jessup, and M. E. Grigg. 
2010. 'Self-mating in the definitive host potentiates clonal outbreaks of the apicomplexan 
parasites Sarcocystis neurona and Toxoplasma gondii', PLoS Genet, 6: e1001261. 
 223 
Wendte, J. M., M. A. Miller, A. K. Nandra, S. M. Peat, P. R. Crosbie, P. A. Conrad, and M. E. 
Grigg. 2010. 'Limited genetic diversity among Sarcocystis neurona strains infecting 
southern sea otters precludes distinction between marine and terrestrial isolates', Vet 
Parasitol, 169: 37-44. 
West, S. A., T. G. Smith, and A. F. Read. 2000. 'Sex allocation and population structure in 
apicomplexan (protozoa) parasites', Proc Biol Sci, 267: 257-63. 
Wootton, J. C., X. Feng, M. T. Ferdig, R. A. Cooper, J. Mu, D. I. Baruch, A. J. Magill, and X. Z. 
Su. 2002. 'Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum', 
Nature, 418: 320-3. 
Woznica, A., A. M. Cantley, C. Beemelmanns, E. Freinkman, J. Clardy, and N. King. 2016. 
'Bacterial lipids activate, synergize, and inhibit a developmental switch in 
choanoflagellates', Proc Natl Acad Sci U S A, 113: 7894-9. 
Woznica, A., J. P. Gerdt, R. E. Hulett, J. Clardy, and N. King. 2017. 'Mating in the Closest 
Living Relatives of Animals Is Induced by a Bacterial Chondroitinase', Cell, 170: 1175-
83 e11. 
Wyrosdick, H. M., and J. J. Schaefer. 2015. 'Toxoplasma gondii: history and diagnostic test 
development', Anim Health Res Rev, 16: 150-62. 
Xiao, J., and R. H. Yolken. 2015. 'Strain hypothesis of Toxoplasma gondii infection on the 
outcome of human diseases', Acta Physiol (Oxf). 
Yamamoto, M., J. S. Ma, C. Mueller, N. Kamiyama, H. Saiga, E. Kubo, T. Kimura, T. Okamoto, 
M. Okuyama, H. Kayama, K. Nagamune, S. Takashima, Y. Matsuura, D. Soldati-Favre, 
and K. Takeda. 2011. 'ATF6beta is a host cellular target of the Toxoplasma gondii 
virulence factor ROP18', Journal of Experimental Medicine, 208: 1533-46. 
Yamamoto, M., M. Okuyama, J. S. Ma, T. Kimura, N. Kamiyama, H. Saiga, J. Ohshima, M. 
Sasai, H. Kayama, T. Okamoto, D. C. Huang, D. Soldati-Favre, K. Horie, J. Takeda, and 
K. Takeda. 2012. 'A cluster of interferon-gamma-inducible p65 GTPases plays a critical 
role in host defense against Toxoplasma gondii', Immunity, 37: 302-13. 
Yan, C., L. J. Liang, K. Y. Zheng, and X. Q. Zhu. 2016. 'Impact of environmental factors on the 
emergence, transmission and distribution of Toxoplasma gondii', Parasit Vectors, 9: 137. 
Yang, C. S., J. M. Yuk, Y. H. Lee, and E. K. Jo. 2015. 'Toxoplasma gondii GRA7-Induced 
TRAF6 Activation Contributes to Host Protective Immunity', Infection and Immunity, 84: 
339-50. 
Yang, N. H., A. Farrell, W. Niedelman, M. Melo, D. N. Lu, L. Julien, G. T. Marth, M. J. 
Gubbels, and J. P. J. Saeij. 2013. 'Genetic basis for phenotypic differences between 
different Toxoplasma gondii type I strains', Bmc Genomics, 14. 
Yarovinsky, F., D. Zhang, J. F. Andersen, G. L. Bannenberg, C. N. Serhan, M. S. Hayden, S. 
Hieny, F. S. Sutterwala, R. A. Flavell, S. Ghosh, and A. Sher. 2005. 'TLR11 activation of 
dendritic cells by a protozoan profilin-like protein', Science, 308: 1626-9. 
Yera, H., D. Ajzenberg, F. Lesle, D. Eyrolle-Guignot, M. Besnard, A. Baud, A. Georges, J. 
Dupouy-Camet, and M. L. Darde. 2014. 'New description of Toxoplasma gondii 
genotypes from French Polynesia', Acta Trop, 134: 10-2. 
Yin, T., D. Cook, and M. Lawrence. 2012. 'ggbio: an R package for extending the grammar of 
graphics for genomic data', Genome Biol, 13: R77. 
Zhang, J., A. Khan, A. Kennard, M. E. Grigg, and J. Parkinson. 2017. 'PopNet: A Markov 
Clustering Approach to Study Population Genetic Structure', Mol Biol Evol. 
 224 
Zhang, K., G. Lin, Y. Han, and J. Li. 2016. 'Serological diagnosis of toxoplasmosis and 
standardization', Clin Chim Acta, 461: 83-9. 
Zhang, N. Z., M. Wang, Y. Xu, E. Petersen, and X. Q. Zhu. 2015. 'Recent advances in 
developing vaccines against Toxoplasma gondii: an update', Expert Rev Vaccines, 14: 
1609-21. 
Zhang, N. Z., Y. Xu, S. Y. Huang, D. H. Zhou, R. A. Wang, and X. Q. Zhu. 2014. 'Sequence 
variation in Toxoplasma gondii rop17 gene among strains from different hosts and 
geographical locations', ScientificWorldJournal, 2014: 349325. 
Zhao, Y., and G. S. Yap. 2014. 'Toxoplasma's arms race with the host interferon response: a 
menage a trois of ROPs', Cell Host Microbe, 15: 517-8. 
Zhou, P., H. Zhang, R. Q. Lin, D. L. Zhang, H. Q. Song, C. Su, and X. Q. Zhu. 2009. 'Genetic 












2011-2017 PhD Candidate, Cell, Molecular, Developmental Biology, and Biophysics, Johns 
Hopkins University, Baltimore, MD 
 Advisor: Dr. Mike E. Grigg 
 
2009 B.A., Molecular, Cellular, and Developmental Biology, The University of Colorado, 
Boulder, CO 




2011-Present Ph.D. Candidate, Program in Cell, Molecular, Developmental Biology, and Biophysics, 
Johns Hopkins University-National Institutes of Health. The Role of Sexual 
Recombination in the Evolution of the Protozoan Parasite, Toxoplasma gondii. 
 
2009-2011 Research Assistant, University of Maryland Baltimore, Microbial Pathogenesis 
Department, Baltimore, MD.  Cloning and characterization of polymorphic outer 
membrane protein expression and clinical sample isolation in Chlamydia. 
 
Fall 2007 Student Researcher, University of Colorado Python Project Laboratory, Boulder, CO.  
Characterization of the python UCP-2 gene within cardiac hypertrophy. 
 
 
FELLOWSHIPS AND AWARDS 
 
2011- Present NIH Intramural Research Training Award (IRTA) Fellowship 
2009 Phi Beta Kappa Honor Society Acceptance 




1. Kennard, A., Khan, A., Miller, M.A., James, E.R., Miller, N., Roos, D.R., Keeling, P., 
Conrad, P.A., Grigg, M.E. (2018) Virulence Shift in a Sexual Clade of Type X 
Toxoplasma Infecting Southern Sea Otters. In Progress. 
2. Zhang, J., Khan, A., Kennard A., Grigg, M.E., Parkinson, J. PopNet: A Markov 
Clustering Approach to Study Population Structure. (2017) Molecular Biology and 
Evolution 34,1799-1811.  
 226 
3. Chudnovskiy, A., A. Mortha, V. Kana, A. Kennard, A. Rahman, R. Remark, I. Mogno, 
R. Ng, S. Gnjatic, A. Solovyov, B. Greenbaum, J. Clemente, J. Faith, Y. Belkaid, M.E. 
Grigg, M. Merad. Host-protozoan interactions shape mucosal immunity and protect 
from bacterial infections through activation of the inflammasome. (2016) Cell, Vol 167, 
Issue 2, 444-456. 
4. Pszenny, V., Ehrenman, K., Romano, J.D., Kennard, A., Schultz, A., Roos, D.S., 
Grigg, M.E., Carruthers, V.B., Coppens, I. A Lipolytic Lecithin: Cholesterol 
Acyltransferase Secreted by Toxoplasma Facilitates Parasite Replication and Egress. 
(2016) J Biol Chem 291, 3725-3746.  
 
MEETINGS AND PRESENTATIONS 
 
2017  CIFAR Integrated Microbial Diversity Program Meeting, Whistler, BC, Canada, June 
7. Poster Presentation, “Cryptic Virulence Among Type X Toxoplasma: A 
Recombinant Clade Infecting North American Wildlife.” 
 
2016  NIH Graduate Student Research Symposium, Bethesda, MD, January 12. Poster 
Presentation, “Cryptic Virulence Among Type X Toxoplasma: A Recombinant Clade 
Infecting North American Wildlife.” 
 
2015   International Congress on Toxoplasmosis & Toxoplasma gondii Biology, Gettysburg, 
PA, June 19. Poster Presentation, “Cryptic Virulence Among Type X Toxoplasma: A 
Recombinant Clade Infecting North American Wildlife.” 
 
2015  NIH Graduate Student Research Symposium, Bethesda, MD, January 13. Poster 
Presentation, “Sex Happens: Evidence of Recombination within a Clade of Toxoplasma 
gondii.” 
 
2014  NIH Graduate Student Research Symposium, Bethesda, MD, January 14. Poster 
Presentation, “Genetic Basis for Host Range Expansion of the Cosmopolitan Parasite 
Toxoplasma gondii.” 
 
2013  NIH Graduate Student Research Symposium, Bethesda, MD, January 15. Poster 
Presentation, “Genetic Basis for Host Range Expansion of the Cosmopolitan Parasite 
Toxoplasma gondii.” 
 
2011  Chlamydia Basic Research Society Conference, Redondo Beach, CA, March 18.  
Attendee, Poster Presented, “Expression of the polymorphic membrane protein gene 





Spring 2015 Lecturer, Research Tools for Studying Disease (~30 students) 
Fall 2014 Scientists Teaching Science Lecturer Course 
Spring 2012 Teaching Assistant, Cellular Biology Laboratory (~20 students) 





Summer 2017 Student Mentor, Bnos Yisroel High School Bridge Program – Sara 
Verschleisser – Epstein-Barr Virus Deregulation of MYC and BCL2L11 








2017 Lead Poster Judge, NIH Post baccalaureate Poster Day, May 4 
2016 Lead Poster Judge, NIH Post baccalaureate Poster Day, April 20 
2015 Poster Judge, NIH Post baccalaureate Poster Day, April 30 
2013-2014 STEM Learning Studios Teaching Outreach with National Commission on 




2017 Integrated Microbial Biodiversity Trainee Workshop 
2016 NIH OITE Translational Science Training Program Bootcamp 
Fall 2014 Scientists Teaching Science Lecturer Course 
Spring 2014 Introduction to Python – NIH  
Fall 2013 Practical Bioinformatics Class – NIH 
Fall 2013  Making Figures in R  
 
 
